{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "84cd6bf6",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import transformers\n",
    "import torch\n",
    "from haystack.document_stores import ElasticsearchDocumentStore\n",
    "from haystack.nodes import BM25Retriever, TfidfRetriever, FilterRetriever, DensePassageRetriever\n",
    "from haystack.nodes import FARMReader\n",
    "from haystack.pipelines import ExtractiveQAPipeline\n",
    "from haystack.utils import print_answers\n",
    "from docx import Document"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "19aa27c3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "importing Jupyter notebook from Load_and_Print.ipynb\n"
     ]
    }
   ],
   "source": [
    "import import_ipynb\n",
    "from Load_and_Print import read_qas, print_result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "15932953",
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_test_data(file):\n",
    "    with open(file) as jfile:\n",
    "        data = json.load(jfile) \n",
    "        samples = []\n",
    "    for i in range (0,10):\n",
    "        contract = \"\".join(data[\"data\"][i][\"paragraphs\"][0][\"context\"].split(\"\\n\"))\n",
    "        samples.append(contract)\n",
    "    return samples"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "3f2b9da6",
   "metadata": {},
   "outputs": [],
   "source": [
    "def read_qas(file):\n",
    "    qas_doc = Document(file)\n",
    "    questions = []\n",
    "    for para in qas_doc.paragraphs:\n",
    "        question = {}\n",
    "        k, v = para.text.split(\":\", 1)\n",
    "        question[k.strip()] = v.strip()\n",
    "        questions.append(question)\n",
    "    return questions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "dcbffd9b",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test_model1(qs, c):\n",
    "    model = transformers.AutoModelForQuestionAnswering.from_pretrained(\"akdeniz27/roberta-large-cuad\")\n",
    "    tokenizer = transformers.AutoTokenizer.from_pretrained(\"akdeniz27/roberta-large-cuad\")\n",
    "    qa = transformers.pipeline(\"question-answering\", model=model, tokenizer=tokenizer)\n",
    "    ans = []\n",
    "    for j in range(0, len(qs)):\n",
    "        print (f\"qs{j+1}\")\n",
    "        querry = list(qs[j].values())[0]\n",
    "        res = qa({\n",
    "        \"question\": querry,\n",
    "        \"context\": c\n",
    "        })\n",
    "        print(res)\n",
    "        ans.append(res)\n",
    "    return ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "6bb12fd2",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test_model2(qs, c):\n",
    "    model = transformers.AutoModelForQuestionAnswering.from_pretrained(\"Rakib/roberta-base-on-cuad\")\n",
    "    tokenizer = transformers.AutoTokenizer.from_pretrained(\"Rakib/roberta-base-on-cuad\")\n",
    "    qa = transformers.pipeline('question-answering', model=model, tokenizer=tokenizer)\n",
    "    ans = []\n",
    "    for j in range(0, len(qs)):\n",
    "        print (f\"qs{j+1}\")\n",
    "        querry = list(qs[j].values())[0]\n",
    "        res = qa({\n",
    "        \"question\": querry,\n",
    "        \"context\": c\n",
    "        })\n",
    "        print(res)\n",
    "        ans.append(res)\n",
    "    return ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "c271e7c8",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test_model3(qs, c, doc_store):\n",
    "    retriever = BM25Retriever(doc_store) \n",
    "    reader = FARMReader(model_name_or_path='Rakib/roberta-base-on-cuad',\n",
    "                        context_window_size=1500,\n",
    "                        use_gpu=True)\n",
    "    qa = ExtractiveQAPipeline(reader=reader, retriever=retriever)\n",
    "    ans = []\n",
    "    for j in range(0, len(qs)):\n",
    "        print (f\"qs{j+1}\")\n",
    "        query = list(qs[j].values())[0]\n",
    "        res = qa.run(\n",
    "            query=query, params={\"Reader\": {\"top_k\": 1},\"Retriever\": {\"top_k\": 1}}\n",
    "        )\n",
    "        print_answers(res, details = \"minimum\")\n",
    "        ans.append(res)\n",
    "    return ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "220b1a40",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test_model4(qs, c, doc_store):\n",
    "    retriever = BM25Retriever(doc_store)\n",
    "    reader = FARMReader(model_name_or_path='akdeniz27/roberta-large-cuad',\n",
    "                        \n",
    "                        context_window_size=1500,\n",
    "                        use_gpu=True)\n",
    "    qa = ExtractiveQAPipeline(reader=reader, retriever=retriever)\n",
    "    ans = []\n",
    "    for j in range(0, len(qs)):\n",
    "        print (f\"qs{j+1}\")\n",
    "        query = list(qs[j].values())[0]\n",
    "        res = qa.run(\n",
    "            query=query, params={\"Reader\": {\"top_k\": 1},\"Retriever\": {\"top_k\": 1}}\n",
    "        )\n",
    "        print_answers(res, details = \"minimum\")\n",
    "        ans.append(res)\n",
    "    return ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "bae35b58",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test_model5(qs, c, doc_store):\n",
    "    retriever = TfidfRetriever(doc_store) \n",
    "    reader = FARMReader(model_name_or_path='Rakib/roberta-base-on-cuad',\n",
    "                        context_window_size=1500,\n",
    "                        use_gpu=True)\n",
    "    qa = ExtractiveQAPipeline(reader=reader, retriever=retriever)\n",
    "    ans = []\n",
    "    for j in range(0, len(qs)):\n",
    "        print (f\"qs{j+1}\")\n",
    "        query = list(qs[j].values())[0]\n",
    "        res = qa.run(\n",
    "            query=query, params={\"Reader\": {\"top_k\": 1},\"Retriever\": {\"top_k\": 1}}\n",
    "        )\n",
    "        print_answers(res, details = \"minimum\")\n",
    "        ans.append(res)\n",
    "    return ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "a5409bdf",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test_model6(qs, c, doc_store):\n",
    "    retriever = FilterRetriever(doc_store) \n",
    "    reader = FARMReader(model_name_or_path='Rakib/roberta-base-on-cuad',\n",
    "                        context_window_size=1500,\n",
    "                        use_gpu=True)\n",
    "    qa = ExtractiveQAPipeline(reader=reader, retriever=retriever)\n",
    "    ans = []\n",
    "    for j in range(0, len(qs)):\n",
    "        print (f\"qs{j+1}\")\n",
    "        query = list(qs[j].values())[0]\n",
    "        res = qa.run(\n",
    "            query=query, params={\"Reader\": {\"top_k\": 1},\"Retriever\": {\"top_k\": 1}}\n",
    "        )\n",
    "        print_answers(res, details = \"minimum\")\n",
    "        ans.append(res)\n",
    "    return ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "31d5fe92",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test_model7(qs, c, doc_store):\n",
    "    retriever = BM25Retriever(doc_store) \n",
    "    reader = FARMReader(model_name_or_path='deepset/bert-base-cased-squad2',\n",
    "                        context_window_size=1500,\n",
    "                        use_gpu=True)\n",
    "    qa = ExtractiveQAPipeline(reader=reader, retriever=retriever)\n",
    "    ans = []\n",
    "    for j in range(0, len(qs)):\n",
    "        print (f\"qs{j+1}\")\n",
    "        query = list(qs[j].values())[0]\n",
    "        res = qa.run(\n",
    "            query=query, params={\"Reader\": {\"top_k\": 1},\"Retriever\": {\"top_k\": 1}}\n",
    "        )\n",
    "        print_answers(res, details = \"minimum\")\n",
    "        ans.append(res)\n",
    "    return ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "76c77c1f",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test_model8(qs, c, doc_store):\n",
    "    retriever = DensePassageRetriever(\n",
    "        document_store=doc_store,\n",
    "        query_embedding_model=\"facebook/dpr-question_encoder-single-nq-base\",\n",
    "        passage_embedding_model=\"facebook/dpr-ctx_encoder-single-nq-base\",\n",
    "        use_gpu=True, embed_title=True)\n",
    "    doc_store.update_embeddings(retriever=retriever)\n",
    "    retriever = BM25Retriever(doc_store) \n",
    "    reader = FARMReader(model_name_or_path='Rakib/roberta-base-on-cuad',\n",
    "                        context_window_size=1500,\n",
    "                        use_gpu=True)\n",
    "    qa = ExtractiveQAPipeline(reader=reader, retriever=retriever)\n",
    "    ans = []\n",
    "    for j in range(0, len(qs)):\n",
    "        print (f\"qs{j+1}\")\n",
    "        query = list(qs[j].values())[0]\n",
    "        res = qa.run(\n",
    "            query=query, params={\"Reader\": {\"top_k\": 1},\"Retriever\": {\"top_k\": 1}}\n",
    "        )\n",
    "        print_answers(res, details = \"minimum\")\n",
    "        ans.append(res)\n",
    "    return res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "bd78fc78",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "def set_doc_store(c, i):\n",
    "    doc_store = ElasticsearchDocumentStore(\n",
    "        host='localhost',\n",
    "        username='elastic', password='hrAezzG2su2WPqvOu8J9',\n",
    "        index= str(i)\n",
    "    )\n",
    "    data_json = [\n",
    "    {\n",
    "        'content':c,\n",
    "        'meta':{\n",
    "            'source': f\"contract {str(i)}\"\n",
    "            }\n",
    "        }\n",
    "    ]\n",
    "    doc_store.write_documents(data_json, index = str(i))\n",
    "    return doc_store"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "e31e2020",
   "metadata": {},
   "outputs": [],
   "source": [
    "qas = read_qas(\"./Questions.docx\")\n",
    "samples = load_test_data(\"./test.json\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "bdf54c3a",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test1():\n",
    "    print(\"Model1 Result\")\n",
    "    for i in range(0, 5):\n",
    "        context = samples[i]\n",
    "        print(f\"contract{i+1}\")\n",
    "        test_model1(qas, context)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "dd982413",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "def test2():\n",
    "    print(\"Model2 Result\")\n",
    "    for i in range(0,5):\n",
    "        context = samples[i]\n",
    "        print(f\"contract{i+1}\")\n",
    "        test_model2(qas, context)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "90f84a41",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "def test3():\n",
    "    print(\"Model3 Result\")\n",
    "    for i in range(0, 5):\n",
    "        context = samples[i]\n",
    "        print(f\"contract{i+1}\")\n",
    "        doc_store = set_doc_store(context, i+20)\n",
    "        test_model3(qas, context, doc_store)\n",
    "        doc_store.delete_index(str(i+20))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "5918a6aa",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "def test4():\n",
    "    print(\"Model4 Result\")\n",
    "    for i in range(0, 5):\n",
    "        context = samples[i]\n",
    "        print(f\"contract{i+1}\")\n",
    "        doc_store = set_doc_store(context, i+30)\n",
    "        test_model4(qas, context, doc_store)\n",
    "        doc_store.delete_index(str(i+30))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "84531dc0",
   "metadata": {},
   "outputs": [],
   "source": [
    " def test5():\n",
    "    print(\"Model5 Result\")\n",
    "    for i in range(0, 5):\n",
    "        context = samples[i]\n",
    "        print(f\"contract{i+1}\")\n",
    "        doc_store = set_doc_store(context, i+40)\n",
    "        test_model5(qas, context, doc_store)\n",
    "        doc_store.delete_index(str(i+40))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "265fc945",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "def test6():    \n",
    "    print(\"Model6 Result\")\n",
    "    for i in range(0, 5):\n",
    "        context = samples[i]\n",
    "        print(f\"contract{i+1}\")\n",
    "        doc_store = set_doc_store(context, i+50)\n",
    "        test_model6(qas, context, doc_store)\n",
    "        doc_store.delete_index(str(i+50))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "aff1cc49",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test7():\n",
    "    print(\"Model7 Result\")\n",
    "    for i in range(0, 5):\n",
    "        context = samples[i]\n",
    "        print(f\"contract{i+1}\")\n",
    "        doc_store = set_doc_store(context, i+60)\n",
    "        test_model7(qas, context, doc_store)\n",
    "        doc_store.delete_index(str(i+60))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "718a398d",
   "metadata": {},
   "outputs": [],
   "source": [
    "def test8():\n",
    "    print(\"Model8 Result\")\n",
    "    for i in range(0, 5):\n",
    "        context = samples[i]\n",
    "        print(f\"contract{i+1}\")\n",
    "        doc_store = set_doc_store(context, i+70)\n",
    "        test_model8(qas, context, doc_store)\n",
    "        doc_store.delete_index(str(i+70))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "255662ea",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model1 Result\n",
      "contract1\n",
      "qs1\n",
      "{'score': 0.7985469698905945, 'start': 14, 'end': 29, 'answer': 'SUPPLY CONTRACT'}\n",
      "qs2\n",
      "{'score': 0.32828816771507263, 'start': 69, 'end': 117, 'answer': 'Shenzhen LOHAS Supply Chain Management Co., Ltd.'}\n",
      "qs3\n",
      "{'score': 0.0012087380746379495, 'start': 69, 'end': 117, 'answer': 'Shenzhen LOHAS Supply Chain Management Co., Ltd.'}\n",
      "qs4\n",
      "{'score': 0.8674935698509216, 'start': 11279, 'end': 11339, 'answer': 'The Contract becomes effective after signed by both parties.'}\n",
      "qs5\n",
      "{'score': 0.5755215287208557, 'start': 10935, 'end': 10999, 'answer': 'The Contract is valid for 5 years, beginning from and ended on .'}\n",
      "qs6\n",
      "{'score': 0.07491620630025864, 'start': 10935, 'end': 10997, 'answer': 'The Contract is valid for 5 years, beginning from and ended on'}\n",
      "qs7\n",
      "{'score': 8.360096614978829e-08, 'start': 10935, 'end': 10997, 'answer': 'The Contract is valid for 5 years, beginning from and ended on'}\n",
      "qs8\n",
      "{'score': 0.00010890018893405795, 'start': 10808, 'end': 10809, 'answer': '.'}\n",
      "qs9\n",
      "{'score': 0.0021954739931970835, 'start': 8649, 'end': 8651, 'answer': 'In'}\n",
      "qs10\n",
      "{'score': 4.13324094949985e-08, 'start': 6935, 'end': 6945, 'answer': 'Inspection'}\n",
      "qs11\n",
      "{'score': 0.0019773836247622967, 'start': 9109, 'end': 9112, 'answer': 'The'}\n",
      "qs12\n",
      "{'score': 0.0047455416060984135, 'start': 7716, 'end': 7718, 'answer': 'If'}\n",
      "qs13\n",
      "{'score': 0.0804082453250885, 'start': 4957, 'end': 4991, 'answer': '(5) One copy of insurance coverage'}\n",
      "contract2\n",
      "qs1\n",
      "{'score': 0.6139049530029297, 'start': 219, 'end': 245, 'answer': 'WEB SITE HOSTING AGREEMENT'}\n",
      "qs2\n",
      "{'score': 0.2207687646150589, 'start': 14717, 'end': 14745, 'answer': 'CENTRACK INTERNATIONAL, INC.'}\n",
      "qs3\n",
      "{'score': 0.9707309603691101, 'start': 286, 'end': 308, 'answer': '6th day of April, 1999'}\n",
      "qs4\n",
      "{'score': 0.994920551776886, 'start': 286, 'end': 308, 'answer': '6th day of April, 1999'}\n",
      "qs5\n",
      "{'score': 0.002181447809562087, 'start': 4839, 'end': 4853, 'answer': 'April 1, 1999.'}\n",
      "qs6\n",
      "{'score': 2.589412542874925e-05, 'start': 10650, 'end': 10653, 'answer': 'the'}\n",
      "qs7\n",
      "{'score': 0.0007184434798546135, 'start': 10465, 'end': 10469, 'answer': 'This'}\n",
      "qs8\n",
      "{'score': 0.00010161995305679739, 'start': 14257, 'end': 14258, 'answer': '.'}\n",
      "qs9\n",
      "{'score': 9.394220978720114e-05, 'start': 10897, 'end': 10898, 'answer': '.'}\n",
      "qs10\n",
      "{'score': 0.00012282248644623905, 'start': 4394, 'end': 4444, 'answer': 'consultation on site operation and administration.'}\n",
      "qs11\n",
      "{'score': 0.00010399042366771027, 'start': 11590, 'end': 11591, 'answer': '.'}\n",
      "qs12\n",
      "{'score': 4.5445784053299576e-05, 'start': 5857, 'end': 5859, 'answer': 'In'}\n",
      "qs13\n",
      "{'score': 5.1940133971584146e-08, 'start': 10655, 'end': 10664, 'answer': 'Agreement'}\n",
      "contract3\n",
      "qs1\n",
      "{'score': 0.9920164346694946, 'start': 90, 'end': 114, 'answer': 'CO-PROMOTION AGREEMENTby'}\n",
      "qs2\n",
      "{'score': 0.35091692209243774, 'start': 156779, 'end': 156800, 'answer': 'Salix Pharmaceuticals'}\n",
      "qs3\n",
      "{'score': 0.9975609183311462, 'start': 193, 'end': 214, 'answer': 'LLCSeptember 26, 2018'}\n",
      "qs4\n",
      "{'score': 0.9976988434791565, 'start': 4665, 'end': 4683, 'answer': 'September 26, 2018'}\n",
      "qs5\n",
      "{'score': 0.0011752203572541475, 'start': 9809, 'end': 9827, 'answer': '\"Calendar Quarter\"'}\n",
      "qs6\n",
      "{'score': 0.00016147484711837023, 'start': 137182, 'end': 137183, 'answer': 'A'}\n",
      "qs7\n",
      "{'score': 0.0006491319509223104, 'start': 137182, 'end': 137183, 'answer': 'A'}\n",
      "qs8\n",
      "{'score': 0.0003763403801713139, 'start': 86218, 'end': 86233, 'answer': 'Applicable Law.'}\n",
      "qs9\n",
      "{'score': 0.01762498915195465, 'start': 137182, 'end': 137245, 'answer': 'A Party shall have the right to terminate this Agreement before'}\n",
      "qs10\n",
      "{'score': 0.018920648843050003, 'start': 101883, 'end': 101890, 'answer': 'Valeant'}\n",
      "qs11\n",
      "{'score': 0.03551631420850754, 'start': 136695, 'end': 136698, 'answer': 'For'}\n",
      "qs12\n",
      "{'score': 0.0014128100592643023, 'start': 84277, 'end': 84279, 'answer': 'If'}\n",
      "qs13\n",
      "{'score': 0.2015908807516098, 'start': 135991, 'end': 136001, 'answer': 'Insurance.'}\n",
      "contract4\n",
      "qs1\n",
      "{'score': 0.5106802582740784, 'start': 16114, 'end': 16130, 'answer': 'Supply Agreement'}\n",
      "qs2\n",
      "{'score': 0.8875135183334351, 'start': 921, 'end': 924, 'answer': 'EKR'}\n",
      "qs3\n",
      "{'score': 0.984517514705658, 'start': 144, 'end': 160, 'answer': 'OCTOBER 15, 2009'}\n",
      "qs4\n",
      "{'score': 0.9351329803466797, 'start': 131521, 'end': 131534, 'answer': 'July 25, 2007'}\n",
      "qs5\n",
      "{'score': 0.8960912823677063, 'start': 7403, 'end': 7450, 'answer': '[**];\"Effective Date\"   Means August 10, 2007;\"'}\n",
      "qs6\n",
      "{'score': 0.003333511995151639, 'start': 71968, 'end': 71971, 'answer': 'All'}\n",
      "qs7\n",
      "{'score': 0.002168105449527502, 'start': 32812, 'end': 32814, 'answer': 'At'}\n",
      "qs8\n",
      "{'score': 0.004224696196615696, 'start': 142827, 'end': 142831, 'answer': 'This'}\n",
      "qs9\n",
      "{'score': 0.050158388912677765, 'start': 32261, 'end': 32263, 'answer': 'At'}\n",
      "qs10\n",
      "{'score': 0.06522710621356964, 'start': 64480, 'end': 64517, 'answer': 'and books referred to in Section 7.2.'}\n",
      "qs11\n",
      "{'score': 0.009872728027403355, 'start': 82157, 'end': 82161, 'answer': 'Each'}\n",
      "qs12\n",
      "{'score': 0.035513393580913544, 'start': 34633, 'end': 34666, 'answer': 'During the Lease Term, PPI shall:'}\n",
      "qs13\n",
      "{'score': 0.12266474217176437, 'start': 34633, 'end': 34666, 'answer': 'During the Lease Term, PPI shall:'}\n",
      "contract5\n",
      "qs1\n",
      "{'score': 0.9031371474266052, 'start': 4128, 'end': 4139, 'answer': 'ENDORSEMENT'}\n",
      "qs2\n",
      "{'score': 0.6812475919723511, 'start': 4260, 'end': 4291, 'answer': 'Thrivent Life Insurance Company'}\n",
      "qs3\n",
      "{'score': 0.9892809987068176, 'start': 55, 'end': 67, 'answer': 'July 1, 2019'}\n",
      "qs4\n",
      "{'score': 0.9028949737548828, 'start': 55, 'end': 67, 'answer': 'July 1, 2019'}\n",
      "qs5\n",
      "{'score': 0.01307819876819849, 'start': 55, 'end': 67, 'answer': 'July 1, 2019'}\n",
      "qs6\n",
      "{'score': 1.4314863960862567e-08, 'start': 55, 'end': 118, 'answer': 'July 1, 2019Thrivent Life Insurance Company has been dissolved.'}\n",
      "qs7\n",
      "{'score': 9.842247905567092e-09, 'start': 55, 'end': 118, 'answer': 'July 1, 2019Thrivent Life Insurance Company has been dissolved.'}\n",
      "qs8\n",
      "{'score': 4.695314137492801e-10, 'start': 28, 'end': 48, 'answer': 'ENDORSEMENTEffective'}\n",
      "qs9\n",
      "{'score': 6.068603397579864e-09, 'start': 55, 'end': 118, 'answer': 'July 1, 2019Thrivent Life Insurance Company has been dissolved.'}\n",
      "qs10\n",
      "{'score': 6.589682965962851e-11, 'start': 55, 'end': 118, 'answer': 'July 1, 2019Thrivent Life Insurance Company has been dissolved.'}\n",
      "qs11\n",
      "{'score': 2.6374558093067435e-10, 'start': 1110, 'end': 1187, 'answer': 'This provision applies only to benefits provided through the General Account.'}\n",
      "qs12\n",
      "{'score': 1.9135214301968517e-08, 'start': 1744, 'end': 1745, 'answer': '.'}\n",
      "qs13\n",
      "{'score': 0.21299657225608826, 'start': 67, 'end': 118, 'answer': 'Thrivent Life Insurance Company has been dissolved.'}\n"
     ]
    }
   ],
   "source": [
    "if __name__ == '__main__':\n",
    "    test1()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "aa0e7422",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model2 Result\n",
      "contract1\n",
      "qs1\n",
      "{'score': 0.3929581940174103, 'start': 14, 'end': 29, 'answer': 'SUPPLY CONTRACT'}\n",
      "qs2\n",
      "{'score': 0.04707128554582596, 'start': 1037, 'end': 1064, 'answer': 'YICHANGTAI\" or \"LEHEYUAN\"),'}\n",
      "qs3\n",
      "{'score': 0.09759918600320816, 'start': 10935, 'end': 10999, 'answer': 'The Contract is valid for 5 years, beginning from and ended on .'}\n",
      "qs4\n",
      "{'score': 0.3961285948753357, 'start': 11279, 'end': 11339, 'answer': 'The Contract becomes effective after signed by both parties.'}\n",
      "qs5\n",
      "{'score': 0.9683458805084229, 'start': 10935, 'end': 10999, 'answer': 'The Contract is valid for 5 years, beginning from and ended on .'}\n",
      "qs6\n",
      "{'score': 0.0008004933479242027, 'start': 831, 'end': 874, 'answer': 'During the validity term of this agreement,'}\n",
      "qs7\n",
      "{'score': 0.0323307067155838, 'start': 10935, 'end': 10999, 'answer': 'The Contract is valid for 5 years, beginning from and ended on .'}\n",
      "qs8\n",
      "{'score': 0.0057416339404881, 'start': 10641, 'end': 10707, 'answer': \"It will be governed by the law of the People's Republic of China ,\"}\n",
      "qs9\n",
      "{'score': 0.000848159717861563, 'start': 8649, 'end': 8651, 'answer': 'In'}\n",
      "qs10\n",
      "{'score': 0.015280717983841896, 'start': 1161, 'end': 1240, 'answer': 'The seller shall be confirmed within three working days after receipt of order.'}\n",
      "qs11\n",
      "{'score': 0.0014886001590639353, 'start': 10397, 'end': 10448, 'answer': 'Arbitration fee shall be borne by the losing party.'}\n",
      "qs12\n",
      "{'score': 0.8061238527297974, 'start': 1161, 'end': 1240, 'answer': 'The seller shall be confirmed within three working days after receipt of order.'}\n",
      "qs13\n",
      "{'score': 0.049616631120443344, 'start': 4957, 'end': 4991, 'answer': '(5) One copy of insurance coverage'}\n",
      "contract2\n",
      "qs1\n",
      "{'score': 0.33296605944633484, 'start': 219, 'end': 245, 'answer': 'WEB SITE HOSTING AGREEMENT'}\n",
      "qs2\n",
      "{'score': 0.17899468541145325, 'start': 392, 'end': 396, 'answer': 'i-on'}\n",
      "qs3\n",
      "{'score': 0.9651941657066345, 'start': 286, 'end': 308, 'answer': '6th day of April, 1999'}\n",
      "qs4\n",
      "{'score': 0.9821634888648987, 'start': 286, 'end': 308, 'answer': '6th day of April, 1999'}\n",
      "qs5\n",
      "{'score': 0.0014985727611929178, 'start': 286, 'end': 308, 'answer': '6th day of April, 1999'}\n",
      "qs6\n",
      "{'score': 0.0002641064638737589, 'start': 10465, 'end': 10469, 'answer': 'This'}\n",
      "qs7\n",
      "{'score': 0.00019185619021300226, 'start': 10465, 'end': 10469, 'answer': 'This'}\n",
      "qs8\n",
      "{'score': 0.0020418844651430845, 'start': 13971, 'end': 14027, 'answer': 'This Agreement was entered into in the State of Florida,'}\n",
      "qs9\n",
      "{'score': 0.00023236939159687608, 'start': 10850, 'end': 10898, 'answer': \"effective upon thirty (30) days' written notice.\"}\n",
      "qs10\n",
      "{'score': 2.2591204469790682e-05, 'start': 2450, 'end': 2451, 'answer': ';'}\n",
      "qs11\n",
      "{'score': 0.0006514769629575312, 'start': 3772, 'end': 3774, 'answer': 'up'}\n",
      "qs12\n",
      "{'score': 0.00021855228987988085, 'start': 4839, 'end': 4853, 'answer': 'April 1, 1999.'}\n",
      "qs13\n",
      "{'score': 8.305337360070553e-07, 'start': 10897, 'end': 10898, 'answer': '.'}\n",
      "contract3\n",
      "qs1\n",
      "{'score': 0.84346604347229, 'start': 861, 'end': 885, 'answer': 'JOINT STEERING COMMITTEE'}\n",
      "qs2\n",
      "{'score': 0.3339616060256958, 'start': 156779, 'end': 156800, 'answer': 'Salix Pharmaceuticals'}\n",
      "qs3\n",
      "{'score': 0.9827240109443665, 'start': 4665, 'end': 4683, 'answer': 'September 26, 2018'}\n",
      "qs4\n",
      "{'score': 0.991005003452301, 'start': 4665, 'end': 4683, 'answer': 'September 26, 2018'}\n",
      "qs5\n",
      "{'score': 0.00025475595612078905, 'start': 25945, 'end': 25946, 'answer': '\"'}\n",
      "qs6\n",
      "{'score': 0.006991188507527113, 'start': 4591, 'end': 4613, 'answer': 'Co-Promotion Agreement'}\n",
      "qs7\n",
      "{'score': 0.0008147936896421015, 'start': 148408, 'end': 148459, 'answer': 'Any such notice shall be deemed to have been given:'}\n",
      "qs8\n",
      "{'score': 0.16604021191596985, 'start': 124299, 'end': 124369, 'answer': 'Valeant represents and warrants to Dova as of the Effective Date that:'}\n",
      "qs9\n",
      "{'score': 0.0018530043307691813, 'start': 148408, 'end': 148459, 'answer': 'Any such notice shall be deemed to have been given:'}\n",
      "qs10\n",
      "{'score': 0.006896701641380787, 'start': 103096, 'end': 103180, 'answer': 'Dova shall reasonably cooperate in any such inspection or audit conducted by Valeant'}\n",
      "qs11\n",
      "{'score': 0.0006363847642205656, 'start': 136695, 'end': 136698, 'answer': 'For'}\n",
      "qs12\n",
      "{'score': 0.006329324562102556, 'start': 81960, 'end': 81998, 'answer': 'event later than [***] after receipt).'}\n",
      "qs13\n",
      "{'score': 0.0013639361131936312, 'start': 69586, 'end': 69593, 'answer': 'Valeant'}\n",
      "contract4\n",
      "qs1\n",
      "{'score': 0.5745531916618347, 'start': 135300, 'end': 135379, 'answer': 'Amended and Restated Strategic Licensing, Distribution and Marketing  Agreement'}\n",
      "qs2\n",
      "{'score': 0.29911690950393677, 'start': 121498, 'end': 121520, 'answer': 'Pacira Pharmaceuticals'}\n",
      "qs3\n",
      "{'score': 0.983331561088562, 'start': 135098, 'end': 135113, 'answer': 'October  , 2009'}\n",
      "qs4\n",
      "{'score': 0.9887353181838989, 'start': 135098, 'end': 135113, 'answer': 'October  , 2009'}\n",
      "qs5\n",
      "{'score': 0.27815788984298706, 'start': 7409, 'end': 7450, 'answer': 'Effective Date\"   Means August 10, 2007;\"'}\n",
      "qs6\n",
      "{'score': 0.001858019852079451, 'start': 102948, 'end': 102954, 'answer': 'During'}\n",
      "qs7\n",
      "{'score': 0.002868768060579896, 'start': 101165, 'end': 101246, 'answer': 'Immediately upon notification from PPI, such post termination  sales shall cease.'}\n",
      "qs8\n",
      "{'score': 0.0019322007428854704, 'start': 142827, 'end': 142831, 'answer': 'This'}\n",
      "qs9\n",
      "{'score': 0.09178182482719421, 'start': 32261, 'end': 32316, 'answer': 'At any time between the Agreement Date and July 1, 2015'}\n",
      "qs10\n",
      "{'score': 0.0006347908056341112, 'start': 65654, 'end': 65657, 'answer': 'The'}\n",
      "qs11\n",
      "{'score': 0.014790958724915981, 'start': 141405, 'end': 141433, 'answer': 'following events of default:'}\n",
      "qs12\n",
      "{'score': 0.03466733545064926, 'start': 107815, 'end': 107850, 'answer': 'Each such notice or document shall:'}\n",
      "qs13\n",
      "{'score': 0.03648878633975983, 'start': 34633, 'end': 34666, 'answer': 'During the Lease Term, PPI shall:'}\n",
      "contract5\n",
      "qs1\n",
      "{'score': 0.49523457884788513, 'start': 4128, 'end': 4139, 'answer': 'ENDORSEMENT'}\n",
      "qs2\n",
      "{'score': 0.11853382736444473, 'start': 174, 'end': 230, 'answer': 'Lutheran Brotherhood Variable Insurance Products Company'}\n",
      "qs3\n",
      "{'score': 0.9626122117042542, 'start': 55, 'end': 67, 'answer': 'July 1, 2019'}\n",
      "qs4\n",
      "{'score': 0.8327916860580444, 'start': 55, 'end': 67, 'answer': 'July 1, 2019'}\n",
      "qs5\n",
      "{'score': 0.5635418891906738, 'start': 55, 'end': 67, 'answer': 'July 1, 2019'}\n",
      "qs6\n",
      "{'score': 8.286166064408462e-08, 'start': 2101, 'end': 2163, 'answer': \"This contract's share, if any, will be credited as a dividend.\"}\n",
      "qs7\n",
      "{'score': 1.4532544128087466e-06, 'start': 55, 'end': 67, 'answer': 'July 1, 2019'}\n",
      "qs8\n",
      "{'score': 1.5445280610038026e-07, 'start': 3950, 'end': 4025, 'answer': 'Society membership rights and privileges cannot be transferred or assigned.'}\n",
      "qs9\n",
      "{'score': 1.3962925038413232e-07, 'start': 3950, 'end': 4025, 'answer': 'Society membership rights and privileges cannot be transferred or assigned.'}\n",
      "qs10\n",
      "{'score': 4.7265172042898485e-07, 'start': 3950, 'end': 4025, 'answer': 'Society membership rights and privileges cannot be transferred or assigned.'}\n",
      "qs11\n",
      "{'score': 1.97454519366147e-05, 'start': 1513, 'end': 1515, 'answer': 'If'}\n",
      "qs12\n",
      "{'score': 2.2166230451148294e-07, 'start': 3950, 'end': 4025, 'answer': 'Society membership rights and privileges cannot be transferred or assigned.'}\n",
      "qs13\n",
      "{'score': 0.05801447108387947, 'start': 362, 'end': 454, 'answer': 'That includes contracts of insurance, separate accounts, and cash and investment securities.'}\n"
     ]
    }
   ],
   "source": [
    "if __name__ == '__main__':\n",
    "    test2()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "dac5069c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model3 Result\n",
      "contract1\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.74s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'SUPPLY CONTRACT',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.83s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD',\n",
      "        'context': 'act is concluded and signed by the Buyer and Seller on , '\n",
      "                   'in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'seller accepts, any party shall not unilaterally cancel '\n",
      "                   'the order before the two sides agreed . 2.3 If the '}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.73s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is concluded and signed by the Buyer and '\n",
      "                  'Seller on , in Hong Kong.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.34s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.97s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is valid for 5 years, beginning from and ended '\n",
      "                  'on .',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.55s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'During the validity term of this agreement,',\n",
      "        'context': 'ement Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: '\n",
      "                   'The Contract is concluded and signed by the Buyer and '\n",
      "                   'Seller on , in Hong Kong. 1. General provisions 1.1 This '\n",
      "                   'is a framework agreement, the terms and conditions are '\n",
      "                   'applied to all purchase orders which signed by this '\n",
      "                   'agreement (hereinafter referred to as the \"order\"). 1.2 If '\n",
      "                   'the provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'seller accepts, any party shall not unil'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.53s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.33s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': \"It will be governed by the law of the People's Republic of \"\n",
      "                  'China ,otherwise it is governed by United Nations '\n",
      "                  'Convention on Contract for the International Sale of Goods.',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.96s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'In case the accident lasts for more than 10 weeks, the '\n",
      "                  'Buyers shall have the right to cancel the Contract.',\n",
      "        'context': 'l not be held responsible for the delay in shipment or '\n",
      "                   'non-delivery, of the goods due to Force Majeure, which '\n",
      "                   'might occur during the process of manufacturing or in the '\n",
      "                   'course of loading or transit. The Sellers shall advise the '\n",
      "                   'Buyers immediately of the occurrence mentioned above and '\n",
      "                   'within fourteen days thereafter, the Sellers shall send by '\n",
      "                   'airmail to the Buyers a certificate of the accident issued '\n",
      "                   'by the competent government authorities, Chamber of '\n",
      "                   'Commerce or registered notary public of the place where '\n",
      "                   'the accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, th'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.89s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Any modification, supplementary, give up should been '\n",
      "                  'written records, only to be valid by buyers and sellers '\n",
      "                  'authorized representative signature and confirmation, '\n",
      "                  'otherwise will be deemed invalid.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.73s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'The penalty, however, shall not exceed 5% of the total '\n",
      "                  'value of the goods involved in the late delivery.',\n",
      "        'context': 'rce or registered notary public of the place where the '\n",
      "                   'accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, the Buyers have the right to '\n",
      "                   'cancel the contract and the Sellers, in spite of the '\n",
      "                   'cancellation, shall still pay the aforesaid penalty to the '\n",
      "                   'Buyers without delay, the seller should refund the money '\n",
      "                   'received and pay the 30% of the total goods price of the '\n",
      "                   'penalty 19. ARBITRATION: All disputes in connection with '\n",
      "                   'this Contract or the execution thereof shall be settled '\n",
      "                   'friendly through negotiations. In case no settlement can '\n",
      "                   'be reached, the case may then be sub'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.41s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.48s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '20' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': '(5) One copy of insurance coverage (6) Copy of cable/letter '\n",
      "                  'to the transportation department of Buyer advising of '\n",
      "                  'particulars as to shipment immediately after shipment is '\n",
      "                  'made.',\n",
      "        'context': 'ped will be paid against the documents stipulated in '\n",
      "                   'Clause 12.2. The Letter of Credit shall be valid until 90 '\n",
      "                   'days after the latest shipment is effected. Under the T/T '\n",
      "                   'The trustee of the buyer remitted the goods to the seller '\n",
      "                   'by telegraphic transfer in batches as agreed upon after '\n",
      "                   'signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 '\n",
      "                   'originals indicating contract number and Shipping Mark (in '\n",
      "                   'case of more than one shipping mark, the invoice shall be '\n",
      "                   'issued separately). (2) One certificate of origin of the '\n",
      "                   'goods. (3) Four original copies of the packing list. (4) '\n",
      "                   'Certificate of Quality and Quantity in 1 original issued '\n",
      "                   'by the agriculture products base. (5) One copy of '\n",
      "                   'insurance coverage (6) Copy of cable/letter to the '\n",
      "                   'transportation department of Buyer advising of particulars '\n",
      "                   'as to shipment immediately after shipment is made.3Source: '\n",
      "                   'LOHA CO. LTD., F-1, 12/9/201912.2 (1) Invoice in 3 '\n",
      "                   'originals indicating contract number and L/C number. (2) '\n",
      "                   'Final acceptance certificate signed by the Buyer and the '\n",
      "                   'Seller. 13. SHIPMENT: CIP The seller shall contract on '\n",
      "                   'usual terms at his own expenses for the carriage of the '\n",
      "                   'goods to the agreed point at the named place of '\n",
      "                   'destination and bear all risks and expenses until the '\n",
      "                   'goods have been delivered to the port of destination. The '\n",
      "                   'Sellers shall ship the goods within the shipment time from '\n",
      "                   'the port of shipment to the port of destination. '\n",
      "                   'Transshipment is allowed. Partial Shipment is allowed. In '\n",
      "                   'case the goods are to be dispatched by parcel post/'}]\n",
      "contract2\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.39s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'WEB SITE HOSTING AGREEMENT',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.82s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'I-ON INTERACTIVE, INC.',\n",
      "        'context': 'll be effective, except pursuant to a written instrument '\n",
      "                   'signed by the party or parties waiving compliance, and any '\n",
      "                   'such waiver shall be effective only in the specific '\n",
      "                   'instance and for the specific purpose stated in such '\n",
      "                   'writing.In the event that any provision hereof is found '\n",
      "                   'invalid or unenforceable pursuant to judicial decree or '\n",
      "                   'decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '-------------------------               '\n",
      "                   '----------------------------- Name: John J. '\n",
      "                   'Lofquist                  Name:   Anna Talerico Title: '\n",
      "                   'President & CEO                  Title:  Vice President'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.21s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.10s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.42s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The term of this Agreement for the Hosted Site shall '\n",
      "                  'commence upon April 1, 1999 and shall continue for a period '\n",
      "                  'of six (6) months, unless earlier terminated in accordance '\n",
      "                  'with provisions hereof.',\n",
      "        'context': \"h any of i-on'sservices, any information that is, in \"\n",
      "                   \"i-on's sole discretion, unlawful, obscene, threatening, \"\n",
      "                   'abusive, libelous, or harmful, or encourages conduct that '\n",
      "                   'would constitute a criminal offense, give rise to civil '\n",
      "                   'liability, or otherwise violate any local, state, '\n",
      "                   'national, or International law.The Customer expressly '\n",
      "                   \"agrees to use all of i-on's services only for lawful \"\n",
      "                   'purposes. Transmission or storage of any information, '\n",
      "                   'data, or material in violation of United States or state '\n",
      "                   'regulation or law is prohibited, including but not limited '\n",
      "                   'to, material protected by copyright, trademark, trade '\n",
      "                   'secret, or any other statute.TERM AND TERMINATIONThe term '\n",
      "                   'of this Agreement for the Hosted Site shall commence upon '\n",
      "                   'April 1, 1999 and shall continue for a period of six (6) '\n",
      "                   'months, unless earlier terminated in accordance with '\n",
      "                   'provisions hereof. This Agreement shall automatically be '\n",
      "                   'renewed for one (1) or more one (1) month periods unless '\n",
      "                   'either the Customer or i-on gives notice to the other '\n",
      "                   'party of its intention not to renew the4 Agreement, which '\n",
      "                   'notice must be given not less than fifteen (15) days '\n",
      "                   'before the end of the respective initial or renewal '\n",
      "                   'term.Either party may terminate this Agreement without '\n",
      "                   \"cause at any time effective upon thirty (30) days' written \"\n",
      "                   'notice. Notwithstanding anything to the contrary contained '\n",
      "                   'in this Agreement, no termination of this Agreement for '\n",
      "                   'any reason whatsoever shall relieve the Customer of the '\n",
      "                   'obligation to pay all amounts due to i-on and to make '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.06s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement shall automatically be renewed for one (1) '\n",
      "                  'or more one (1) month periods unless either the Customer or '\n",
      "                  'i-on gives notice to the other party of its intention not '\n",
      "                  'to renew the4 Agreement, which notice must be given not '\n",
      "                  'less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'y local, state, national, or International law.The '\n",
      "                   \"Customer expressly agrees to use all of i-on's services \"\n",
      "                   'only for lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to \"}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.50s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:09<00:00,  9.45s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement was entered into in the State of Florida, '\n",
      "                  'and its validity, construction, interpretation, and legal '\n",
      "                  'effect shall be governed by the laws and judicial decisions '\n",
      "                  'of the State of Florida applicable to contracts entered '\n",
      "                  'into and performed entirely within the State of Florida.',\n",
      "        'context': ' the name of the other party or to bind such other party '\n",
      "                   'in any manner.No waiver of any provision of this Agreement '\n",
      "                   'or any rights or obligations of either party hereunder '\n",
      "                   'shall be effective, except pursuant to a written '\n",
      "                   'instrument signed by the party or parties waiving '\n",
      "                   'compliance, and any such waiver shall be effective only in '\n",
      "                   'the specific instance and for the specific purpose stated '\n",
      "                   'in such writing.In the event that any provision hereof is '\n",
      "                   'found invalid or unenforceable pursuant to judicial decree '\n",
      "                   'or decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '--------------------'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.83s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.59s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:09<00:00,  9.19s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': \"i-on's liability for damages to the Customer for any cause \"\n",
      "                  'whatsoever, regardless of the form of action, and whether '\n",
      "                  'in contract or in tort, including negligence, shall be '\n",
      "                  \"limited to one (1) month's fees and the remaining portion \"\n",
      "                  'of any prepaid fees.',\n",
      "        'context': '15) days before the end of the respective initial or '\n",
      "                   'renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to the Customer for \"\n",
      "                   'any cause whatsoever, regardless of the form of action, '\n",
      "                   'and whether in contract or in tort, including negligence, '\n",
      "                   \"shall be limited to one (1) month's fees and the remaining \"\n",
      "                   'portion of any prepaid fees.INDEMNIFICATIONThe Customer '\n",
      "                   'agrees to indemnify and hold harmless i-on, against any '\n",
      "                   'lawsuits, claims, damages, or liabilities (or actions or '\n",
      "                   'proceedings in respect thereof) to which i-on may become '\n",
      "                   \"subject related to or arising out of Customer's use of \"\n",
      "                   \"i-on's services, and will reimburse i-on for all legal and \"\n",
      "                   \"other expenses, including attorney's fees, incurred in \"\n",
      "                   'connection with investigating, defending, or settling any '\n",
      "                   'such loss, claim, damage, liability, action, or proceeding '\n",
      "                   'whether or not in connection with pending or threatened '\n",
      "                   'litigation in which i-on is a party. The provisions of '\n",
      "                   'this Agreement relating to ind'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.86s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'not less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'r lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to the Customer for \"\n",
      "                   'any cause whatsoever, regardless of the form of action, '\n",
      "                   'and whether in contract or in tort, inclu'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:10<00:00, 10.59s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '21' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "contract3\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:34<00:00, 15.68s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'CO-PROMOTION AGREEMENT',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:39<00:00, 16.61s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22842, -22820) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Valeant Pharmaceuticals North America LLC, a Delaware '\n",
      "                  'limited liability company (\"Valeant\"). Dova and Valeant are '\n",
      "                  'each referred to individually as a \"Party\" and together as '\n",
      "                  'the \"Parties\".',\n",
      "        'context': '.16 Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the following mutual promises and obligations, and for '\n",
      "                   'other good and valuable consideration the adequacy and '\n",
      "                   'sufficiency of which are hereby acknowledged, the Parties '\n",
      "                   'agree as follows:CONFIDENTIAL TREATMENT HAS BE'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:36<00:00, 16.11s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:39<00:00, 16.55s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:40<00:00, 16.68s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended f',\n",
      "        'context': 'ccordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Ad'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:39<00:00, 16.66s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended f',\n",
      "        'context': 'ccordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Ad'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:39<00:00, 16.60s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28588, -28480) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'icians, generally accepted standards of good clinical '\n",
      "                  'practices adopted by current FDA regulations, as well as '\n",
      "                  'any state laws and regulations (i) impacting the promotion '\n",
      "                  'of pharmaceutical products, (ii) governing the provision of '\n",
      "                  'meals',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:41<00:00, 16.93s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13683, -13613) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6773, -6703) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'ments, interest), together with all documented out-of- '\n",
      "                  \"pocket costs and expenses, including attorney's fees, \"\n",
      "                  'reasonably incurred.1.40 \"Net Sales\" shall mean, for an '\n",
      "                  'applicable period, the aggregate amount, without '\n",
      "                  'duplication, equal to the Specialty Pharmacy Net Sales for '\n",
      "                  'each SKU, the Retail Net Sales for each SKU, if any, and '\n",
      "                  'the Non-Retail Net Sales f',\n",
      "        'context': '\" shall have the meaning set forth in Section 3.1.1.38 '\n",
      "                   '\"Know-How\" shall mean information, whether or not in '\n",
      "                   'written form, including biological, chemical, '\n",
      "                   'pharmacological, toxicological, medical or clinical, '\n",
      "                   'analytical, quality, manufacturing, research, or sales and '\n",
      "                   'marketing information, including processes, methods, '\n",
      "                   'procedures, techniques, plans, programs and data.1.39 '\n",
      "                   '\"Losses\" shall mean any and all amounts paid or payable to '\n",
      "                   'Third Parties with respect to a Claim (including any and '\n",
      "                   'all losses, damages, obligations, liabilities, fines, '\n",
      "                   'fees, penalties, awards, judgments, interest), together '\n",
      "                   'with all documented out-of- pocket costs and expenses, '\n",
      "                   'including attorney\\'s fees, reasonably incurred.1.40 \"Net '\n",
      "                   'Sales\" shall mean, for an applicable period, the aggregate '\n",
      "                   'amount, without duplication, equal to the Specialty '\n",
      "                   'Pharmacy Net Sales for each SKU, the Retail Net Sales for '\n",
      "                   'each SKU, if any, and the Non-Retail Net Sales for each '\n",
      "                   'SKU.1.41 \"Non-Retail Institution\" shall mean any '\n",
      "                   'institution (other than the Specialty Pharmacies, Retail '\n",
      "                   'Pharmacies and Intermediaries) to which Dova (or its '\n",
      "                   'Affiliates or its Intermediaries) sells and/or ships units '\n",
      "                   'of Product during the Term, which shall include group '\n",
      "                   'purchasing organizations (GPOs), hospitals, clinics, long '\n",
      "                   'term care facilities and any outlets that are a member of '\n",
      "                   'an Integrated Delivery Network (IDN), and with which Dova '\n",
      "                   'or its Affiliates do not have data agreements which '\n",
      "                   'enables Dova to track shipments of Product from such '\n",
      "                   'institution t'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:35<00:00, 15.96s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28588, -28480) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'icians, generally accepted standards of good clinical '\n",
      "                  'practices adopted by current FDA regulations, as well as '\n",
      "                  'any state laws and regulations (i) impacting the promotion '\n",
      "                  'of pharmaceutical products, (ii) governing the provision of '\n",
      "                  'meals',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:36<00:00, 16.09s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-27976, -27891) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13288, -13116) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'l of the terms and conditions hereof in all respects and '\n",
      "                  'shall assume all obligations',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:35<00:00, 15.96s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-8074, -7659) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-20465, -20209) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'ugs to the FDA. Visit www.fda.gov/medwatch or call 1-800- '\n",
      "                  'FDA-1088.CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                  'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE '\n",
      "                  'INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS '\n",
      "                  'ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT '\n",
      "                  'HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE '\n",
      "                  'COMMISSION.Source: DOVA PHARMACEUTICALS INC., 10-Q, '\n",
      "                  '11/8/2018For p',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:39<00:00, 16.55s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6806, -6437) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'licensed, developed, and marketed innovative products to '\n",
      "                  \"improve patients' lives and arm health care providers with \"\n",
      "                  'life-changing solutions for many chronic and debilitating '\n",
      "                  'conditions. Salix currently markets its product line to '\n",
      "                  'U.S. health care providers through an expanded sales force '\n",
      "                  'that focuses on gastroenterology, hepatology, pain '\n",
      "                  'specialists, and primary care',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:37<00:00, 16.30s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '22' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'ive Remedies. 4613.14 Waiver of Rule of Construction. '\n",
      "                  '4613.15 Use of Names. 4613.16 Further Actions and '\n",
      "                  'Documents. 4713.17 Certain Conventions. 4713.18 '\n",
      "                  'Counterparts. 47iiiCONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                  'REQUESTED FOR PORTIONS OF',\n",
      "        'context': 'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF CONTENTS '\n",
      "                   '(continued)12.6 Survival. 43ARTICLE 13 MISCELLANEOUS '\n",
      "                   '4313.1 Force Majeure. 4313.2 Assignment. 4313.3 '\n",
      "                   'Severability. 4413.4 Notices. 4413.5 Governing Law. 4513.6 '\n",
      "                   'Dispute Resolution. 4513.7 Waiver of Jury Trial. 4513.8 '\n",
      "                   'Entire Agreement; Amendments. 4613.9 Headings. 4613.10 '\n",
      "                   'Independent Contractors. 4613.11 Third Party '\n",
      "                   'Beneficiaries. 4613.12 Waiver. 4613.13 Cumulative '\n",
      "                   'Remedies. 4613.14 Waiver of Rule of Construction. 4613.15 '\n",
      "                   'Use of Names. 4613.16 Further Actions and Documents. '\n",
      "                   '4713.17 Certain Conventions. 4713.18 Counterparts. '\n",
      "                   '47iiiCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018CO-PROMOTION AGREEMENTThis Co-Promotion '\n",
      "                   'Agreement (this \"Agreement\") is entered into and dated as '\n",
      "                   'of September 26, 2018 (the \"Effective Date\") by and '\n",
      "                   'between Dova Pharmaceuticals, Inc., a Delaware corporation '\n",
      "                   '(\"Dova\"), and Valeant Pharmaceuticals North America LLC, a '\n",
      "                   'Delaware limited liability company (\"Valeant\"). Dova and '\n",
      "                   'Valeant are each referred'}]\n",
      "contract4\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.27s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'processing specifications, sales and marketing  materials '\n",
      "                  'and technology relatin',\n",
      "        'context': 'ng price of Product;\"PPI Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'otherwise created during the Term by  PPI or any of its '\n",
      "                   'Affiliates;   -10-\"PPI IP\"   Means the Copyrights, PPI '\n",
      "                   \"Know-How, PPI Patents and PPI Improvements; and PPI's \"\n",
      "                   'interest in Joint  Improvements;\"PPI Know-How\"Means all '\n",
      "                   'information, procedures, instructions, techniques, data, '\n",
      "                   'technical information, knowledge and  experience '\n",
      "                   '(including, without limitation, toxicological, '\n",
      "                   'pharmaceutical, clinical, non-clinical and medical data,  '\n",
      "                   'health registration data and marketing data), designs, '\n",
      "                   'dossiers (including, without limitation, manufacturing  '\n",
      "                   'assay and quality control dossiers) manufacturing '\n",
      "                   'formulae, processing specifications, sales and marketing  '\n",
      "                   'materials and technology relating to the Product;\"PPI '\n",
      "                   'Patents\"Means those patents set out in Schedule I which '\n",
      "                   'cover the Products and such other patents as PPI may '\n",
      "                   'include  from time to time, including additions, '\n",
      "                   'divisions, confirmations, continuations-in-part, '\n",
      "                   'substitutions, re-issues,  re-examinations, extensions, '\n",
      "                   'registrations, patent terms extensions, supplementary '\n",
      "                   'protection certificates and  renewals of any of the above '\n",
      "                   'or any other patents owned or licensed by PPI subsequent '\n",
      "                   'to the Effective Date  which cover the Products or any '\n",
      "                   'Improvements;   -11-\"Product(s)\"Means: (i) DepoDur '\n",
      "                   'Injectible Liposomal Epidural [**] mg/ml [**]; (ii) '\n",
      "                   'DepoDur Injectible Liposomal Epidural  [**] mg/[**] ml '\n",
      "                   '[**]; (iii) such other presentations and do'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:20<00:00, 13.47s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'mprov',\n",
      "        'context': 'any acts, events, non-happenings, omissions or accidents '\n",
      "                   'beyond the  reasonable control of the Party to perform and '\n",
      "                   'in particular but without limiting the generality thereof '\n",
      "                   'shall  include strikes and labor disturbances, lock-outs, '\n",
      "                   'industrial action, civil commotion, riot, invasion, war, '\n",
      "                   'threat of  or preparation for war, terrorist activity, '\n",
      "                   'fire, explosion, storm, flood, earthquake, subsidence, '\n",
      "                   'epidemic or other  natural physical disaster, '\n",
      "                   'impossibility of the use of railways, shipping, aircraft, '\n",
      "                   'motor transport, or other means  of public or private '\n",
      "                   'transport, failure or suspension of utilities, '\n",
      "                   'unavailability, shortage or interruption in the  supply of '\n",
      "                   'raw material, and political interference with the normal '\n",
      "                   'operation of either Party;\"Improvements\"Means any '\n",
      "                   'discovery, development, improvement, know-how or patent '\n",
      "                   'relating to the Product generated,  conceived, reduced to '\n",
      "                   'practice or otherwise created during the Term by PPI or '\n",
      "                   'EKR (or any Affiliate of PPI or  EKR);\"Joint '\n",
      "                   'Improvements\"   Means any Improvements generated, '\n",
      "                   'conceived, reduced to practice or other created jointly by '\n",
      "                   'EKR and PPI or  their Affiliates.\"Known In-Channel  '\n",
      "                   'Product Units\"   Shall have the meaning set forth in '\n",
      "                   'Section 3.19 hereof;   -8-\"Marketing Authorization\"Means '\n",
      "                   'the new drug application (\"NDA\") and all other necessary '\n",
      "                   'regulatory and governmental approvals by a  Regulatory '\n",
      "                   'Authority or other governmental body required to market '\n",
      "                   'and sell the Product in any country of the  Territory, '\n",
      "                   'including, but not li'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:22<00:00, 13.80s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9915, -9902) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ct in a country',\n",
      "        'context': 'ct\") and the Controlled Substances  Act, as amended (21 '\n",
      "                   'U.S.C. §801 et seq.), or as defined in attendant '\n",
      "                   'regulations promulgated under authorities  granted by the '\n",
      "                   'FD&C Act, together with any equivalent laws, rules, '\n",
      "                   'regulations, codes or guidelines having  effect in any '\n",
      "                   'jurisdiction in the Territory;\"Calendar Year\"    Shall '\n",
      "                   'mean the period of twelve months commencing on 1st January '\n",
      "                   'in any year, and each consecutive period  of twelve months '\n",
      "                   'thereafter during the Term;\"cGMP\"    Means Current Good '\n",
      "                   'Manufacturing Practices pursuant to 21 CFR Parts 210 and '\n",
      "                   '211, as may be amended from  time to time;\"Commercial '\n",
      "                   'Launch\"Shall mean the date of the first arm\\'s length sale '\n",
      "                   'by EKR to an unaffiliated Third Party customer for '\n",
      "                   'commercial  use of Product in a country within the '\n",
      "                   'Territory following the grant of Marketing Authorization '\n",
      "                   'and any  necessary pricing approval in that '\n",
      "                   'country;\"Commercialization  Committee\"   Shall mean the '\n",
      "                   'committee to be set up under the terms of Article 5;   '\n",
      "                   '-4-\"Competing Product\"Means any [**] ([**] hours) [**] '\n",
      "                   'preparation (other than the Product) available in a '\n",
      "                   'country in the Territory  which competes or would compete '\n",
      "                   'directly with the Product. For the avoidance of doubt, the '\n",
      "                   'definition of  \"Competing Product\" does not include '\n",
      "                   'Depobupivacaine or any improvement thereto;\"Confidential '\n",
      "                   'Information\"Means all confidential information, data and '\n",
      "                   'materials in whatever form disclosed by or on behalf of '\n",
      "                   'one Party  or its Affiliates to the other Party or its '\n",
      "                   'Affiliates includ'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:22<00:00, 13.76s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9915, -9902) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'ct in a country',\n",
      "        'context': 'ct\") and the Controlled Substances  Act, as amended (21 '\n",
      "                   'U.S.C. §801 et seq.), or as defined in attendant '\n",
      "                   'regulations promulgated under authorities  granted by the '\n",
      "                   'FD&C Act, together with any equivalent laws, rules, '\n",
      "                   'regulations, codes or guidelines having  effect in any '\n",
      "                   'jurisdiction in the Territory;\"Calendar Year\"    Shall '\n",
      "                   'mean the period of twelve months commencing on 1st January '\n",
      "                   'in any year, and each consecutive period  of twelve months '\n",
      "                   'thereafter during the Term;\"cGMP\"    Means Current Good '\n",
      "                   'Manufacturing Practices pursuant to 21 CFR Parts 210 and '\n",
      "                   '211, as may be amended from  time to time;\"Commercial '\n",
      "                   'Launch\"Shall mean the date of the first arm\\'s length sale '\n",
      "                   'by EKR to an unaffiliated Third Party customer for '\n",
      "                   'commercial  use of Product in a country within the '\n",
      "                   'Territory following the grant of Marketing Authorization '\n",
      "                   'and any  necessary pricing approval in that '\n",
      "                   'country;\"Commercialization  Committee\"   Shall mean the '\n",
      "                   'committee to be set up under the terms of Article 5;   '\n",
      "                   '-4-\"Competing Product\"Means any [**] ([**] hours) [**] '\n",
      "                   'preparation (other than the Product) available in a '\n",
      "                   'country in the Territory  which competes or would compete '\n",
      "                   'directly with the Product. For the avoidance of doubt, the '\n",
      "                   'definition of  \"Competing Product\" does not include '\n",
      "                   'Depobupivacaine or any improvement thereto;\"Confidential '\n",
      "                   'Information\"Means all confidential information, data and '\n",
      "                   'materials in whatever form disclosed by or on behalf of '\n",
      "                   'one Party  or its Affiliates to the other Party or its '\n",
      "                   'Affiliates includ'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:25<00:00, 14.30s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'its own cost and expense take all actions necessary to '\n",
      "                  'comply with all Applicable Laws and  obtain and maintain '\n",
      "                  'all necessary license, permits, records and authorizations '\n",
      "                  'PPI is required to obtain and maintain hereunder so as to  '\n",
      "                  'enable PPI to perform its obligations hereunder and under '\n",
      "                  'the Supply Agreement so as to enable EKR to fully exercise '\n",
      "                  'the Distribution  Rights.   3.18 Assignment of ICS '\n",
      "                  'Agreement. The Part',\n",
      "        'context': ' enable EKR to  fully exploit the Distribution Rights '\n",
      "                   'granted hereunder. For purpose of this Section, the '\n",
      "                   'contact person for each of the parties is set forth  '\n",
      "                   'below.3.15 Reserved.   3.16 Recalls and PostMarket '\n",
      "                   'Notifications. All costs of safety alerts and all other '\n",
      "                   'forms of notifications regarding safety risks associated '\n",
      "                   'with the Products in the United States shall be borne by '\n",
      "                   'PPI to the extent arising prior to the Agreement Date and '\n",
      "                   'by EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:28<00:00, 14.80s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'The Lease Term shall automatically renew at the end of each '\n",
      "                  'calendar quarter of  the Lease Term.',\n",
      "        'context': 'n principal amount of [**]  Dollars ($[**]), such note to '\n",
      "                   'be substantially in the form attached hereto as Exhibit '\n",
      "                   '3.20(b) (the \"Promissory Note\").  (c) Commencing as of the '\n",
      "                   'Agreement Date, EKR agrees to lease the Transferred '\n",
      "                   'Equipment to PPI through the end of the then-current  '\n",
      "                   'calendar quarter and, subject to renewal as provided '\n",
      "                   'below, on a calendar quarter-to-calendar quarter   '\n",
      "                   '-21-basis thereafter (the \"Lease Term\"), for use solely in '\n",
      "                   \"connection with the (i) performance of PPI's obligations \"\n",
      "                   'under the Supply  Agreement, (ii) the supply of Products '\n",
      "                   \"to PPI's other licensees and collaborators and (iii) the \"\n",
      "                   \"supply of placebo for PPI's Exparel  product to PPI's \"\n",
      "                   'other licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; '}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:26<00:00, 14.48s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 't described in Section 17.5 below.(d) At any time between '\n",
      "                  'the Agreement Date and July 1, 2015, EKR shall have the',\n",
      "        'context': 'r and, subject to renewal as provided below, on a calendar '\n",
      "                   'quarter-to-calendar quarter   -21-basis thereafter (the '\n",
      "                   '\"Lease Term\"), for use solely in connection with the (i) '\n",
      "                   \"performance of PPI's obligations under the Supply  \"\n",
      "                   \"Agreement, (ii) the supply of Products to PPI's other \"\n",
      "                   'licensees and collaborators and (iii) the supply of '\n",
      "                   \"placebo for PPI's Exparel  product to PPI's other \"\n",
      "                   'licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; and '\n",
      "                   '(ii) the termination of the Step-in Right described in  '\n",
      "                   'Section 17.5.(e) At any time after July 1, 2015, PPI shall '\n",
      "                   'have the right, exercisable upon sixty (60) days prior '\n",
      "                   'written notice to EKR, to terminate the Lease Term and '\n",
      "                   'repurchase the Transferred Equipment from EKR, subject to '\n",
      "                   'payment'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.92s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-14412, -14055) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': '(including, but not limited to, any license or other rights '\n",
      "                  'of PPI or any of its Affiliates, whether as a licensor,  '\n",
      "                  'licensee or otherwise relation to any of the fore',\n",
      "        'context': ' in relation to any Party or an Affiliate the possession '\n",
      "                   'directly or indirectly, of the power to direct or  cause '\n",
      "                   'the direction of the management and policies of such firm, '\n",
      "                   'person or entity, by contract or otherwise, or  the '\n",
      "                   'ownership either directly or indirectly of 50% or more of '\n",
      "                   'the voting securities of such Party;\"Copyrights\"Means (i) '\n",
      "                   'the copyright registrations and applications for '\n",
      "                   'registration identified on Schedule III, (ii) works of  '\n",
      "                   'authorship whether or not copyrightable and (iii) any '\n",
      "                   'other copyrights and works, together with all common law  '\n",
      "                   'rights, used or held for use by PPI or any of its '\n",
      "                   'Affiliates in connection with the Products in the '\n",
      "                   'Territory  (including, but not limited to, any license or '\n",
      "                   'other rights of PPI or any of its Affiliates, whether as a '\n",
      "                   'licensor,  licensee or otherwise relation to any of the '\n",
      "                   'foregoing);\"Current Base Price\"    Means the Product\\'s '\n",
      "                   'current (as of the Effective Date) net average selling '\n",
      "                   'price of $[**] ([**] mg) and $[**]  ([**] mg);\"DEA\"    '\n",
      "                   'Shall mean the United States Drug Enforcement '\n",
      "                   'Administration and any successor thereto performing '\n",
      "                   'similar  functions;\"Distribution Rights\"   Shall have the '\n",
      "                   'meaning set forth in Section 2.1 hereof;\"Domain Name\"    '\n",
      "                   'Shall mean Depodur.com and any other domain names owned or '\n",
      "                   'licensed by PPI related to the Product set forth  on '\n",
      "                   'Schedule IV hereto;   -6-\"EKR Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'other created during the Term by EKR or  any of its '\n",
      "                   'Affiliates.Endo'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.92s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28124, -27557) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24013, -23763) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': \"ment, PPI has   -19-assigned to EKR all of PPI's right, \"\n",
      "                  'title and interest under that certain Commercial '\n",
      "                  'Outsourcing Services Agreement between PPI (f/k/a  '\n",
      "                  'SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                  'Solutions, Inc. (\"ICS\")  dated',\n",
      "        'context': 'y EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of  the Effective Date, the Parties have entered into an '\n",
      "                   'Assignment and Assumption Agreement to further evidence '\n",
      "                   'the foregoing assignment  and assumption of the ICS '\n",
      "                   'Agreement.   3.19 Product in Channel. All sales of Product '\n",
      "                   'conducted by PPI and its distributors and wholesalers '\n",
      "                   '(and, to the knowledge of PPI, by Endo Pharmaceuticals and '\n",
      "                   'its distributors and wholesalers) during the six month '\n",
      "                   'period prior to the Effective Date have been condu'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.88s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-1498, -1241) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-191, -11) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-19849, -19217) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'nment for the benefit of creditors;      -86-$900,000   '\n",
      "                  'October  , 2009(c) A receiver is appointed for the assets '\n",
      "                  'of Maker upon request by any Person(s) other than Maker, or '\n",
      "                  'Maker makes a formal  request for appointment of a '\n",
      "                  'receiver; or   (d) Any proceedin',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:27<00:00, 14.59s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24858, -24517) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24858, -24611) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': \"[**]   [**][**] Attorneys'  Ref:   Country   Application  \"\n",
      "                  'date   Application  no.   Patent/  Publication no.   Grant '\n",
      "                  'date   Expiry date   Status  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [*',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:31<00:00, 15.22s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-29016, -28733) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-30125, -29908) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22284, -21925) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24743, -24088) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'fect. It is agreed that:  (a) no Party has entered into '\n",
      "                  'this Agreement in reliance upon any representation, '\n",
      "                  'warranty or undertaking of the other Party  which is not '\n",
      "                  'expressly set out in this Agreement;   -64-  (b) no Party '\n",
      "                  'shall have any remedy in respect of misrepresentation or '\n",
      "                  'unt',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:31<00:00, 15.21s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '23' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'bination with the Trademarks.   2.3 Grant of Trademark '\n",
      "                  'Rights. PPI hereby grants to EKR a royalty free and '\n",
      "                  'exclusive license (with the right to sublicense) to use '\n",
      "                  'the  Trademarks in the Territory solely in conn',\n",
      "        'context': 'ouse the Products (the \"Distribution Rights\") in the Field '\n",
      "                   'in the Territory during the Term, as  well as to make or '\n",
      "                   'have made the Products anywhere in the world for import or '\n",
      "                   'sale in the Field in the Territory in each case, under the '\n",
      "                   'PPI  IP provided that PPI retains all rights necessary to '\n",
      "                   'manufacture and supply the Products to EKR in accordance '\n",
      "                   'with this Agreement and the  Supply Agreement. Such grant '\n",
      "                   'by PPI shall include the right of EKR to market the '\n",
      "                   'Product in the Territory during the Term as an EKR  '\n",
      "                   \"product using in addition to the Trademarks, EKR's own \"\n",
      "                   'trademarks, trade dress, trade names and other proprietary '\n",
      "                   'designations in  combination with the Trademarks.   2.3 '\n",
      "                   'Grant of Trademark Rights. PPI hereby grants to EKR a '\n",
      "                   'royalty free and exclusive license (with the right to '\n",
      "                   'sublicense) to use the  Trademarks in the Territory solely '\n",
      "                   'in connection with the exercise of the Distribution Rights '\n",
      "                   'in the Territory during the Term (and thereafter  as set '\n",
      "                   'forth in Section 17.4) and EKR shall market and sell the '\n",
      "                   'Products under the Trademarks. For the avoidance of doubt, '\n",
      "                   'the term  \"exclusive\" for the   -14-purposes of Sections '\n",
      "                   '2.1, 2.2 and 2.3 means to the exclusion of all others, '\n",
      "                   'including PPI and its Affiliates, except to the extent '\n",
      "                   'necessary to  enable PPI to perform its specific '\n",
      "                   'obligations under this Agreement and the Supply Agreement. '\n",
      "                   'Notwithstanding the foregoing, nothing  contained herein '\n",
      "                   'shall prohibit PPI from utilizing the Trademarks in the '\n",
      "                   'Territory in connection with its'}]\n",
      "contract5\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.68s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ENDORSEMENT',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.57s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Lutheran Brotherhood Variable Insurance Products Company',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.87s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.74s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.81s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.02s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'Society membership rights and privileges cannot be '\n",
      "                  'transferred or assigned.',\n",
      "        'context': 'ife Insurance Company.Is amended to read:We, we, Our, our, '\n",
      "                   'Us, us, Society. Thrivent Financial for Lutherans.ENTIRE '\n",
      "                   'CONTRACTIn the ENTIRE CONTRACT section, the first phrase '\n",
      "                   'and numbered list are amended to read:The Entire Contract '\n",
      "                   'consists of: 1) This contract including any attached '\n",
      "                   'riders, amendments, or endorsements; 2) The Application '\n",
      "                   'attached to this contract; and 3) The Articles of '\n",
      "                   'Incorporation and Bylaws of the Society and all amendments '\n",
      "                   'to them. Benefits will not be reduced or eliminated by any '\n",
      "                   'future amendments to our Articles of Incorporation or '\n",
      "                   'Bylaws.ASSIGNMENTThe ASSIGNMENT section is amended to '\n",
      "                   'include the following:You may transfer ownership of this '\n",
      "                   'contract in accordance with our bylaws. Society membership '\n",
      "                   'rights and privileges cannot be transferred or assigned. '\n",
      "                   'VB-TL-TFFL (18) page TL-2Source: THRIVENT VARIABLE '\n",
      "                   'INSURANCE ACCOUNT B, N-6, 7/1/2019Contract Number: '\n",
      "                   'ENDORSEMENT (continued)The following words or phrases in '\n",
      "                   'this contract are amended as follows. Any reference to: Is '\n",
      "                   'amended to read:Thrivent Life Insurance Company Thrivent '\n",
      "                   'Financial for Lutheransthe Company the Societythe company. '\n",
      "                   'the SocietyA Stock Life Insurance Company. A Fraternal '\n",
      "                   'Benefit Society625 Fourth Avenue South. 4321 North Ballard '\n",
      "                   'Road Minneapolis, MN 55415 Appleton, WI '\n",
      "                   '54919-0001Minneapolis, MN Appleton, WIHome Office. Service '\n",
      "                   'CenterNonparticipating Eligible for annual dividends '\n",
      "                   'Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABL'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.87s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.95s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'You may make the extra payment by an equivalent reduction '\n",
      "                  'in benefits or by a payment in cash.',\n",
      "        'context': 'for Lutherans.\" All benefits and other terms of this '\n",
      "                   'contract remain unchanged except as described below.You '\n",
      "                   'may direct inquiries to:Thrivent Financial for Lutherans '\n",
      "                   '4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute '}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.72s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.70s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'You may make the extra payment by an equivalent reduction '\n",
      "                  'in benefits or by a payment in cash.',\n",
      "        'context': 'for Lutherans.\" All benefits and other terms of this '\n",
      "                   'contract remain unchanged except as described below.You '\n",
      "                   'may direct inquiries to:Thrivent Financial for Lutherans '\n",
      "                   '4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute '}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.72s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.03s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.80s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '24' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'That includes contracts of insurance, separate accounts, '\n",
      "                  'and cash and investment securities.',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n"
     ]
    }
   ],
   "source": [
    "if __name__ == '__main__':\n",
    "    test3()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "53103c6a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model4 Result\n",
      "contract1\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:19<00:00, 19.05s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'SUPPLY CONTRACT',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:18<00:00, 18.67s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Shenzhen LOHAS Supply Chain Management Co., Ltd.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:20<00:00, 20.04s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Shenzhen LOHAS Supply Chain Management Co., Ltd.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:19<00:00, 19.48s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is valid for 5 years, beginning from and ended '\n",
      "                  'on . This Contract is made out in three originals in both '\n",
      "                  'Chinese and English, each language being legally of the '\n",
      "                  'equal effect. Conflicts between these two languages arising '\n",
      "                  'there from, if any, shall be subject to Chinese version. '\n",
      "                  'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                  'Contract becomes effective after signed by both parties.',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:19<00:00, 19.21s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is valid for 5 years, beginning from and ended '\n",
      "                  'on .',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:21<00:00, 21.26s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is valid for 5 years, beginning from and ended '\n",
      "                  'on',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:19<00:00, 19.41s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'In case the accident lasts for more than 10 weeks, the '\n",
      "                  'Buyers shall have the right to cancel the Contract.',\n",
      "        'context': 'l not be held responsible for the delay in shipment or '\n",
      "                   'non-delivery, of the goods due to Force Majeure, which '\n",
      "                   'might occur during the process of manufacturing or in the '\n",
      "                   'course of loading or transit. The Sellers shall advise the '\n",
      "                   'Buyers immediately of the occurrence mentioned above and '\n",
      "                   'within fourteen days thereafter, the Sellers shall send by '\n",
      "                   'airmail to the Buyers a certificate of the accident issued '\n",
      "                   'by the competent government authorities, Chamber of '\n",
      "                   'Commerce or registered notary public of the place where '\n",
      "                   'the accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, th'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:19<00:00, 19.31s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': \"It will be governed by the law of the People's Republic of \"\n",
      "                  'China ,otherwise it is governed by United Nations '\n",
      "                  'Convention on Contract for the International Sale of Goods.',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:20<00:00, 20.67s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'In case the accident lasts for more than 10 weeks, the '\n",
      "                  'Buyers shall have the right to cancel the Contract.',\n",
      "        'context': 'l not be held responsible for the delay in shipment or '\n",
      "                   'non-delivery, of the goods due to Force Majeure, which '\n",
      "                   'might occur during the process of manufacturing or in the '\n",
      "                   'course of loading or transit. The Sellers shall advise the '\n",
      "                   'Buyers immediately of the occurrence mentioned above and '\n",
      "                   'within fourteen days thereafter, the Sellers shall send by '\n",
      "                   'airmail to the Buyers a certificate of the accident issued '\n",
      "                   'by the competent government authorities, Chamber of '\n",
      "                   'Commerce or registered notary public of the place where '\n",
      "                   'the accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, th'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:20<00:00, 20.35s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Inspection',\n",
      "        'context': 'all within 72 hours after the shipment of the goods, '\n",
      "                   'advise the shipping department of buyer by fax or E-mail '\n",
      "                   'of Contract No., goods name, quantity, value, number of '\n",
      "                   'packages, gross weight, measurements and the estimated '\n",
      "                   'arrival time of the goods at the destination. 15. '\n",
      "                   'GUARANTEE OF QUALITY: The Sellers guarantee that the '\n",
      "                   'commodity hereof is complies in all respects with the '\n",
      "                   'quality and specification stipulated in this Contract. 16. '\n",
      "                   'CLAIMS: Within 7 days after the arrival of the goods at '\n",
      "                   'destination, should the quality, specification, or '\n",
      "                   'quantity be found not in conformity with the stipulations '\n",
      "                   'of the Contract except those claims for which the '\n",
      "                   'insurance company or the owners of the vessel are liable, '\n",
      "                   'the Buyers, on the strength of the Inspection Certificate '\n",
      "                   'issued by the China Commodity Inspection Bureau, have the '\n",
      "                   'right to claim for replacement with new goods, or for '\n",
      "                   'compensation, and all the expenses (such as inspection '\n",
      "                   'charges, freight for returning the goods and for sending '\n",
      "                   'the replacement, insurance premium, storage and loading '\n",
      "                   'and unloading charges etc.) shall be borne by the Sellers. '\n",
      "                   'The Certificate so issued shall be accepted as the base of '\n",
      "                   \"a claim. The Sellers, in accordance with the Buyers' \"\n",
      "                   'claim, shall be responsible for the immediate elimination '\n",
      "                   'of the defect(s), complete or partial replacement of the '\n",
      "                   'commodity or shall devaluate the commodity according to '\n",
      "                   'the state of defect(s). Where necessary, the Buyers shall '\n",
      "                   'be at liberty to eliminate the defect(s) themselves '}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:22<00:00, 22.93s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'The penalty, however, shall not exceed 5% of the total '\n",
      "                  'value of the goods involved in the late delivery.',\n",
      "        'context': 'rce or registered notary public of the place where the '\n",
      "                   'accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, the Buyers have the right to '\n",
      "                   'cancel the contract and the Sellers, in spite of the '\n",
      "                   'cancellation, shall still pay the aforesaid penalty to the '\n",
      "                   'Buyers without delay, the seller should refund the money '\n",
      "                   'received and pay the 30% of the total goods price of the '\n",
      "                   'penalty 19. ARBITRATION: All disputes in connection with '\n",
      "                   'this Contract or the execution thereof shall be settled '\n",
      "                   'friendly through negotiations. In case no settlement can '\n",
      "                   'be reached, the case may then be sub'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:22<00:00, 22.82s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'In case the accident lasts for more than 10 weeks, the '\n",
      "                  'Buyers shall have the right to cancel the Contract.',\n",
      "        'context': 'l not be held responsible for the delay in shipment or '\n",
      "                   'non-delivery, of the goods due to Force Majeure, which '\n",
      "                   'might occur during the process of manufacturing or in the '\n",
      "                   'course of loading or transit. The Sellers shall advise the '\n",
      "                   'Buyers immediately of the occurrence mentioned above and '\n",
      "                   'within fourteen days thereafter, the Sellers shall send by '\n",
      "                   'airmail to the Buyers a certificate of the accident issued '\n",
      "                   'by the competent government authorities, Chamber of '\n",
      "                   'Commerce or registered notary public of the place where '\n",
      "                   'the accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, th'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:20<00:00, 20.53s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '30' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'INSURANCE: To be covered by the',\n",
      "        'context': 'Exit Inspection and Quarantine Bureau of China, by the '\n",
      "                   'agent whom is certified by the government where the goods '\n",
      "                   'is exported. And the goods must be marked with the IPPC '\n",
      "                   'stamps, which are certified by the government agent of '\n",
      "                   'Botanical-Inspection and Quarantine Bureau. 6. SHIPPING '\n",
      "                   'MARK: The Sellers shall mark on each package with fadeless '\n",
      "                   'paint the package number, gross weight, net weight, '\n",
      "                   'measurements and the wordings: \"KEEP AWAY FROM '\n",
      "                   'MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the '\n",
      "                   'shipping mark on each package with fadeless paint. 7. DATE '\n",
      "                   'OF SHIPMENT: According to specific order by YICHANGTAI or '\n",
      "                   'LEHEYUAN. 8. PORT OF SHIPMENT:2Source: LOHA CO. LTD., F-1, '\n",
      "                   '12/9/20199. PORT OF DESTINATION: SHENZHEN, GUANGDONG, '\n",
      "                   'CHINA 10. INSURANCE: To be covered by the Seller for 110% '\n",
      "                   'invoice value against All Risks and War Risk. 11. PAYMENT: '\n",
      "                   'Under Letter of Credit or T/T: Under the Letter of Credit: '\n",
      "                   'The Buyer shall open an irrevocable letter of credit with '\n",
      "                   'the bank within 30 days after signing the contract, in '\n",
      "                   'favor of the Seller, for 100% value of the total contract '\n",
      "                   'value. The letter of credit should state that partial '\n",
      "                   \"shipments are allowed. The Buyer's agent agrees to pay for \"\n",
      "                   'the goods in accordance with the actual amount of the '\n",
      "                   'goods shipped. 80% of the system value being shipped will '\n",
      "                   'be paid against the documents stipulated in Clause 12.1. '\n",
      "                   'The remaining 20% of the system value being shipped will '\n",
      "                   'be paid against the documents stipulated in Clause 12.2. '\n",
      "                   'The Letter of Credit shall be va'}]\n",
      "contract2\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:26<00:00, 26.33s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'WEB SITE HOSTING AGREEMENT',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:27<00:00, 27.04s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'i-on interactive,',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:30<00:00, 30.04s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:30<00:00, 30.08s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:30<00:00, 30.70s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The term of this Agreement for the Hosted Site shall '\n",
      "                  'commence upon April 1, 1999 and shall continue for a period '\n",
      "                  'of six (6) months, unless earlier terminated in accordance '\n",
      "                  'with provisions hereof.',\n",
      "        'context': \"h any of i-on'sservices, any information that is, in \"\n",
      "                   \"i-on's sole discretion, unlawful, obscene, threatening, \"\n",
      "                   'abusive, libelous, or harmful, or encourages conduct that '\n",
      "                   'would constitute a criminal offense, give rise to civil '\n",
      "                   'liability, or otherwise violate any local, state, '\n",
      "                   'national, or International law.The Customer expressly '\n",
      "                   \"agrees to use all of i-on's services only for lawful \"\n",
      "                   'purposes. Transmission or storage of any information, '\n",
      "                   'data, or material in violation of United States or state '\n",
      "                   'regulation or law is prohibited, including but not limited '\n",
      "                   'to, material protected by copyright, trademark, trade '\n",
      "                   'secret, or any other statute.TERM AND TERMINATIONThe term '\n",
      "                   'of this Agreement for the Hosted Site shall commence upon '\n",
      "                   'April 1, 1999 and shall continue for a period of six (6) '\n",
      "                   'months, unless earlier terminated in accordance with '\n",
      "                   'provisions hereof. This Agreement shall automatically be '\n",
      "                   'renewed for one (1) or more one (1) month periods unless '\n",
      "                   'either the Customer or i-on gives notice to the other '\n",
      "                   'party of its intention not to renew the4 Agreement, which '\n",
      "                   'notice must be given not less than fifteen (15) days '\n",
      "                   'before the end of the respective initial or renewal '\n",
      "                   'term.Either party may terminate this Agreement without '\n",
      "                   \"cause at any time effective upon thirty (30) days' written \"\n",
      "                   'notice. Notwithstanding anything to the contrary contained '\n",
      "                   'in this Agreement, no termination of this Agreement for '\n",
      "                   'any reason whatsoever shall relieve the Customer of the '\n",
      "                   'obligation to pay all amounts due to i-on and to make '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:34<00:00, 34.64s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement shall automatically be renewed for one (1) '\n",
      "                  'or more one (1) month periods unless either the Customer or '\n",
      "                  'i-on gives notice to the other party of its intention not '\n",
      "                  'to renew the4 Agreement, which notice must be given not '\n",
      "                  'less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'y local, state, national, or International law.The '\n",
      "                   \"Customer expressly agrees to use all of i-on's services \"\n",
      "                   'only for lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to \"}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:28<00:00, 28.91s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement shall automatically be renewed for one (1) '\n",
      "                  'or more one (1) month periods unless either the Customer or '\n",
      "                  'i-on gives notice to the other party of its intention not '\n",
      "                  'to renew the4 Agreement, which notice must be given not '\n",
      "                  'less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'y local, state, national, or International law.The '\n",
      "                   \"Customer expressly agrees to use all of i-on's services \"\n",
      "                   'only for lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to \"}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:30<00:00, 30.73s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement was entered into in the State of Florida, '\n",
      "                  'and its validity, construction, interpretation, and legal '\n",
      "                  'effect shall be governed by the laws and judicial decisions '\n",
      "                  'of the State of Florida applicable to contracts entered '\n",
      "                  'into and performed entirely within the State of Florida.',\n",
      "        'context': ' the name of the other party or to bind such other party '\n",
      "                   'in any manner.No waiver of any provision of this Agreement '\n",
      "                   'or any rights or obligations of either party hereunder '\n",
      "                   'shall be effective, except pursuant to a written '\n",
      "                   'instrument signed by the party or parties waiving '\n",
      "                   'compliance, and any such waiver shall be effective only in '\n",
      "                   'the specific instance and for the specific purpose stated '\n",
      "                   'in such writing.In the event that any provision hereof is '\n",
      "                   'found invalid or unenforceable pursuant to judicial decree '\n",
      "                   'or decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '--------------------'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:29<00:00, 29.73s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:30<00:00, 30.42s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'unauthorized access to the physical location of the '\n",
      "                  'Hosting             Computer;',\n",
      "        'context': '1 (that may be shared by other             Web sites) to a '\n",
      "                   'leading Internet backbone access provider such '\n",
      "                   'as             UUNET, and reasonable efforts to maintain '\n",
      "                   'such connectivity with the             phone company and '\n",
      "                   'the Internet backbone access provider;      2. use of the '\n",
      "                   'Hosting Computer (that may be shared by other Web '\n",
      "                   'sites)             as described in this Agreement and '\n",
      "                   'maintenance required to keep such             Hosting '\n",
      "                   'Computer in good working order;      3. physical space for '\n",
      "                   'the Hosting Computer at a facility that '\n",
      "                   'maintains             proper environmental conditions in '\n",
      "                   'the area(s) where the Hosting             Computer is '\n",
      "                   'located and maintains reasonable efforts to '\n",
      "                   'prevent             unauthorized access to the physical '\n",
      "                   'location of the Hosting             Computer;      4. an '\n",
      "                   'emergency electrical power backup system for the '\n",
      "                   'Hosting             Computer;      5. up to 150 MB of '\n",
      "                   'mirrored computer storage on the Hosting Computer;      6. '\n",
      "                   'archival backups of such mirrored computer storage on a '\n",
      "                   'weekly             basis;    2          7.  off-site '\n",
      "                   'storage of such backups at separate facility than '\n",
      "                   'the              location of the Hosting Computer;      '\n",
      "                   '8.  use of the Microsoft Windows NT Server 4.0 or higher '\n",
      "                   'operating              system software for the Hosting '\n",
      "                   'Computer and the Hosted Site;      9.  use of the '\n",
      "                   'Microsoft Internet Information Service (IIS) 3.0 '\n",
      "                   'or              higher Web server software for the Hosted '\n",
      "                   'Site (providing support              for the HTTP W'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:30<00:00, 30.09s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': \"i-on's liability for damages to the Customer for any cause \"\n",
      "                  'whatsoever, regardless of the form of action, and whether '\n",
      "                  'in contract or in tort, including negligence, shall be '\n",
      "                  \"limited to one (1) month's fees and the remaining portion \"\n",
      "                  'of any prepaid fees.',\n",
      "        'context': '15) days before the end of the respective initial or '\n",
      "                   'renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to the Customer for \"\n",
      "                   'any cause whatsoever, regardless of the form of action, '\n",
      "                   'and whether in contract or in tort, including negligence, '\n",
      "                   \"shall be limited to one (1) month's fees and the remaining \"\n",
      "                   'portion of any prepaid fees.INDEMNIFICATIONThe Customer '\n",
      "                   'agrees to indemnify and hold harmless i-on, against any '\n",
      "                   'lawsuits, claims, damages, or liabilities (or actions or '\n",
      "                   'proceedings in respect thereof) to which i-on may become '\n",
      "                   \"subject related to or arising out of Customer's use of \"\n",
      "                   \"i-on's services, and will reimburse i-on for all legal and \"\n",
      "                   \"other expenses, including attorney's fees, incurred in \"\n",
      "                   'connection with investigating, defending, or settling any '\n",
      "                   'such loss, claim, damage, liability, action, or proceeding '\n",
      "                   'whether or not in connection with pending or threatened '\n",
      "                   'litigation in which i-on is a party. The provisions of '\n",
      "                   'this Agreement relating to ind'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:33<00:00, 33.75s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'At',\n",
      "        'context': 'ation or maintenance services for the Hosted Site.The '\n",
      "                   'Customer is solely responsible for all customer support '\n",
      "                   'required by users of Hosted Site. In the case of a problem '\n",
      "                   'with the Hosted Site that is the responsibility of i-on '\n",
      "                   'according to this Agreement, the Customer shall directly '\n",
      "                   'notify i-on, which shall report the resolution of such '\n",
      "                   'problem directly to the Customer. If the problem of which '\n",
      "                   'i-on is notified is not a problem that is the '\n",
      "                   'responsibility of i-on according to this Agreement, the '\n",
      "                   'time spent by i-on relating to the incident will count '\n",
      "                   \"towards the Customer's monthly allocation of Web \"\n",
      "                   'administration services, and any additional time3 '\n",
      "                   'exceeding such allocation will be billed to the Customer '\n",
      "                   'at the rate set forth for such services. At no time will '\n",
      "                   'i-on take responsibility for directly interacting with the '\n",
      "                   \"Customer's users. The Customer acknowledges that this \"\n",
      "                   'Agreement is explicitly not an agreement for i-on to '\n",
      "                   'provide \"help desk\" services to the users of the Hosted '\n",
      "                   'Site.The Customer is solely responsible for all marketing '\n",
      "                   'and promotion of the Hosted Site and is solely responsible '\n",
      "                   'for generating traffic to the Hosted Site.The Customer is '\n",
      "                   'solely responsible for the security of its administrator '\n",
      "                   'account(s) and respective password(s) for the Hosted Site, '\n",
      "                   'and is solely responsible for any loss of data or damage '\n",
      "                   'to the Hosted Site that arises out of any breach of such '\n",
      "                   'security.The Customer is solely responsible for any and '\n",
      "                   'all advertising on the Hosted Site.The Customer is r'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:34<00:00, 34.23s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '31' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'i-on will use best efforts to schedule and perform such '\n",
      "                  'maintenance between the hours of 8pm and 8am Eastern '\n",
      "                  'Standard Time on weekdays, or during weekends.Under this '\n",
      "                  'Agreement, i-on will provide the following limited services '\n",
      "                  'for the Hosted Site:',\n",
      "        'context': ' site may exist on a single computer system with other Web '\n",
      "                   'sites.The term \"Hosted Site\" shall mean the Web site of '\n",
      "                   'the Customer that is hosted by i-on under the terms and '\n",
      "                   'conditions of this Agreement.The term \"Hosting Computer\" '\n",
      "                   'shall mean the computer system and related equipment on '\n",
      "                   'which the Hosted Site exists.SERVICES PROVIDED TO THE '\n",
      "                   'CUSTOMERi-on will maintain the operation of the Hosted '\n",
      "                   'Site continuously, twenty-four (24) hours per day, seven '\n",
      "                   '(7) days per week, including holidays, with the exception '\n",
      "                   'of reasonable hardware and software maintenance that must '\n",
      "                   'be performed on the Hosting Computer and/or the Hosted '\n",
      "                   'Site. i-on will use best efforts to schedule and perform '\n",
      "                   'such maintenance between the hours of 8pm and 8am Eastern '\n",
      "                   'Standard Time on weekdays, or during weekends.Under this '\n",
      "                   'Agreement, i-on will provide the following limited '\n",
      "                   'services for the Hosted Site:      1. connectivity to the '\n",
      "                   'Internet via a T1 (that may be shared by other             '\n",
      "                   'Web sites) to a leading Internet backbone access provider '\n",
      "                   'such as             UUNET, and reasonable efforts to '\n",
      "                   'maintain such connectivity with the             phone '\n",
      "                   'company and the Internet backbone access provider;      2. '\n",
      "                   'use of the Hosting Computer (that may be shared by other '\n",
      "                   'Web sites)             as described in this Agreement and '\n",
      "                   'maintenance required to keep such             Hosting '\n",
      "                   'Computer in good working order;      3. physical space for '\n",
      "                   'the Hosting Computer at a facility that '\n",
      "                   'maintains             proper environmental cond'}]\n",
      "contract3\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [05:13<00:00, 52.21s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'CO-PROMOTION AGREEMENT',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [05:18<00:00, 53.08s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Dova and Valeant are each referred to individually as a '\n",
      "                  '\"Party\" and together as the \"Parties\".',\n",
      "        'context': 'ain Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the following mutual promises and obligations, and for '\n",
      "                   'other good and valuable consideration the adequacy and '\n",
      "                   'sufficiency of which are hereby acknowledged, the Parties '\n",
      "                   'agree as follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED '\n",
      "                   'FOR PORTIONS OF THIS EXHIBIT. THE '}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [05:07<00:00, 51.21s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22778, -22762) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [05:03<00:00, 50.63s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [05:07<00:00, 51.19s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended f',\n",
      "        'context': 'ccordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Ad'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [05:19<00:00, 53.32s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-3943, -3942) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended from time to time, and '\n",
      "                  'the regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                  'shall mean any untoward medical occurrence in a',\n",
      "        'context': 'l activities, and Valeant desires to conduct such '\n",
      "                   'activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Adverse Event\".1.3 \"Affiliate\" shall mean, '\n",
      "                   'with respect to any Per'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [05:18<00:00, 53.14s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'ons promulgated thereunder.1.2 \"Adverse Event\" shall mean '\n",
      "                  'any untoward medical occurrence in a',\n",
      "        'context': 'ation of the following mutual promises and obligations, '\n",
      "                   'and for other good and valuable consideration the adequacy '\n",
      "                   'and sufficiency of which are hereby acknowledged, the '\n",
      "                   'Parties agree as follows:CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018ARTICLE 1   '\n",
      "                   'DEFINITIONS1.1 \"Act\" shall mean the Federal Food, Drug and '\n",
      "                   'Cosmetic Act, 21 U.S.C. § 301 et seq., as it may be '\n",
      "                   'amended from time to time, and the regulations promulgated '\n",
      "                   'thereunder.1.2 \"Adverse Event\" shall mean any untoward '\n",
      "                   'medical occurrence in a patient or clinical investigation '\n",
      "                   'subject who is administered the Product, but which does '\n",
      "                   'not necessarily have a causal relationship with the '\n",
      "                   'treatment for which the Product is used. An \"Adverse '\n",
      "                   'Event\" can include any unfavorable and unintended sign '\n",
      "                   '(including an abnormal laboratory finding), symptom or '\n",
      "                   'disease temporally associated with the use of the Product, '\n",
      "                   'whether or not related to the Product. A pre-existing '\n",
      "                   'condition that worsened in severity after administration '\n",
      "                   'of the Product would be considered an \"Adverse Event\".1.3 '\n",
      "                   '\"Affiliate\" shall mean, with respect to any Person, any '\n",
      "                   'other Person that directly or indirectly controls, is '\n",
      "                   'controlled by or is under common control with such '\n",
      "                   'Person. '}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [04:54<00:00, 49.10s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6773, -6703) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'ments, interest), together with all documented out-of- '\n",
      "                  \"pocket costs and expenses, including attorney's fees, \"\n",
      "                  'reasonably incurred.1.40 \"Net Sales\" shall mean, for an '\n",
      "                  'applicable period, the aggregate amount, without '\n",
      "                  'duplication, equal to the Specialty Pharmacy Net Sales for '\n",
      "                  'each SKU, the Retail Net Sales for each SKU, if any, and '\n",
      "                  'the Non-Retail Net Sales f',\n",
      "        'context': '\" shall have the meaning set forth in Section 3.1.1.38 '\n",
      "                   '\"Know-How\" shall mean information, whether or not in '\n",
      "                   'written form, including biological, chemical, '\n",
      "                   'pharmacological, toxicological, medical or clinical, '\n",
      "                   'analytical, quality, manufacturing, research, or sales and '\n",
      "                   'marketing information, including processes, methods, '\n",
      "                   'procedures, techniques, plans, programs and data.1.39 '\n",
      "                   '\"Losses\" shall mean any and all amounts paid or payable to '\n",
      "                   'Third Parties with respect to a Claim (including any and '\n",
      "                   'all losses, damages, obligations, liabilities, fines, '\n",
      "                   'fees, penalties, awards, judgments, interest), together '\n",
      "                   'with all documented out-of- pocket costs and expenses, '\n",
      "                   'including attorney\\'s fees, reasonably incurred.1.40 \"Net '\n",
      "                   'Sales\" shall mean, for an applicable period, the aggregate '\n",
      "                   'amount, without duplication, equal to the Specialty '\n",
      "                   'Pharmacy Net Sales for each SKU, the Retail Net Sales for '\n",
      "                   'each SKU, if any, and the Non-Retail Net Sales for each '\n",
      "                   'SKU.1.41 \"Non-Retail Institution\" shall mean any '\n",
      "                   'institution (other than the Specialty Pharmacies, Retail '\n",
      "                   'Pharmacies and Intermediaries) to which Dova (or its '\n",
      "                   'Affiliates or its Intermediaries) sells and/or ships units '\n",
      "                   'of Product during the Term, which shall include group '\n",
      "                   'purchasing organizations (GPOs), hospitals, clinics, long '\n",
      "                   'term care facilities and any outlets that are a member of '\n",
      "                   'an Integrated Delivery Network (IDN), and with which Dova '\n",
      "                   'or its Affiliates do not have data agreements which '\n",
      "                   'enables Dova to track shipments of Product from such '\n",
      "                   'institution t'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [05:14<00:00, 52.49s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'icians, generally accepted standards of good clinical '\n",
      "                  'practices adopted by current FDA regulations, as well as '\n",
      "                  'any state laws and regulations (i) impacting the promotion '\n",
      "                  'of pharmaceutical products, (ii) governing the provision of '\n",
      "                  'meals',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [04:19<00:00, 43.20s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-27976, -27891) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-25101, -24574) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-27083, -26465) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'l of the terms and conditions hereof in all respects and '\n",
      "                  'shall assume all obligations',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [04:18<00:00, 43.15s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-20465, -20209) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-20465, -20376) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'of this Agreement.13.16 Further Actions and Documents. Each '\n",
      "                  'Party agrees to execute, acknowledge and deliver all such '\n",
      "                  'furtherSource: DOVA PHARMACEUTICALS INC., 10-Q, '\n",
      "                  '11/8/2018instruments, and to do all such further acts, as '\n",
      "                  'may be reasonably necessary or a',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [04:15<00:00, 42.65s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'ons promulgated thereunder.1.2 \"Adverse Event\" shall mean '\n",
      "                  'any untoward medical occurrence in a',\n",
      "        'context': 'ation of the following mutual promises and obligations, '\n",
      "                   'and for other good and valuable consideration the adequacy '\n",
      "                   'and sufficiency of which are hereby acknowledged, the '\n",
      "                   'Parties agree as follows:CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018ARTICLE 1   '\n",
      "                   'DEFINITIONS1.1 \"Act\" shall mean the Federal Food, Drug and '\n",
      "                   'Cosmetic Act, 21 U.S.C. § 301 et seq., as it may be '\n",
      "                   'amended from time to time, and the regulations promulgated '\n",
      "                   'thereunder.1.2 \"Adverse Event\" shall mean any untoward '\n",
      "                   'medical occurrence in a patient or clinical investigation '\n",
      "                   'subject who is administered the Product, but which does '\n",
      "                   'not necessarily have a causal relationship with the '\n",
      "                   'treatment for which the Product is used. An \"Adverse '\n",
      "                   'Event\" can include any unfavorable and unintended sign '\n",
      "                   '(including an abnormal laboratory finding), symptom or '\n",
      "                   'disease temporally associated with the use of the Product, '\n",
      "                   'whether or not related to the Product. A pre-existing '\n",
      "                   'condition that worsened in severity after administration '\n",
      "                   'of the Product would be considered an \"Adverse Event\".1.3 '\n",
      "                   '\"Affiliate\" shall mean, with respect to any Person, any '\n",
      "                   'other Person that directly or indirectly controls, is '\n",
      "                   'controlled by or is under common control with such '\n",
      "                   'Person. '}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [04:12<00:00, 42.03s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '32' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'nd Valeant desires to conduct such activities, for the '\n",
      "                  'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                  'of th',\n",
      "        'context': 'ment (this \"Agreement\") is entered into and dated as of '\n",
      "                   'September 26, 2018 (the \"Effective Date\") by and between '\n",
      "                   'Dova Pharmaceuticals, Inc., a Delaware corporation '\n",
      "                   '(\"Dova\"), and Valeant Pharmaceuticals North America LLC, a '\n",
      "                   'Delaware limited liability company (\"Valeant\"). Dova and '\n",
      "                   'Valeant are each referred to individually as a \"Party\" and '\n",
      "                   'together as the \"Parties\".RECITALSWHEREAS, Dova has '\n",
      "                   'developed and has rights to market and sell the Product '\n",
      "                   '(as defined below) in the Territory;WHEREAS, the Parties '\n",
      "                   'believe that it would be mutually beneficial to '\n",
      "                   'collaborate on promotional activities for the Product and, '\n",
      "                   'accordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulat'}]\n",
      "contract4\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:42<00:00, 37.07s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ions, sales and marketing  materials and technology relatin',\n",
      "        'context': 'f Product;\"PPI Improvement\"   Means any Improvement '\n",
      "                   'generated, conceived, reduced to practice or otherwise '\n",
      "                   'created during the Term by  PPI or any of its '\n",
      "                   'Affiliates;   -10-\"PPI IP\"   Means the Copyrights, PPI '\n",
      "                   \"Know-How, PPI Patents and PPI Improvements; and PPI's \"\n",
      "                   'interest in Joint  Improvements;\"PPI Know-How\"Means all '\n",
      "                   'information, procedures, instructions, techniques, data, '\n",
      "                   'technical information, knowledge and  experience '\n",
      "                   '(including, without limitation, toxicological, '\n",
      "                   'pharmaceutical, clinical, non-clinical and medical data,  '\n",
      "                   'health registration data and marketing data), designs, '\n",
      "                   'dossiers (including, without limitation, manufacturing  '\n",
      "                   'assay and quality control dossiers) manufacturing '\n",
      "                   'formulae, processing specifications, sales and marketing  '\n",
      "                   'materials and technology relating to the Product;\"PPI '\n",
      "                   'Patents\"Means those patents set out in Schedule I which '\n",
      "                   'cover the Products and such other patents as PPI may '\n",
      "                   'include  from time to time, including additions, '\n",
      "                   'divisions, confirmations, continuations-in-part, '\n",
      "                   'substitutions, re-issues,  re-examinations, extensions, '\n",
      "                   'registrations, patent terms extensions, supplementary '\n",
      "                   'protection certificates and  renewals of any of the above '\n",
      "                   'or any other patents owned or licensed by PPI subsequent '\n",
      "                   'to the Effective Date  which cover the Products or any '\n",
      "                   'Improvements;   -11-\"Product(s)\"Means: (i) DepoDur '\n",
      "                   'Injectible Liposomal Epidural [**] mg/ml [**]; (ii) '\n",
      "                   'DepoDur Injectible Liposomal Epidural  [**] mg/[**] ml '\n",
      "                   '[**]; (iii) such other presentations and dosages whic'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:47<00:00, 37.97s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-5261, -5233) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': '(each, a \"Party\"  and collectively, the \"Parties\")',\n",
      "        'context': 'ent in its entirety as set forth herein in order to '\n",
      "                   'provide for: (i) certain  changes to the financial terms '\n",
      "                   'set forth in the Original Agreement, (ii) the transfer of '\n",
      "                   'Marketing Authorizations (as defined below) from PPI '\n",
      "                   \"to      -1-EKR, and EKR's assumption of obligations \"\n",
      "                   'thereunder, (iii) the transfer of title to certain '\n",
      "                   'manufacturing equipment from PPI to EKR and the lease  of '\n",
      "                   'such equipment back from EKR to PPI and (iv) certain other '\n",
      "                   'changes as are set forth herein; all of the foregoing '\n",
      "                   'subject to and in accordance  with the terms and '\n",
      "                   'conditions of this Agreement.NOW THEREFORE, in '\n",
      "                   'consideration of the following mutual agreements and '\n",
      "                   'covenants set forth herein and intending to be legally  '\n",
      "                   'bound hereby, PPI and EKR (each, a \"Party\"  and '\n",
      "                   'collectively, the \"Parties\")  acknowledge and agree that '\n",
      "                   'this Agreement shall amend and  supersede in its entirety '\n",
      "                   'the Original Agreement and hereby agree as '\n",
      "                   'follows:Operative Provisions   -2-1. Definitions   1.1 As '\n",
      "                   'used in this Agreement, the following words and '\n",
      "                   'expressions have the following meanings:\"Affiliate\"With '\n",
      "                   'respect to any Party to this Agreement shall mean any '\n",
      "                   'company, corporation, firm, individual or other  entity '\n",
      "                   'which Controls, is Controlled by or is under common '\n",
      "                   'Control with such Party to this Agreement for only  so '\n",
      "                   'long as such Control exists;   -3-\"Applicable Laws\"Shall '\n",
      "                   'mean all laws, rules and regulations regarding the '\n",
      "                   'manufacture, packaging, labeling, import, export,  '\n",
      "                   'storage, distribution, representation, promotion, marketi'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:48<00:00, 38.07s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9915, -9902) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'OCTOBER 15, 2009',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:51<00:00, 38.61s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'its own cost and expense take all actions necessary to '\n",
      "                  'comply with all Applicable Laws and  obtain and maintain '\n",
      "                  'all necessary license, permits, records and authorizations '\n",
      "                  'PPI is required to obtain and maintain hereunder so as to  '\n",
      "                  'enable PPI to perform its obligations hereunder and under '\n",
      "                  'the Supply Agreement so as to enable EKR to fully exercise '\n",
      "                  'the Distribution  Rights.   3.18 Assignment of ICS '\n",
      "                  'Agreement. The Part',\n",
      "        'context': ' enable EKR to  fully exploit the Distribution Rights '\n",
      "                   'granted hereunder. For purpose of this Section, the '\n",
      "                   'contact person for each of the parties is set forth  '\n",
      "                   'below.3.15 Reserved.   3.16 Recalls and PostMarket '\n",
      "                   'Notifications. All costs of safety alerts and all other '\n",
      "                   'forms of notifications regarding safety risks associated '\n",
      "                   'with the Products in the United States shall be borne by '\n",
      "                   'PPI to the extent arising prior to the Agreement Date and '\n",
      "                   'by EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of '}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|██████████████████████████████████████████████████████| 6/6 [1:04:14<00:00, 642.43s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28469, -28158) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'its own cost and expense take all actions necessary to '\n",
      "                  'comply with all Applicable Laws and  obtain and maintain '\n",
      "                  'all necessary license, permits, records and authorizations '\n",
      "                  'PPI is required to obtain and maintain hereunder so as to  '\n",
      "                  'enable PPI to perform its obligations hereunder and under '\n",
      "                  'the Supply Agreement so as to enable EKR to fully exercise '\n",
      "                  'the Distribution  Rights.   3.18 Assignment of ICS '\n",
      "                  'Agreement. The Part',\n",
      "        'context': ' enable EKR to  fully exploit the Distribution Rights '\n",
      "                   'granted hereunder. For purpose of this Section, the '\n",
      "                   'contact person for each of the parties is set forth  '\n",
      "                   'below.3.15 Reserved.   3.16 Recalls and PostMarket '\n",
      "                   'Notifications. All costs of safety alerts and all other '\n",
      "                   'forms of notifications regarding safety risks associated '\n",
      "                   'with the Products in the United States shall be borne by '\n",
      "                   'PPI to the extent arising prior to the Agreement Date and '\n",
      "                   'by EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:42<00:00, 37.16s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'ies acknowledge that effective upon the termination or '\n",
      "                  'expiration of the Transition Services and Inventory Agree',\n",
      "        'context': ' forms of notifications regarding safety risks associated '\n",
      "                   'with the Products in the United States shall be borne by '\n",
      "                   'PPI to the extent arising prior to the Agreement Date and '\n",
      "                   'by EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of  the Effective Date, the Parties have entered into an '\n",
      "                   'Assignment and Assumption Agreement to further evidence '\n",
      "                   'the foregoing assignment  and assumption of the ICS '\n",
      "                   'Agreement.   3.19 Product in Channel. All sales of Product '\n",
      "                   'conducted by PPI and its distributors and wh'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:51<00:00, 38.54s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'The Lease Term shall automatically renew at the end of each '\n",
      "                  'calendar quarter of  the Lease Term.',\n",
      "        'context': 'n principal amount of [**]  Dollars ($[**]), such note to '\n",
      "                   'be substantially in the form attached hereto as Exhibit '\n",
      "                   '3.20(b) (the \"Promissory Note\").  (c) Commencing as of the '\n",
      "                   'Agreement Date, EKR agrees to lease the Transferred '\n",
      "                   'Equipment to PPI through the end of the then-current  '\n",
      "                   'calendar quarter and, subject to renewal as provided '\n",
      "                   'below, on a calendar quarter-to-calendar quarter   '\n",
      "                   '-21-basis thereafter (the \"Lease Term\"), for use solely in '\n",
      "                   \"connection with the (i) performance of PPI's obligations \"\n",
      "                   'under the Supply  Agreement, (ii) the supply of Products '\n",
      "                   \"to PPI's other licensees and collaborators and (iii) the \"\n",
      "                   \"supply of placebo for PPI's Exparel  product to PPI's \"\n",
      "                   'other licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; '}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:57<00:00, 39.51s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-14412, -14055) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': '(including, but not limited to, any license or other rights '\n",
      "                  'of PPI or any of its Affiliates, whether as a licensor,  '\n",
      "                  'licensee or otherwise relation to any of the fore',\n",
      "        'context': ' in relation to any Party or an Affiliate the possession '\n",
      "                   'directly or indirectly, of the power to direct or  cause '\n",
      "                   'the direction of the management and policies of such firm, '\n",
      "                   'person or entity, by contract or otherwise, or  the '\n",
      "                   'ownership either directly or indirectly of 50% or more of '\n",
      "                   'the voting securities of such Party;\"Copyrights\"Means (i) '\n",
      "                   'the copyright registrations and applications for '\n",
      "                   'registration identified on Schedule III, (ii) works of  '\n",
      "                   'authorship whether or not copyrightable and (iii) any '\n",
      "                   'other copyrights and works, together with all common law  '\n",
      "                   'rights, used or held for use by PPI or any of its '\n",
      "                   'Affiliates in connection with the Products in the '\n",
      "                   'Territory  (including, but not limited to, any license or '\n",
      "                   'other rights of PPI or any of its Affiliates, whether as a '\n",
      "                   'licensor,  licensee or otherwise relation to any of the '\n",
      "                   'foregoing);\"Current Base Price\"    Means the Product\\'s '\n",
      "                   'current (as of the Effective Date) net average selling '\n",
      "                   'price of $[**] ([**] mg) and $[**]  ([**] mg);\"DEA\"    '\n",
      "                   'Shall mean the United States Drug Enforcement '\n",
      "                   'Administration and any successor thereto performing '\n",
      "                   'similar  functions;\"Distribution Rights\"   Shall have the '\n",
      "                   'meaning set forth in Section 2.1 hereof;\"Domain Name\"    '\n",
      "                   'Shall mean Depodur.com and any other domain names owned or '\n",
      "                   'licensed by PPI related to the Product set forth  on '\n",
      "                   'Schedule IV hereto;   -6-\"EKR Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'other created during the Term by EKR or  any of its '\n",
      "                   'Affiliates.Endo'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [04:00<00:00, 40.11s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-32724, -32399) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 't described in Section 17.5 below.(d) At any time between '\n",
      "                  'the Agreement Date and July 1, 2015, EKR shall have the',\n",
      "        'context': 'r and, subject to renewal as provided below, on a calendar '\n",
      "                   'quarter-to-calendar quarter   -21-basis thereafter (the '\n",
      "                   '\"Lease Term\"), for use solely in connection with the (i) '\n",
      "                   \"performance of PPI's obligations under the Supply  \"\n",
      "                   \"Agreement, (ii) the supply of Products to PPI's other \"\n",
      "                   'licensees and collaborators and (iii) the supply of '\n",
      "                   \"placebo for PPI's Exparel  product to PPI's other \"\n",
      "                   'licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; and '\n",
      "                   '(ii) the termination of the Step-in Right described in  '\n",
      "                   'Section 17.5.(e) At any time after July 1, 2015, PPI shall '\n",
      "                   'have the right, exercisable upon sixty (60) days prior '\n",
      "                   'written notice to EKR, to terminate the Lease Term and '\n",
      "                   'repurchase the Transferred Equipment from EKR, subject to '\n",
      "                   'payment'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:49<00:00, 38.27s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-779, -564) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-19849, -19217) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-1223, -1213) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'g, Distribution and Marketing  Agreement dated as of '\n",
      "                  'October  , 2009 by and between Maker and Payee (the '\n",
      "                  '\"Agreement\")  and is subject to the terms thereof. This '\n",
      "                  'Note is  subject to offset as expressly provided for i',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:49<00:00, 38.19s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'ts that: (i) prior to the Agreement Date, it has provided '\n",
      "                  'EKR with complete, up- to-date copies of the Transferred '\n",
      "                  'NDA and all material correspondence with Regulatory '\n",
      "                  'Authorities in the   -15-Territory in connection with the '\n",
      "                  'Transferred NDA (including, but not limited to, any '\n",
      "                  'periodic and annual report submissions, and all  adverse '\n",
      "                  'event reports and data) and (ii) on the Agreement Date, EKR '\n",
      "                  'shall receive sole ownersh',\n",
      "        'context': 'th the terms and conditions of the Supply Agreement.   3.2 '\n",
      "                   'Transfer of Transferred NDA. Effective as of the Agreement '\n",
      "                   'Date, PPI hereby sells, transfers, conveys and assigns to '\n",
      "                   'EKR all right, title  and interest in and to [**] (the '\n",
      "                   '\"Transferred NDA\"). Each Party shall, within five (5) '\n",
      "                   'business days after the Agreement Date, file with the  FDA '\n",
      "                   'a notice letter, substantially in the form attached as '\n",
      "                   'Schedule XI(A) or Schedule XI(B) (as applicable), '\n",
      "                   'regarding the transfer to EKR of  the Transferred NDA. PPI '\n",
      "                   'represents, warrants and covenants that: (i) prior to the '\n",
      "                   'Agreement Date, it has provided EKR with complete, up- '\n",
      "                   'to-date copies of the Transferred NDA and all material '\n",
      "                   'correspondence with Regulatory Authorities in the   '\n",
      "                   '-15-Territory in connection with the Transferred NDA '\n",
      "                   '(including, but not limited to, any periodic and annual '\n",
      "                   'report submissions, and all  adverse event reports and '\n",
      "                   'data) and (ii) on the Agreement Date, EKR shall receive '\n",
      "                   'sole ownership of, and good and valid title to, the  '\n",
      "                   'Transferred NDA, free and clear of any liens and '\n",
      "                   'encumbrances. For the avoidance of doubt, nothing in this '\n",
      "                   \"Agreement regarding the  appointment of EKR as PPI's \"\n",
      "                   'distributor of the Products shall be construed to diminish '\n",
      "                   'any rights of EKR as holder of the Transferred  NDA. Upon '\n",
      "                   'termination of this Agreement for any reason except by EKR '\n",
      "                   'pursuant to Section 16.1(a), EKR shall promptly transfer '\n",
      "                   'the Transferred NDA and related regulatory documentation '\n",
      "                   'to PPI in accordance with Section 17.1(e).   3.3 '}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:52<00:00, 38.80s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-30903, -30294) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-30903, -30869) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'f Control shall also include (in addition to any of the '\n",
      "                  'transactions described above in the definition of Change '\n",
      "                  'of  Control), any sale of securities of PPI or its '\n",
      "                  'Affiliates directly by the holder (the \"Holder\") of such '\n",
      "                  'securities (other than to an Affiliate of  such Holder) in '\n",
      "                  'which such sale results in a transfer of more than 50% of '\n",
      "                  'the outstanding voting stock of PPI or its Affiliates.21. '\n",
      "                  'General Provisions   21.1 Relationship of the Parties. '\n",
      "                  'Nothing in this agreement is deemed to constitute a '\n",
      "                  'partnership, agency, employer-employee or joint venture '\n",
      "                  'relationship between the Parties. No Party shall i',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [03:54<00:00, 39.06s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-30903, -30869) with a span answer. \n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '33' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'bination with the Trademarks.   2.3 Grant of Trademark '\n",
      "                  'Rights. PPI hereby grants to EKR a royalty free and '\n",
      "                  'exclusive license (with the right to sublicense) to use '\n",
      "                  'the  Trademarks in the Territory solely in conn',\n",
      "        'context': 'ouse the Products (the \"Distribution Rights\") in the Field '\n",
      "                   'in the Territory during the Term, as  well as to make or '\n",
      "                   'have made the Products anywhere in the world for import or '\n",
      "                   'sale in the Field in the Territory in each case, under the '\n",
      "                   'PPI  IP provided that PPI retains all rights necessary to '\n",
      "                   'manufacture and supply the Products to EKR in accordance '\n",
      "                   'with this Agreement and the  Supply Agreement. Such grant '\n",
      "                   'by PPI shall include the right of EKR to market the '\n",
      "                   'Product in the Territory during the Term as an EKR  '\n",
      "                   \"product using in addition to the Trademarks, EKR's own \"\n",
      "                   'trademarks, trade dress, trade names and other proprietary '\n",
      "                   'designations in  combination with the Trademarks.   2.3 '\n",
      "                   'Grant of Trademark Rights. PPI hereby grants to EKR a '\n",
      "                   'royalty free and exclusive license (with the right to '\n",
      "                   'sublicense) to use the  Trademarks in the Territory solely '\n",
      "                   'in connection with the exercise of the Distribution Rights '\n",
      "                   'in the Territory during the Term (and thereafter  as set '\n",
      "                   'forth in Section 17.4) and EKR shall market and sell the '\n",
      "                   'Products under the Trademarks. For the avoidance of doubt, '\n",
      "                   'the term  \"exclusive\" for the   -14-purposes of Sections '\n",
      "                   '2.1, 2.2 and 2.3 means to the exclusion of all others, '\n",
      "                   'including PPI and its Affiliates, except to the extent '\n",
      "                   'necessary to  enable PPI to perform its specific '\n",
      "                   'obligations under this Agreement and the Supply Agreement. '\n",
      "                   'Notwithstanding the foregoing, nothing  contained herein '\n",
      "                   'shall prohibit PPI from utilizing the Trademarks in the '\n",
      "                   'Territory in connection with its'}]\n",
      "contract5\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.52s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ENDORSEMENT',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.78s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Thrivent Life Insurance Company',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.87s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.16s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.93s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.09s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                  'dissolved.',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|███████████████████████████████████████████████████████| 1/1 [41:50<00:00, 2510.03s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                  'dissolved.',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:09<00:00,  9.87s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Entire Contract consists of: 1) This contract including any '\n",
      "                  'attached riders, amendments, or endorsements; 2) The '\n",
      "                  'Application attached to this contract; and 3) The Articles '\n",
      "                  'of Incorporation and Bylaws of the Society and all '\n",
      "                  'amendments to them.',\n",
      "        'context': 'tract are amended:DEFINITIONSThe DEFINITIONS section of '\n",
      "                   'the contract is amended to include the following:Service '\n",
      "                   'Center. Where this contract is administered. Our Service '\n",
      "                   'Center address is 4321 North Ballard Road, Appleton, WI '\n",
      "                   '54919-0001.And in the DEFINITIONS section, the '\n",
      "                   'definition:We, Our, Us. Lutheran Brotherhood Variable '\n",
      "                   'Insurance Products Company.Which previously was amended to '\n",
      "                   'read:We, Our, Us. Thrivent Life Insurance Company.Is '\n",
      "                   'amended to read:We, we, Our, our, Us, us, Society. '\n",
      "                   'Thrivent Financial for Lutherans.ENTIRE CONTRACTIn the '\n",
      "                   'ENTIRE CONTRACT section, the first phrase and numbered '\n",
      "                   'list are amended to read:The Entire Contract consists of: '\n",
      "                   '1) This contract including any attached riders, '\n",
      "                   'amendments, or endorsements; 2) The Application attached '\n",
      "                   'to this contract; and 3) The Articles of Incorporation and '\n",
      "                   'Bylaws of the Society and all amendments to them. Benefits '\n",
      "                   'will not be reduced or eliminated by any future amendments '\n",
      "                   'to our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheran'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.70s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                  'dissolved.',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.02s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Rights and privileges of membership are set forth in the '\n",
      "                  'Articles of Incorporation and Bylaws of the Society.',\n",
      "        'context': 'ded through the General Account. If the solvency of the '\n",
      "                   'Society becomes impaired, you may be required to make an '\n",
      "                   'extra payment. The Board of Directors will determine the '\n",
      "                   'amount of any extra payment. It will be based on each '\n",
      "                   \"member's fair share of the deficiency. You may make the \"\n",
      "                   'extra payment by an equivalent reduction in benefits or by '\n",
      "                   'a payment in cash. If you do not make the extra payment '\n",
      "                   'within 60 days from the date we notify you of your share '\n",
      "                   'of the deficiency, the amount will be charged as an '\n",
      "                   'indebtedness against the contract with interest compounded '\n",
      "                   'at the rate of 5% per year.MEMBERSHIP. The person(s) named '\n",
      "                   'as the Insured(s) or the Annuitant(s) is a benefit member '\n",
      "                   'of the Society. Rights and privileges of membership are '\n",
      "                   'set forth in the Articles of Incorporation and Bylaws of '\n",
      "                   'the Society. These rights and privileges are separate from '\n",
      "                   'the ownership of this contract.DIVIDENDS. Each year, we '\n",
      "                   \"will determine our divisible surplus. This contract's \"\n",
      "                   'share, if any, will be credited as a dividend. Since we do '\n",
      "                   'not expect this contract to contribute to divisible '\n",
      "                   'surplus, it is not expected that any dividends will be '\n",
      "                   'credited.DIVIDEND OPTIONS. If dividends are credited after '\n",
      "                   'premiums can no longer be paid under this contract, '\n",
      "                   'dividends will be paid in cash. Otherwise, dividends will '\n",
      "                   'be applied under the Payment of Premium option unless the '\n",
      "                   'Cash option has been chosen in writing.Cash. Dividends are '\n",
      "                   'paid in cash.Payment of Premium. Dividends are applied as '\n",
      "                   'payment of a Net Premium. VB'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.96s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                  'is a benefit member of the Society. Rights and privileges '\n",
      "                  'of membership are set forth in the Articles of '\n",
      "                  'Incorporation and Bylaws of the Society. These rights and '\n",
      "                  'privileges are separate from the ownership of this '\n",
      "                  'contract.',\n",
      "        'context': 'ts provided through the General Account. If the solvency '\n",
      "                   'of the Society becomes impaired, you may be required to '\n",
      "                   'make an extra payment. The Board of Directors will '\n",
      "                   'determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under this contract, dividends will be paid '\n",
      "                   'in cash. Otherwise, dividends will be applied under the '\n",
      "                   'Payment of Premium option unless the Cash option has been '\n",
      "                   'chosen in writing.Cash. Dividends are paid in cash.Payment '\n",
      "                   'of Premium. Dividends are applied as payment of a Net Pre'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.57s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'If',\n",
      "        'context': 'his contract remain unchanged except as described '\n",
      "                   'below.You may direct inquiries to:Thrivent Financial for '\n",
      "                   'Lutherans 4321 N. Ballard Road Appleton, WI 54919-0001 '\n",
      "                   '(800) 847-4836The following amendments apply in lieu of '\n",
      "                   'any contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.97s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '34' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'Thrivent Life Insurance Company',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n"
     ]
    }
   ],
   "source": [
    "if __name__ == '__main__':\n",
    "    test4()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "b6698b98",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model5 Result\n",
      "contract1\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.54s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'SUPPLY CONTRACT',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.43s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD',\n",
      "        'context': 'act is concluded and signed by the Buyer and Seller on , '\n",
      "                   'in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'seller accepts, any party shall not unilaterally cancel '\n",
      "                   'the order before the two sides agreed . 2.3 If the '}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.70s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is concluded and signed by the Buyer and '\n",
      "                  'Seller on , in Hong Kong.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.27s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.09s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is valid for 5 years, beginning from and ended '\n",
      "                  'on .',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.58s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'During the validity term of this agreement,',\n",
      "        'context': 'ement Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: '\n",
      "                   'The Contract is concluded and signed by the Buyer and '\n",
      "                   'Seller on , in Hong Kong. 1. General provisions 1.1 This '\n",
      "                   'is a framework agreement, the terms and conditions are '\n",
      "                   'applied to all purchase orders which signed by this '\n",
      "                   'agreement (hereinafter referred to as the \"order\"). 1.2 If '\n",
      "                   'the provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'seller accepts, any party shall not unil'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.08s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.29s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': \"It will be governed by the law of the People's Republic of \"\n",
      "                  'China ,otherwise it is governed by United Nations '\n",
      "                  'Convention on Contract for the International Sale of Goods.',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.74s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'In case the accident lasts for more than 10 weeks, the '\n",
      "                  'Buyers shall have the right to cancel the Contract.',\n",
      "        'context': 'l not be held responsible for the delay in shipment or '\n",
      "                   'non-delivery, of the goods due to Force Majeure, which '\n",
      "                   'might occur during the process of manufacturing or in the '\n",
      "                   'course of loading or transit. The Sellers shall advise the '\n",
      "                   'Buyers immediately of the occurrence mentioned above and '\n",
      "                   'within fourteen days thereafter, the Sellers shall send by '\n",
      "                   'airmail to the Buyers a certificate of the accident issued '\n",
      "                   'by the competent government authorities, Chamber of '\n",
      "                   'Commerce or registered notary public of the place where '\n",
      "                   'the accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, th'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.51s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Any modification, supplementary, give up should been '\n",
      "                  'written records, only to be valid by buyers and sellers '\n",
      "                  'authorized representative signature and confirmation, '\n",
      "                  'otherwise will be deemed invalid.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.54s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'The penalty, however, shall not exceed 5% of the total '\n",
      "                  'value of the goods involved in the late delivery.',\n",
      "        'context': 'rce or registered notary public of the place where the '\n",
      "                   'accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, the Buyers have the right to '\n",
      "                   'cancel the contract and the Sellers, in spite of the '\n",
      "                   'cancellation, shall still pay the aforesaid penalty to the '\n",
      "                   'Buyers without delay, the seller should refund the money '\n",
      "                   'received and pay the 30% of the total goods price of the '\n",
      "                   'penalty 19. ARBITRATION: All disputes in connection with '\n",
      "                   'this Contract or the execution thereof shall be settled '\n",
      "                   'friendly through negotiations. In case no settlement can '\n",
      "                   'be reached, the case may then be sub'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.73s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.51s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '40' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': '(5) One copy of insurance coverage (6) Copy of cable/letter '\n",
      "                  'to the transportation department of Buyer advising of '\n",
      "                  'particulars as to shipment immediately after shipment is '\n",
      "                  'made.',\n",
      "        'context': 'ped will be paid against the documents stipulated in '\n",
      "                   'Clause 12.2. The Letter of Credit shall be valid until 90 '\n",
      "                   'days after the latest shipment is effected. Under the T/T '\n",
      "                   'The trustee of the buyer remitted the goods to the seller '\n",
      "                   'by telegraphic transfer in batches as agreed upon after '\n",
      "                   'signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 '\n",
      "                   'originals indicating contract number and Shipping Mark (in '\n",
      "                   'case of more than one shipping mark, the invoice shall be '\n",
      "                   'issued separately). (2) One certificate of origin of the '\n",
      "                   'goods. (3) Four original copies of the packing list. (4) '\n",
      "                   'Certificate of Quality and Quantity in 1 original issued '\n",
      "                   'by the agriculture products base. (5) One copy of '\n",
      "                   'insurance coverage (6) Copy of cable/letter to the '\n",
      "                   'transportation department of Buyer advising of particulars '\n",
      "                   'as to shipment immediately after shipment is made.3Source: '\n",
      "                   'LOHA CO. LTD., F-1, 12/9/201912.2 (1) Invoice in 3 '\n",
      "                   'originals indicating contract number and L/C number. (2) '\n",
      "                   'Final acceptance certificate signed by the Buyer and the '\n",
      "                   'Seller. 13. SHIPMENT: CIP The seller shall contract on '\n",
      "                   'usual terms at his own expenses for the carriage of the '\n",
      "                   'goods to the agreed point at the named place of '\n",
      "                   'destination and bear all risks and expenses until the '\n",
      "                   'goods have been delivered to the port of destination. The '\n",
      "                   'Sellers shall ship the goods within the shipment time from '\n",
      "                   'the port of shipment to the port of destination. '\n",
      "                   'Transshipment is allowed. Partial Shipment is allowed. In '\n",
      "                   'case the goods are to be dispatched by parcel post/'}]\n",
      "contract2\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.59s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'WEB SITE HOSTING AGREEMENT',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.55s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'I-ON INTERACTIVE, INC.',\n",
      "        'context': 'll be effective, except pursuant to a written instrument '\n",
      "                   'signed by the party or parties waiving compliance, and any '\n",
      "                   'such waiver shall be effective only in the specific '\n",
      "                   'instance and for the specific purpose stated in such '\n",
      "                   'writing.In the event that any provision hereof is found '\n",
      "                   'invalid or unenforceable pursuant to judicial decree or '\n",
      "                   'decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '-------------------------               '\n",
      "                   '----------------------------- Name: John J. '\n",
      "                   'Lofquist                  Name:   Anna Talerico Title: '\n",
      "                   'President & CEO                  Title:  Vice President'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.73s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.61s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.66s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The term of this Agreement for the Hosted Site shall '\n",
      "                  'commence upon April 1, 1999 and shall continue for a period '\n",
      "                  'of six (6) months, unless earlier terminated in accordance '\n",
      "                  'with provisions hereof.',\n",
      "        'context': \"h any of i-on'sservices, any information that is, in \"\n",
      "                   \"i-on's sole discretion, unlawful, obscene, threatening, \"\n",
      "                   'abusive, libelous, or harmful, or encourages conduct that '\n",
      "                   'would constitute a criminal offense, give rise to civil '\n",
      "                   'liability, or otherwise violate any local, state, '\n",
      "                   'national, or International law.The Customer expressly '\n",
      "                   \"agrees to use all of i-on's services only for lawful \"\n",
      "                   'purposes. Transmission or storage of any information, '\n",
      "                   'data, or material in violation of United States or state '\n",
      "                   'regulation or law is prohibited, including but not limited '\n",
      "                   'to, material protected by copyright, trademark, trade '\n",
      "                   'secret, or any other statute.TERM AND TERMINATIONThe term '\n",
      "                   'of this Agreement for the Hosted Site shall commence upon '\n",
      "                   'April 1, 1999 and shall continue for a period of six (6) '\n",
      "                   'months, unless earlier terminated in accordance with '\n",
      "                   'provisions hereof. This Agreement shall automatically be '\n",
      "                   'renewed for one (1) or more one (1) month periods unless '\n",
      "                   'either the Customer or i-on gives notice to the other '\n",
      "                   'party of its intention not to renew the4 Agreement, which '\n",
      "                   'notice must be given not less than fifteen (15) days '\n",
      "                   'before the end of the respective initial or renewal '\n",
      "                   'term.Either party may terminate this Agreement without '\n",
      "                   \"cause at any time effective upon thirty (30) days' written \"\n",
      "                   'notice. Notwithstanding anything to the contrary contained '\n",
      "                   'in this Agreement, no termination of this Agreement for '\n",
      "                   'any reason whatsoever shall relieve the Customer of the '\n",
      "                   'obligation to pay all amounts due to i-on and to make '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.95s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement shall automatically be renewed for one (1) '\n",
      "                  'or more one (1) month periods unless either the Customer or '\n",
      "                  'i-on gives notice to the other party of its intention not '\n",
      "                  'to renew the4 Agreement, which notice must be given not '\n",
      "                  'less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'y local, state, national, or International law.The '\n",
      "                   \"Customer expressly agrees to use all of i-on's services \"\n",
      "                   'only for lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to \"}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.65s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.53s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement was entered into in the State of Florida, '\n",
      "                  'and its validity, construction, interpretation, and legal '\n",
      "                  'effect shall be governed by the laws and judicial decisions '\n",
      "                  'of the State of Florida applicable to contracts entered '\n",
      "                  'into and performed entirely within the State of Florida.',\n",
      "        'context': ' the name of the other party or to bind such other party '\n",
      "                   'in any manner.No waiver of any provision of this Agreement '\n",
      "                   'or any rights or obligations of either party hereunder '\n",
      "                   'shall be effective, except pursuant to a written '\n",
      "                   'instrument signed by the party or parties waiving '\n",
      "                   'compliance, and any such waiver shall be effective only in '\n",
      "                   'the specific instance and for the specific purpose stated '\n",
      "                   'in such writing.In the event that any provision hereof is '\n",
      "                   'found invalid or unenforceable pursuant to judicial decree '\n",
      "                   'or decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '--------------------'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.53s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.92s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.72s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': \"i-on's liability for damages to the Customer for any cause \"\n",
      "                  'whatsoever, regardless of the form of action, and whether '\n",
      "                  'in contract or in tort, including negligence, shall be '\n",
      "                  \"limited to one (1) month's fees and the remaining portion \"\n",
      "                  'of any prepaid fees.',\n",
      "        'context': '15) days before the end of the respective initial or '\n",
      "                   'renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to the Customer for \"\n",
      "                   'any cause whatsoever, regardless of the form of action, '\n",
      "                   'and whether in contract or in tort, including negligence, '\n",
      "                   \"shall be limited to one (1) month's fees and the remaining \"\n",
      "                   'portion of any prepaid fees.INDEMNIFICATIONThe Customer '\n",
      "                   'agrees to indemnify and hold harmless i-on, against any '\n",
      "                   'lawsuits, claims, damages, or liabilities (or actions or '\n",
      "                   'proceedings in respect thereof) to which i-on may become '\n",
      "                   \"subject related to or arising out of Customer's use of \"\n",
      "                   \"i-on's services, and will reimburse i-on for all legal and \"\n",
      "                   \"other expenses, including attorney's fees, incurred in \"\n",
      "                   'connection with investigating, defending, or settling any '\n",
      "                   'such loss, claim, damage, liability, action, or proceeding '\n",
      "                   'whether or not in connection with pending or threatened '\n",
      "                   'litigation in which i-on is a party. The provisions of '\n",
      "                   'this Agreement relating to ind'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:08<00:00,  8.12s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'not less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'r lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to the Customer for \"\n",
      "                   'any cause whatsoever, regardless of the form of action, '\n",
      "                   'and whether in contract or in tort, inclu'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.84s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '41' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "contract3\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:22<00:00, 13.79s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'CO-PROMOTION AGREEMENT',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:25<00:00, 14.22s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22842, -22820) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Valeant Pharmaceuticals North America LLC, a Delaware '\n",
      "                  'limited liability company (\"Valeant\"). Dova and Valeant are '\n",
      "                  'each referred to individually as a \"Party\" and together as '\n",
      "                  'the \"Parties\".',\n",
      "        'context': '.16 Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the following mutual promises and obligations, and for '\n",
      "                   'other good and valuable consideration the adequacy and '\n",
      "                   'sufficiency of which are hereby acknowledged, the Parties '\n",
      "                   'agree as follows:CONFIDENTIAL TREATMENT HAS BE'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:25<00:00, 14.30s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.83s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:16<00:00, 12.79s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended f',\n",
      "        'context': 'ccordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Ad'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.92s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended f',\n",
      "        'context': 'ccordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Ad'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.89s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28588, -28480) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'icians, generally accepted standards of good clinical '\n",
      "                  'practices adopted by current FDA regulations, as well as '\n",
      "                  'any state laws and regulations (i) impacting the promotion '\n",
      "                  'of pharmaceutical products, (ii) governing the provision of '\n",
      "                  'meals',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.92s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13683, -13613) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6773, -6703) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'ments, interest), together with all documented out-of- '\n",
      "                  \"pocket costs and expenses, including attorney's fees, \"\n",
      "                  'reasonably incurred.1.40 \"Net Sales\" shall mean, for an '\n",
      "                  'applicable period, the aggregate amount, without '\n",
      "                  'duplication, equal to the Specialty Pharmacy Net Sales for '\n",
      "                  'each SKU, the Retail Net Sales for each SKU, if any, and '\n",
      "                  'the Non-Retail Net Sales f',\n",
      "        'context': '\" shall have the meaning set forth in Section 3.1.1.38 '\n",
      "                   '\"Know-How\" shall mean information, whether or not in '\n",
      "                   'written form, including biological, chemical, '\n",
      "                   'pharmacological, toxicological, medical or clinical, '\n",
      "                   'analytical, quality, manufacturing, research, or sales and '\n",
      "                   'marketing information, including processes, methods, '\n",
      "                   'procedures, techniques, plans, programs and data.1.39 '\n",
      "                   '\"Losses\" shall mean any and all amounts paid or payable to '\n",
      "                   'Third Parties with respect to a Claim (including any and '\n",
      "                   'all losses, damages, obligations, liabilities, fines, '\n",
      "                   'fees, penalties, awards, judgments, interest), together '\n",
      "                   'with all documented out-of- pocket costs and expenses, '\n",
      "                   'including attorney\\'s fees, reasonably incurred.1.40 \"Net '\n",
      "                   'Sales\" shall mean, for an applicable period, the aggregate '\n",
      "                   'amount, without duplication, equal to the Specialty '\n",
      "                   'Pharmacy Net Sales for each SKU, the Retail Net Sales for '\n",
      "                   'each SKU, if any, and the Non-Retail Net Sales for each '\n",
      "                   'SKU.1.41 \"Non-Retail Institution\" shall mean any '\n",
      "                   'institution (other than the Specialty Pharmacies, Retail '\n",
      "                   'Pharmacies and Intermediaries) to which Dova (or its '\n",
      "                   'Affiliates or its Intermediaries) sells and/or ships units '\n",
      "                   'of Product during the Term, which shall include group '\n",
      "                   'purchasing organizations (GPOs), hospitals, clinics, long '\n",
      "                   'term care facilities and any outlets that are a member of '\n",
      "                   'an Integrated Delivery Network (IDN), and with which Dova '\n",
      "                   'or its Affiliates do not have data agreements which '\n",
      "                   'enables Dova to track shipments of Product from such '\n",
      "                   'institution t'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.19s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28588, -28480) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'icians, generally accepted standards of good clinical '\n",
      "                  'practices adopted by current FDA regulations, as well as '\n",
      "                  'any state laws and regulations (i) impacting the promotion '\n",
      "                  'of pharmaceutical products, (ii) governing the provision of '\n",
      "                  'meals',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:16<00:00, 12.78s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-27976, -27891) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13288, -13116) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'l of the terms and conditions hereof in all respects and '\n",
      "                  'shall assume all obligations',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.98s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-8074, -7659) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-20465, -20209) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'ugs to the FDA. Visit www.fda.gov/medwatch or call 1-800- '\n",
      "                  'FDA-1088.CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                  'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE '\n",
      "                  'INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS '\n",
      "                  'ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT '\n",
      "                  'HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE '\n",
      "                  'COMMISSION.Source: DOVA PHARMACEUTICALS INC., 10-Q, '\n",
      "                  '11/8/2018For p',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.88s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6806, -6437) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'licensed, developed, and marketed innovative products to '\n",
      "                  \"improve patients' lives and arm health care providers with \"\n",
      "                  'life-changing solutions for many chronic and debilitating '\n",
      "                  'conditions. Salix currently markets its product line to '\n",
      "                  'U.S. health care providers through an expanded sales force '\n",
      "                  'that focuses on gastroenterology, hepatology, pain '\n",
      "                  'specialists, and primary care',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.21s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '42' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'ive Remedies. 4613.14 Waiver of Rule of Construction. '\n",
      "                  '4613.15 Use of Names. 4613.16 Further Actions and '\n",
      "                  'Documents. 4713.17 Certain Conventions. 4713.18 '\n",
      "                  'Counterparts. 47iiiCONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                  'REQUESTED FOR PORTIONS OF',\n",
      "        'context': 'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF CONTENTS '\n",
      "                   '(continued)12.6 Survival. 43ARTICLE 13 MISCELLANEOUS '\n",
      "                   '4313.1 Force Majeure. 4313.2 Assignment. 4313.3 '\n",
      "                   'Severability. 4413.4 Notices. 4413.5 Governing Law. 4513.6 '\n",
      "                   'Dispute Resolution. 4513.7 Waiver of Jury Trial. 4513.8 '\n",
      "                   'Entire Agreement; Amendments. 4613.9 Headings. 4613.10 '\n",
      "                   'Independent Contractors. 4613.11 Third Party '\n",
      "                   'Beneficiaries. 4613.12 Waiver. 4613.13 Cumulative '\n",
      "                   'Remedies. 4613.14 Waiver of Rule of Construction. 4613.15 '\n",
      "                   'Use of Names. 4613.16 Further Actions and Documents. '\n",
      "                   '4713.17 Certain Conventions. 4713.18 Counterparts. '\n",
      "                   '47iiiCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018CO-PROMOTION AGREEMENTThis Co-Promotion '\n",
      "                   'Agreement (this \"Agreement\") is entered into and dated as '\n",
      "                   'of September 26, 2018 (the \"Effective Date\") by and '\n",
      "                   'between Dova Pharmaceuticals, Inc., a Delaware corporation '\n",
      "                   '(\"Dova\"), and Valeant Pharmaceuticals North America LLC, a '\n",
      "                   'Delaware limited liability company (\"Valeant\"). Dova and '\n",
      "                   'Valeant are each referred'}]\n",
      "contract4\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:08<00:00, 11.45s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'processing specifications, sales and marketing  materials '\n",
      "                  'and technology relatin',\n",
      "        'context': 'ng price of Product;\"PPI Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'otherwise created during the Term by  PPI or any of its '\n",
      "                   'Affiliates;   -10-\"PPI IP\"   Means the Copyrights, PPI '\n",
      "                   \"Know-How, PPI Patents and PPI Improvements; and PPI's \"\n",
      "                   'interest in Joint  Improvements;\"PPI Know-How\"Means all '\n",
      "                   'information, procedures, instructions, techniques, data, '\n",
      "                   'technical information, knowledge and  experience '\n",
      "                   '(including, without limitation, toxicological, '\n",
      "                   'pharmaceutical, clinical, non-clinical and medical data,  '\n",
      "                   'health registration data and marketing data), designs, '\n",
      "                   'dossiers (including, without limitation, manufacturing  '\n",
      "                   'assay and quality control dossiers) manufacturing '\n",
      "                   'formulae, processing specifications, sales and marketing  '\n",
      "                   'materials and technology relating to the Product;\"PPI '\n",
      "                   'Patents\"Means those patents set out in Schedule I which '\n",
      "                   'cover the Products and such other patents as PPI may '\n",
      "                   'include  from time to time, including additions, '\n",
      "                   'divisions, confirmations, continuations-in-part, '\n",
      "                   'substitutions, re-issues,  re-examinations, extensions, '\n",
      "                   'registrations, patent terms extensions, supplementary '\n",
      "                   'protection certificates and  renewals of any of the above '\n",
      "                   'or any other patents owned or licensed by PPI subsequent '\n",
      "                   'to the Effective Date  which cover the Products or any '\n",
      "                   'Improvements;   -11-\"Product(s)\"Means: (i) DepoDur '\n",
      "                   'Injectible Liposomal Epidural [**] mg/ml [**]; (ii) '\n",
      "                   'DepoDur Injectible Liposomal Epidural  [**] mg/[**] ml '\n",
      "                   '[**]; (iii) such other presentations and do'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:11<00:00, 11.86s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'mprov',\n",
      "        'context': 'any acts, events, non-happenings, omissions or accidents '\n",
      "                   'beyond the  reasonable control of the Party to perform and '\n",
      "                   'in particular but without limiting the generality thereof '\n",
      "                   'shall  include strikes and labor disturbances, lock-outs, '\n",
      "                   'industrial action, civil commotion, riot, invasion, war, '\n",
      "                   'threat of  or preparation for war, terrorist activity, '\n",
      "                   'fire, explosion, storm, flood, earthquake, subsidence, '\n",
      "                   'epidemic or other  natural physical disaster, '\n",
      "                   'impossibility of the use of railways, shipping, aircraft, '\n",
      "                   'motor transport, or other means  of public or private '\n",
      "                   'transport, failure or suspension of utilities, '\n",
      "                   'unavailability, shortage or interruption in the  supply of '\n",
      "                   'raw material, and political interference with the normal '\n",
      "                   'operation of either Party;\"Improvements\"Means any '\n",
      "                   'discovery, development, improvement, know-how or patent '\n",
      "                   'relating to the Product generated,  conceived, reduced to '\n",
      "                   'practice or otherwise created during the Term by PPI or '\n",
      "                   'EKR (or any Affiliate of PPI or  EKR);\"Joint '\n",
      "                   'Improvements\"   Means any Improvements generated, '\n",
      "                   'conceived, reduced to practice or other created jointly by '\n",
      "                   'EKR and PPI or  their Affiliates.\"Known In-Channel  '\n",
      "                   'Product Units\"   Shall have the meaning set forth in '\n",
      "                   'Section 3.19 hereof;   -8-\"Marketing Authorization\"Means '\n",
      "                   'the new drug application (\"NDA\") and all other necessary '\n",
      "                   'regulatory and governmental approvals by a  Regulatory '\n",
      "                   'Authority or other governmental body required to market '\n",
      "                   'and sell the Product in any country of the  Territory, '\n",
      "                   'including, but not li'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:10<00:00, 11.72s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9915, -9902) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ct in a country',\n",
      "        'context': 'ct\") and the Controlled Substances  Act, as amended (21 '\n",
      "                   'U.S.C. §801 et seq.), or as defined in attendant '\n",
      "                   'regulations promulgated under authorities  granted by the '\n",
      "                   'FD&C Act, together with any equivalent laws, rules, '\n",
      "                   'regulations, codes or guidelines having  effect in any '\n",
      "                   'jurisdiction in the Territory;\"Calendar Year\"    Shall '\n",
      "                   'mean the period of twelve months commencing on 1st January '\n",
      "                   'in any year, and each consecutive period  of twelve months '\n",
      "                   'thereafter during the Term;\"cGMP\"    Means Current Good '\n",
      "                   'Manufacturing Practices pursuant to 21 CFR Parts 210 and '\n",
      "                   '211, as may be amended from  time to time;\"Commercial '\n",
      "                   'Launch\"Shall mean the date of the first arm\\'s length sale '\n",
      "                   'by EKR to an unaffiliated Third Party customer for '\n",
      "                   'commercial  use of Product in a country within the '\n",
      "                   'Territory following the grant of Marketing Authorization '\n",
      "                   'and any  necessary pricing approval in that '\n",
      "                   'country;\"Commercialization  Committee\"   Shall mean the '\n",
      "                   'committee to be set up under the terms of Article 5;   '\n",
      "                   '-4-\"Competing Product\"Means any [**] ([**] hours) [**] '\n",
      "                   'preparation (other than the Product) available in a '\n",
      "                   'country in the Territory  which competes or would compete '\n",
      "                   'directly with the Product. For the avoidance of doubt, the '\n",
      "                   'definition of  \"Competing Product\" does not include '\n",
      "                   'Depobupivacaine or any improvement thereto;\"Confidential '\n",
      "                   'Information\"Means all confidential information, data and '\n",
      "                   'materials in whatever form disclosed by or on behalf of '\n",
      "                   'one Party  or its Affiliates to the other Party or its '\n",
      "                   'Affiliates includ'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:13<00:00, 12.24s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9915, -9902) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'ct in a country',\n",
      "        'context': 'ct\") and the Controlled Substances  Act, as amended (21 '\n",
      "                   'U.S.C. §801 et seq.), or as defined in attendant '\n",
      "                   'regulations promulgated under authorities  granted by the '\n",
      "                   'FD&C Act, together with any equivalent laws, rules, '\n",
      "                   'regulations, codes or guidelines having  effect in any '\n",
      "                   'jurisdiction in the Territory;\"Calendar Year\"    Shall '\n",
      "                   'mean the period of twelve months commencing on 1st January '\n",
      "                   'in any year, and each consecutive period  of twelve months '\n",
      "                   'thereafter during the Term;\"cGMP\"    Means Current Good '\n",
      "                   'Manufacturing Practices pursuant to 21 CFR Parts 210 and '\n",
      "                   '211, as may be amended from  time to time;\"Commercial '\n",
      "                   'Launch\"Shall mean the date of the first arm\\'s length sale '\n",
      "                   'by EKR to an unaffiliated Third Party customer for '\n",
      "                   'commercial  use of Product in a country within the '\n",
      "                   'Territory following the grant of Marketing Authorization '\n",
      "                   'and any  necessary pricing approval in that '\n",
      "                   'country;\"Commercialization  Committee\"   Shall mean the '\n",
      "                   'committee to be set up under the terms of Article 5;   '\n",
      "                   '-4-\"Competing Product\"Means any [**] ([**] hours) [**] '\n",
      "                   'preparation (other than the Product) available in a '\n",
      "                   'country in the Territory  which competes or would compete '\n",
      "                   'directly with the Product. For the avoidance of doubt, the '\n",
      "                   'definition of  \"Competing Product\" does not include '\n",
      "                   'Depobupivacaine or any improvement thereto;\"Confidential '\n",
      "                   'Information\"Means all confidential information, data and '\n",
      "                   'materials in whatever form disclosed by or on behalf of '\n",
      "                   'one Party  or its Affiliates to the other Party or its '\n",
      "                   'Affiliates includ'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:12<00:00, 12.15s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'its own cost and expense take all actions necessary to '\n",
      "                  'comply with all Applicable Laws and  obtain and maintain '\n",
      "                  'all necessary license, permits, records and authorizations '\n",
      "                  'PPI is required to obtain and maintain hereunder so as to  '\n",
      "                  'enable PPI to perform its obligations hereunder and under '\n",
      "                  'the Supply Agreement so as to enable EKR to fully exercise '\n",
      "                  'the Distribution  Rights.   3.18 Assignment of ICS '\n",
      "                  'Agreement. The Part',\n",
      "        'context': ' enable EKR to  fully exploit the Distribution Rights '\n",
      "                   'granted hereunder. For purpose of this Section, the '\n",
      "                   'contact person for each of the parties is set forth  '\n",
      "                   'below.3.15 Reserved.   3.16 Recalls and PostMarket '\n",
      "                   'Notifications. All costs of safety alerts and all other '\n",
      "                   'forms of notifications regarding safety risks associated '\n",
      "                   'with the Products in the United States shall be borne by '\n",
      "                   'PPI to the extent arising prior to the Agreement Date and '\n",
      "                   'by EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:14<00:00, 12.34s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'The Lease Term shall automatically renew at the end of each '\n",
      "                  'calendar quarter of  the Lease Term.',\n",
      "        'context': 'n principal amount of [**]  Dollars ($[**]), such note to '\n",
      "                   'be substantially in the form attached hereto as Exhibit '\n",
      "                   '3.20(b) (the \"Promissory Note\").  (c) Commencing as of the '\n",
      "                   'Agreement Date, EKR agrees to lease the Transferred '\n",
      "                   'Equipment to PPI through the end of the then-current  '\n",
      "                   'calendar quarter and, subject to renewal as provided '\n",
      "                   'below, on a calendar quarter-to-calendar quarter   '\n",
      "                   '-21-basis thereafter (the \"Lease Term\"), for use solely in '\n",
      "                   \"connection with the (i) performance of PPI's obligations \"\n",
      "                   'under the Supply  Agreement, (ii) the supply of Products '\n",
      "                   \"to PPI's other licensees and collaborators and (iii) the \"\n",
      "                   \"supply of placebo for PPI's Exparel  product to PPI's \"\n",
      "                   'other licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; '}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:14<00:00, 12.41s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 't described in Section 17.5 below.(d) At any time between '\n",
      "                  'the Agreement Date and July 1, 2015, EKR shall have the',\n",
      "        'context': 'r and, subject to renewal as provided below, on a calendar '\n",
      "                   'quarter-to-calendar quarter   -21-basis thereafter (the '\n",
      "                   '\"Lease Term\"), for use solely in connection with the (i) '\n",
      "                   \"performance of PPI's obligations under the Supply  \"\n",
      "                   \"Agreement, (ii) the supply of Products to PPI's other \"\n",
      "                   'licensees and collaborators and (iii) the supply of '\n",
      "                   \"placebo for PPI's Exparel  product to PPI's other \"\n",
      "                   'licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; and '\n",
      "                   '(ii) the termination of the Step-in Right described in  '\n",
      "                   'Section 17.5.(e) At any time after July 1, 2015, PPI shall '\n",
      "                   'have the right, exercisable upon sixty (60) days prior '\n",
      "                   'written notice to EKR, to terminate the Lease Term and '\n",
      "                   'repurchase the Transferred Equipment from EKR, subject to '\n",
      "                   'payment'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:14<00:00, 12.49s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-14412, -14055) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': '(including, but not limited to, any license or other rights '\n",
      "                  'of PPI or any of its Affiliates, whether as a licensor,  '\n",
      "                  'licensee or otherwise relation to any of the fore',\n",
      "        'context': ' in relation to any Party or an Affiliate the possession '\n",
      "                   'directly or indirectly, of the power to direct or  cause '\n",
      "                   'the direction of the management and policies of such firm, '\n",
      "                   'person or entity, by contract or otherwise, or  the '\n",
      "                   'ownership either directly or indirectly of 50% or more of '\n",
      "                   'the voting securities of such Party;\"Copyrights\"Means (i) '\n",
      "                   'the copyright registrations and applications for '\n",
      "                   'registration identified on Schedule III, (ii) works of  '\n",
      "                   'authorship whether or not copyrightable and (iii) any '\n",
      "                   'other copyrights and works, together with all common law  '\n",
      "                   'rights, used or held for use by PPI or any of its '\n",
      "                   'Affiliates in connection with the Products in the '\n",
      "                   'Territory  (including, but not limited to, any license or '\n",
      "                   'other rights of PPI or any of its Affiliates, whether as a '\n",
      "                   'licensor,  licensee or otherwise relation to any of the '\n",
      "                   'foregoing);\"Current Base Price\"    Means the Product\\'s '\n",
      "                   'current (as of the Effective Date) net average selling '\n",
      "                   'price of $[**] ([**] mg) and $[**]  ([**] mg);\"DEA\"    '\n",
      "                   'Shall mean the United States Drug Enforcement '\n",
      "                   'Administration and any successor thereto performing '\n",
      "                   'similar  functions;\"Distribution Rights\"   Shall have the '\n",
      "                   'meaning set forth in Section 2.1 hereof;\"Domain Name\"    '\n",
      "                   'Shall mean Depodur.com and any other domain names owned or '\n",
      "                   'licensed by PPI related to the Product set forth  on '\n",
      "                   'Schedule IV hereto;   -6-\"EKR Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'other created during the Term by EKR or  any of its '\n",
      "                   'Affiliates.Endo'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:13<00:00, 12.30s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28124, -27557) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24013, -23763) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': \"ment, PPI has   -19-assigned to EKR all of PPI's right, \"\n",
      "                  'title and interest under that certain Commercial '\n",
      "                  'Outsourcing Services Agreement between PPI (f/k/a  '\n",
      "                  'SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                  'Solutions, Inc. (\"ICS\")  dated',\n",
      "        'context': 'y EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of  the Effective Date, the Parties have entered into an '\n",
      "                   'Assignment and Assumption Agreement to further evidence '\n",
      "                   'the foregoing assignment  and assumption of the ICS '\n",
      "                   'Agreement.   3.19 Product in Channel. All sales of Product '\n",
      "                   'conducted by PPI and its distributors and wholesalers '\n",
      "                   '(and, to the knowledge of PPI, by Endo Pharmaceuticals and '\n",
      "                   'its distributors and wholesalers) during the six month '\n",
      "                   'period prior to the Effective Date have been condu'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:13<00:00, 12.32s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-1498, -1241) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-191, -11) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-19849, -19217) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'nment for the benefit of creditors;      -86-$900,000   '\n",
      "                  'October  , 2009(c) A receiver is appointed for the assets '\n",
      "                  'of Maker upon request by any Person(s) other than Maker, or '\n",
      "                  'Maker makes a formal  request for appointment of a '\n",
      "                  'receiver; or   (d) Any proceedin',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:14<00:00, 12.44s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24858, -24517) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24858, -24611) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': \"[**]   [**][**] Attorneys'  Ref:   Country   Application  \"\n",
      "                  'date   Application  no.   Patent/  Publication no.   Grant '\n",
      "                  'date   Expiry date   Status  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [*',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:13<00:00, 12.30s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-29016, -28733) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-30125, -29908) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22284, -21925) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24743, -24088) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'fect. It is agreed that:  (a) no Party has entered into '\n",
      "                  'this Agreement in reliance upon any representation, '\n",
      "                  'warranty or undertaking of the other Party  which is not '\n",
      "                  'expressly set out in this Agreement;   -64-  (b) no Party '\n",
      "                  'shall have any remedy in respect of misrepresentation or '\n",
      "                  'unt',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:12<00:00, 12.04s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '43' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'bination with the Trademarks.   2.3 Grant of Trademark '\n",
      "                  'Rights. PPI hereby grants to EKR a royalty free and '\n",
      "                  'exclusive license (with the right to sublicense) to use '\n",
      "                  'the  Trademarks in the Territory solely in conn',\n",
      "        'context': 'ouse the Products (the \"Distribution Rights\") in the Field '\n",
      "                   'in the Territory during the Term, as  well as to make or '\n",
      "                   'have made the Products anywhere in the world for import or '\n",
      "                   'sale in the Field in the Territory in each case, under the '\n",
      "                   'PPI  IP provided that PPI retains all rights necessary to '\n",
      "                   'manufacture and supply the Products to EKR in accordance '\n",
      "                   'with this Agreement and the  Supply Agreement. Such grant '\n",
      "                   'by PPI shall include the right of EKR to market the '\n",
      "                   'Product in the Territory during the Term as an EKR  '\n",
      "                   \"product using in addition to the Trademarks, EKR's own \"\n",
      "                   'trademarks, trade dress, trade names and other proprietary '\n",
      "                   'designations in  combination with the Trademarks.   2.3 '\n",
      "                   'Grant of Trademark Rights. PPI hereby grants to EKR a '\n",
      "                   'royalty free and exclusive license (with the right to '\n",
      "                   'sublicense) to use the  Trademarks in the Territory solely '\n",
      "                   'in connection with the exercise of the Distribution Rights '\n",
      "                   'in the Territory during the Term (and thereafter  as set '\n",
      "                   'forth in Section 17.4) and EKR shall market and sell the '\n",
      "                   'Products under the Trademarks. For the avoidance of doubt, '\n",
      "                   'the term  \"exclusive\" for the   -14-purposes of Sections '\n",
      "                   '2.1, 2.2 and 2.3 means to the exclusion of all others, '\n",
      "                   'including PPI and its Affiliates, except to the extent '\n",
      "                   'necessary to  enable PPI to perform its specific '\n",
      "                   'obligations under this Agreement and the Supply Agreement. '\n",
      "                   'Notwithstanding the foregoing, nothing  contained herein '\n",
      "                   'shall prohibit PPI from utilizing the Trademarks in the '\n",
      "                   'Territory in connection with its'}]\n",
      "contract5\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.26s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ENDORSEMENT',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.20s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Lutheran Brotherhood Variable Insurance Products Company',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.20s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.23s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.26s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.29s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'Society membership rights and privileges cannot be '\n",
      "                  'transferred or assigned.',\n",
      "        'context': 'ife Insurance Company.Is amended to read:We, we, Our, our, '\n",
      "                   'Us, us, Society. Thrivent Financial for Lutherans.ENTIRE '\n",
      "                   'CONTRACTIn the ENTIRE CONTRACT section, the first phrase '\n",
      "                   'and numbered list are amended to read:The Entire Contract '\n",
      "                   'consists of: 1) This contract including any attached '\n",
      "                   'riders, amendments, or endorsements; 2) The Application '\n",
      "                   'attached to this contract; and 3) The Articles of '\n",
      "                   'Incorporation and Bylaws of the Society and all amendments '\n",
      "                   'to them. Benefits will not be reduced or eliminated by any '\n",
      "                   'future amendments to our Articles of Incorporation or '\n",
      "                   'Bylaws.ASSIGNMENTThe ASSIGNMENT section is amended to '\n",
      "                   'include the following:You may transfer ownership of this '\n",
      "                   'contract in accordance with our bylaws. Society membership '\n",
      "                   'rights and privileges cannot be transferred or assigned. '\n",
      "                   'VB-TL-TFFL (18) page TL-2Source: THRIVENT VARIABLE '\n",
      "                   'INSURANCE ACCOUNT B, N-6, 7/1/2019Contract Number: '\n",
      "                   'ENDORSEMENT (continued)The following words or phrases in '\n",
      "                   'this contract are amended as follows. Any reference to: Is '\n",
      "                   'amended to read:Thrivent Life Insurance Company Thrivent '\n",
      "                   'Financial for Lutheransthe Company the Societythe company. '\n",
      "                   'the SocietyA Stock Life Insurance Company. A Fraternal '\n",
      "                   'Benefit Society625 Fourth Avenue South. 4321 North Ballard '\n",
      "                   'Road Minneapolis, MN 55415 Appleton, WI '\n",
      "                   '54919-0001Minneapolis, MN Appleton, WIHome Office. Service '\n",
      "                   'CenterNonparticipating Eligible for annual dividends '\n",
      "                   'Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABL'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.33s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.46s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'You may make the extra payment by an equivalent reduction '\n",
      "                  'in benefits or by a payment in cash.',\n",
      "        'context': 'for Lutherans.\" All benefits and other terms of this '\n",
      "                   'contract remain unchanged except as described below.You '\n",
      "                   'may direct inquiries to:Thrivent Financial for Lutherans '\n",
      "                   '4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute '}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.30s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.34s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'You may make the extra payment by an equivalent reduction '\n",
      "                  'in benefits or by a payment in cash.',\n",
      "        'context': 'for Lutherans.\" All benefits and other terms of this '\n",
      "                   'contract remain unchanged except as described below.You '\n",
      "                   'may direct inquiries to:Thrivent Financial for Lutherans '\n",
      "                   '4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute '}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.32s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.30s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.45s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '44' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'That includes contracts of insurance, separate accounts, '\n",
      "                  'and cash and investment securities.',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n"
     ]
    }
   ],
   "source": [
    "if __name__ == '__main__':   \n",
    "    test5()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "36bbd198",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model6 Result\n",
      "contract1\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.57s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'SUPPLY CONTRACT',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.64s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD',\n",
      "        'context': 'act is concluded and signed by the Buyer and Seller on , '\n",
      "                   'in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'seller accepts, any party shall not unilaterally cancel '\n",
      "                   'the order before the two sides agreed . 2.3 If the '}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.10s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is concluded and signed by the Buyer and '\n",
      "                  'Seller on , in Hong Kong.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.06s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.95s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is valid for 5 years, beginning from and ended '\n",
      "                  'on .',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.43s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'During the validity term of this agreement,',\n",
      "        'context': 'ement Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: '\n",
      "                   'The Contract is concluded and signed by the Buyer and '\n",
      "                   'Seller on , in Hong Kong. 1. General provisions 1.1 This '\n",
      "                   'is a framework agreement, the terms and conditions are '\n",
      "                   'applied to all purchase orders which signed by this '\n",
      "                   'agreement (hereinafter referred to as the \"order\"). 1.2 If '\n",
      "                   'the provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'seller accepts, any party shall not unil'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.95s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.04s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': \"It will be governed by the law of the People's Republic of \"\n",
      "                  'China ,otherwise it is governed by United Nations '\n",
      "                  'Convention on Contract for the International Sale of Goods.',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.27s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'In case the accident lasts for more than 10 weeks, the '\n",
      "                  'Buyers shall have the right to cancel the Contract.',\n",
      "        'context': 'l not be held responsible for the delay in shipment or '\n",
      "                   'non-delivery, of the goods due to Force Majeure, which '\n",
      "                   'might occur during the process of manufacturing or in the '\n",
      "                   'course of loading or transit. The Sellers shall advise the '\n",
      "                   'Buyers immediately of the occurrence mentioned above and '\n",
      "                   'within fourteen days thereafter, the Sellers shall send by '\n",
      "                   'airmail to the Buyers a certificate of the accident issued '\n",
      "                   'by the competent government authorities, Chamber of '\n",
      "                   'Commerce or registered notary public of the place where '\n",
      "                   'the accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, th'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.46s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Any modification, supplementary, give up should been '\n",
      "                  'written records, only to be valid by buyers and sellers '\n",
      "                  'authorized representative signature and confirmation, '\n",
      "                  'otherwise will be deemed invalid.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.43s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'The penalty, however, shall not exceed 5% of the total '\n",
      "                  'value of the goods involved in the late delivery.',\n",
      "        'context': 'rce or registered notary public of the place where the '\n",
      "                   'accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, the Buyers have the right to '\n",
      "                   'cancel the contract and the Sellers, in spite of the '\n",
      "                   'cancellation, shall still pay the aforesaid penalty to the '\n",
      "                   'Buyers without delay, the seller should refund the money '\n",
      "                   'received and pay the 30% of the total goods price of the '\n",
      "                   'penalty 19. ARBITRATION: All disputes in connection with '\n",
      "                   'this Contract or the execution thereof shall be settled '\n",
      "                   'friendly through negotiations. In case no settlement can '\n",
      "                   'be reached, the case may then be sub'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.50s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.18s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '50' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': '(5) One copy of insurance coverage (6) Copy of cable/letter '\n",
      "                  'to the transportation department of Buyer advising of '\n",
      "                  'particulars as to shipment immediately after shipment is '\n",
      "                  'made.',\n",
      "        'context': 'ped will be paid against the documents stipulated in '\n",
      "                   'Clause 12.2. The Letter of Credit shall be valid until 90 '\n",
      "                   'days after the latest shipment is effected. Under the T/T '\n",
      "                   'The trustee of the buyer remitted the goods to the seller '\n",
      "                   'by telegraphic transfer in batches as agreed upon after '\n",
      "                   'signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 '\n",
      "                   'originals indicating contract number and Shipping Mark (in '\n",
      "                   'case of more than one shipping mark, the invoice shall be '\n",
      "                   'issued separately). (2) One certificate of origin of the '\n",
      "                   'goods. (3) Four original copies of the packing list. (4) '\n",
      "                   'Certificate of Quality and Quantity in 1 original issued '\n",
      "                   'by the agriculture products base. (5) One copy of '\n",
      "                   'insurance coverage (6) Copy of cable/letter to the '\n",
      "                   'transportation department of Buyer advising of particulars '\n",
      "                   'as to shipment immediately after shipment is made.3Source: '\n",
      "                   'LOHA CO. LTD., F-1, 12/9/201912.2 (1) Invoice in 3 '\n",
      "                   'originals indicating contract number and L/C number. (2) '\n",
      "                   'Final acceptance certificate signed by the Buyer and the '\n",
      "                   'Seller. 13. SHIPMENT: CIP The seller shall contract on '\n",
      "                   'usual terms at his own expenses for the carriage of the '\n",
      "                   'goods to the agreed point at the named place of '\n",
      "                   'destination and bear all risks and expenses until the '\n",
      "                   'goods have been delivered to the port of destination. The '\n",
      "                   'Sellers shall ship the goods within the shipment time from '\n",
      "                   'the port of shipment to the port of destination. '\n",
      "                   'Transshipment is allowed. Partial Shipment is allowed. In '\n",
      "                   'case the goods are to be dispatched by parcel post/'}]\n",
      "contract2\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.87s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'WEB SITE HOSTING AGREEMENT',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.94s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'I-ON INTERACTIVE, INC.',\n",
      "        'context': 'll be effective, except pursuant to a written instrument '\n",
      "                   'signed by the party or parties waiving compliance, and any '\n",
      "                   'such waiver shall be effective only in the specific '\n",
      "                   'instance and for the specific purpose stated in such '\n",
      "                   'writing.In the event that any provision hereof is found '\n",
      "                   'invalid or unenforceable pursuant to judicial decree or '\n",
      "                   'decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '-------------------------               '\n",
      "                   '----------------------------- Name: John J. '\n",
      "                   'Lofquist                  Name:   Anna Talerico Title: '\n",
      "                   'President & CEO                  Title:  Vice President'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.31s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.67s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.38s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The term of this Agreement for the Hosted Site shall '\n",
      "                  'commence upon April 1, 1999 and shall continue for a period '\n",
      "                  'of six (6) months, unless earlier terminated in accordance '\n",
      "                  'with provisions hereof.',\n",
      "        'context': \"h any of i-on'sservices, any information that is, in \"\n",
      "                   \"i-on's sole discretion, unlawful, obscene, threatening, \"\n",
      "                   'abusive, libelous, or harmful, or encourages conduct that '\n",
      "                   'would constitute a criminal offense, give rise to civil '\n",
      "                   'liability, or otherwise violate any local, state, '\n",
      "                   'national, or International law.The Customer expressly '\n",
      "                   \"agrees to use all of i-on's services only for lawful \"\n",
      "                   'purposes. Transmission or storage of any information, '\n",
      "                   'data, or material in violation of United States or state '\n",
      "                   'regulation or law is prohibited, including but not limited '\n",
      "                   'to, material protected by copyright, trademark, trade '\n",
      "                   'secret, or any other statute.TERM AND TERMINATIONThe term '\n",
      "                   'of this Agreement for the Hosted Site shall commence upon '\n",
      "                   'April 1, 1999 and shall continue for a period of six (6) '\n",
      "                   'months, unless earlier terminated in accordance with '\n",
      "                   'provisions hereof. This Agreement shall automatically be '\n",
      "                   'renewed for one (1) or more one (1) month periods unless '\n",
      "                   'either the Customer or i-on gives notice to the other '\n",
      "                   'party of its intention not to renew the4 Agreement, which '\n",
      "                   'notice must be given not less than fifteen (15) days '\n",
      "                   'before the end of the respective initial or renewal '\n",
      "                   'term.Either party may terminate this Agreement without '\n",
      "                   \"cause at any time effective upon thirty (30) days' written \"\n",
      "                   'notice. Notwithstanding anything to the contrary contained '\n",
      "                   'in this Agreement, no termination of this Agreement for '\n",
      "                   'any reason whatsoever shall relieve the Customer of the '\n",
      "                   'obligation to pay all amounts due to i-on and to make '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.38s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement shall automatically be renewed for one (1) '\n",
      "                  'or more one (1) month periods unless either the Customer or '\n",
      "                  'i-on gives notice to the other party of its intention not '\n",
      "                  'to renew the4 Agreement, which notice must be given not '\n",
      "                  'less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'y local, state, national, or International law.The '\n",
      "                   \"Customer expressly agrees to use all of i-on's services \"\n",
      "                   'only for lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to \"}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.17s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.49s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement was entered into in the State of Florida, '\n",
      "                  'and its validity, construction, interpretation, and legal '\n",
      "                  'effect shall be governed by the laws and judicial decisions '\n",
      "                  'of the State of Florida applicable to contracts entered '\n",
      "                  'into and performed entirely within the State of Florida.',\n",
      "        'context': ' the name of the other party or to bind such other party '\n",
      "                   'in any manner.No waiver of any provision of this Agreement '\n",
      "                   'or any rights or obligations of either party hereunder '\n",
      "                   'shall be effective, except pursuant to a written '\n",
      "                   'instrument signed by the party or parties waiving '\n",
      "                   'compliance, and any such waiver shall be effective only in '\n",
      "                   'the specific instance and for the specific purpose stated '\n",
      "                   'in such writing.In the event that any provision hereof is '\n",
      "                   'found invalid or unenforceable pursuant to judicial decree '\n",
      "                   'or decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '--------------------'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.26s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.40s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.30s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': \"i-on's liability for damages to the Customer for any cause \"\n",
      "                  'whatsoever, regardless of the form of action, and whether '\n",
      "                  'in contract or in tort, including negligence, shall be '\n",
      "                  \"limited to one (1) month's fees and the remaining portion \"\n",
      "                  'of any prepaid fees.',\n",
      "        'context': '15) days before the end of the respective initial or '\n",
      "                   'renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to the Customer for \"\n",
      "                   'any cause whatsoever, regardless of the form of action, '\n",
      "                   'and whether in contract or in tort, including negligence, '\n",
      "                   \"shall be limited to one (1) month's fees and the remaining \"\n",
      "                   'portion of any prepaid fees.INDEMNIFICATIONThe Customer '\n",
      "                   'agrees to indemnify and hold harmless i-on, against any '\n",
      "                   'lawsuits, claims, damages, or liabilities (or actions or '\n",
      "                   'proceedings in respect thereof) to which i-on may become '\n",
      "                   \"subject related to or arising out of Customer's use of \"\n",
      "                   \"i-on's services, and will reimburse i-on for all legal and \"\n",
      "                   \"other expenses, including attorney's fees, incurred in \"\n",
      "                   'connection with investigating, defending, or settling any '\n",
      "                   'such loss, claim, damage, liability, action, or proceeding '\n",
      "                   'whether or not in connection with pending or threatened '\n",
      "                   'litigation in which i-on is a party. The provisions of '\n",
      "                   'this Agreement relating to ind'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.42s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'not less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'r lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to the Customer for \"\n",
      "                   'any cause whatsoever, regardless of the form of action, '\n",
      "                   'and whether in contract or in tort, inclu'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.38s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '51' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "contract3\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.22s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'CO-PROMOTION AGREEMENT',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:21<00:00, 13.52s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22842, -22820) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Valeant Pharmaceuticals North America LLC, a Delaware '\n",
      "                  'limited liability company (\"Valeant\"). Dova and Valeant are '\n",
      "                  'each referred to individually as a \"Party\" and together as '\n",
      "                  'the \"Parties\".',\n",
      "        'context': '.16 Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the following mutual promises and obligations, and for '\n",
      "                   'other good and valuable consideration the adequacy and '\n",
      "                   'sufficiency of which are hereby acknowledged, the Parties '\n",
      "                   'agree as follows:CONFIDENTIAL TREATMENT HAS BE'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:22<00:00, 13.82s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:23<00:00, 13.91s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:22<00:00, 13.82s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended f',\n",
      "        'context': 'ccordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Ad'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:23<00:00, 13.97s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended f',\n",
      "        'context': 'ccordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Ad'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:23<00:00, 13.93s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28588, -28480) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'icians, generally accepted standards of good clinical '\n",
      "                  'practices adopted by current FDA regulations, as well as '\n",
      "                  'any state laws and regulations (i) impacting the promotion '\n",
      "                  'of pharmaceutical products, (ii) governing the provision of '\n",
      "                  'meals',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:25<00:00, 14.24s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13683, -13613) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6773, -6703) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'ments, interest), together with all documented out-of- '\n",
      "                  \"pocket costs and expenses, including attorney's fees, \"\n",
      "                  'reasonably incurred.1.40 \"Net Sales\" shall mean, for an '\n",
      "                  'applicable period, the aggregate amount, without '\n",
      "                  'duplication, equal to the Specialty Pharmacy Net Sales for '\n",
      "                  'each SKU, the Retail Net Sales for each SKU, if any, and '\n",
      "                  'the Non-Retail Net Sales f',\n",
      "        'context': '\" shall have the meaning set forth in Section 3.1.1.38 '\n",
      "                   '\"Know-How\" shall mean information, whether or not in '\n",
      "                   'written form, including biological, chemical, '\n",
      "                   'pharmacological, toxicological, medical or clinical, '\n",
      "                   'analytical, quality, manufacturing, research, or sales and '\n",
      "                   'marketing information, including processes, methods, '\n",
      "                   'procedures, techniques, plans, programs and data.1.39 '\n",
      "                   '\"Losses\" shall mean any and all amounts paid or payable to '\n",
      "                   'Third Parties with respect to a Claim (including any and '\n",
      "                   'all losses, damages, obligations, liabilities, fines, '\n",
      "                   'fees, penalties, awards, judgments, interest), together '\n",
      "                   'with all documented out-of- pocket costs and expenses, '\n",
      "                   'including attorney\\'s fees, reasonably incurred.1.40 \"Net '\n",
      "                   'Sales\" shall mean, for an applicable period, the aggregate '\n",
      "                   'amount, without duplication, equal to the Specialty '\n",
      "                   'Pharmacy Net Sales for each SKU, the Retail Net Sales for '\n",
      "                   'each SKU, if any, and the Non-Retail Net Sales for each '\n",
      "                   'SKU.1.41 \"Non-Retail Institution\" shall mean any '\n",
      "                   'institution (other than the Specialty Pharmacies, Retail '\n",
      "                   'Pharmacies and Intermediaries) to which Dova (or its '\n",
      "                   'Affiliates or its Intermediaries) sells and/or ships units '\n",
      "                   'of Product during the Term, which shall include group '\n",
      "                   'purchasing organizations (GPOs), hospitals, clinics, long '\n",
      "                   'term care facilities and any outlets that are a member of '\n",
      "                   'an Integrated Delivery Network (IDN), and with which Dova '\n",
      "                   'or its Affiliates do not have data agreements which '\n",
      "                   'enables Dova to track shipments of Product from such '\n",
      "                   'institution t'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:25<00:00, 14.29s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28588, -28480) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'icians, generally accepted standards of good clinical '\n",
      "                  'practices adopted by current FDA regulations, as well as '\n",
      "                  'any state laws and regulations (i) impacting the promotion '\n",
      "                  'of pharmaceutical products, (ii) governing the provision of '\n",
      "                  'meals',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:28<00:00, 14.81s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-27976, -27891) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13288, -13116) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'l of the terms and conditions hereof in all respects and '\n",
      "                  'shall assume all obligations',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:26<00:00, 14.41s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-8074, -7659) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-20465, -20209) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'ugs to the FDA. Visit www.fda.gov/medwatch or call 1-800- '\n",
      "                  'FDA-1088.CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                  'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE '\n",
      "                  'INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS '\n",
      "                  'ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT '\n",
      "                  'HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE '\n",
      "                  'COMMISSION.Source: DOVA PHARMACEUTICALS INC., 10-Q, '\n",
      "                  '11/8/2018For p',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:27<00:00, 14.58s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6806, -6437) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'licensed, developed, and marketed innovative products to '\n",
      "                  \"improve patients' lives and arm health care providers with \"\n",
      "                  'life-changing solutions for many chronic and debilitating '\n",
      "                  'conditions. Salix currently markets its product line to '\n",
      "                  'U.S. health care providers through an expanded sales force '\n",
      "                  'that focuses on gastroenterology, hepatology, pain '\n",
      "                  'specialists, and primary care',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:28<00:00, 14.67s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '52' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'ive Remedies. 4613.14 Waiver of Rule of Construction. '\n",
      "                  '4613.15 Use of Names. 4613.16 Further Actions and '\n",
      "                  'Documents. 4713.17 Certain Conventions. 4713.18 '\n",
      "                  'Counterparts. 47iiiCONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                  'REQUESTED FOR PORTIONS OF',\n",
      "        'context': 'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF CONTENTS '\n",
      "                   '(continued)12.6 Survival. 43ARTICLE 13 MISCELLANEOUS '\n",
      "                   '4313.1 Force Majeure. 4313.2 Assignment. 4313.3 '\n",
      "                   'Severability. 4413.4 Notices. 4413.5 Governing Law. 4513.6 '\n",
      "                   'Dispute Resolution. 4513.7 Waiver of Jury Trial. 4513.8 '\n",
      "                   'Entire Agreement; Amendments. 4613.9 Headings. 4613.10 '\n",
      "                   'Independent Contractors. 4613.11 Third Party '\n",
      "                   'Beneficiaries. 4613.12 Waiver. 4613.13 Cumulative '\n",
      "                   'Remedies. 4613.14 Waiver of Rule of Construction. 4613.15 '\n",
      "                   'Use of Names. 4613.16 Further Actions and Documents. '\n",
      "                   '4713.17 Certain Conventions. 4713.18 Counterparts. '\n",
      "                   '47iiiCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018CO-PROMOTION AGREEMENTThis Co-Promotion '\n",
      "                   'Agreement (this \"Agreement\") is entered into and dated as '\n",
      "                   'of September 26, 2018 (the \"Effective Date\") by and '\n",
      "                   'between Dova Pharmaceuticals, Inc., a Delaware corporation '\n",
      "                   '(\"Dova\"), and Valeant Pharmaceuticals North America LLC, a '\n",
      "                   'Delaware limited liability company (\"Valeant\"). Dova and '\n",
      "                   'Valeant are each referred'}]\n",
      "contract4\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.92s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'processing specifications, sales and marketing  materials '\n",
      "                  'and technology relatin',\n",
      "        'context': 'ng price of Product;\"PPI Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'otherwise created during the Term by  PPI or any of its '\n",
      "                   'Affiliates;   -10-\"PPI IP\"   Means the Copyrights, PPI '\n",
      "                   \"Know-How, PPI Patents and PPI Improvements; and PPI's \"\n",
      "                   'interest in Joint  Improvements;\"PPI Know-How\"Means all '\n",
      "                   'information, procedures, instructions, techniques, data, '\n",
      "                   'technical information, knowledge and  experience '\n",
      "                   '(including, without limitation, toxicological, '\n",
      "                   'pharmaceutical, clinical, non-clinical and medical data,  '\n",
      "                   'health registration data and marketing data), designs, '\n",
      "                   'dossiers (including, without limitation, manufacturing  '\n",
      "                   'assay and quality control dossiers) manufacturing '\n",
      "                   'formulae, processing specifications, sales and marketing  '\n",
      "                   'materials and technology relating to the Product;\"PPI '\n",
      "                   'Patents\"Means those patents set out in Schedule I which '\n",
      "                   'cover the Products and such other patents as PPI may '\n",
      "                   'include  from time to time, including additions, '\n",
      "                   'divisions, confirmations, continuations-in-part, '\n",
      "                   'substitutions, re-issues,  re-examinations, extensions, '\n",
      "                   'registrations, patent terms extensions, supplementary '\n",
      "                   'protection certificates and  renewals of any of the above '\n",
      "                   'or any other patents owned or licensed by PPI subsequent '\n",
      "                   'to the Effective Date  which cover the Products or any '\n",
      "                   'Improvements;   -11-\"Product(s)\"Means: (i) DepoDur '\n",
      "                   'Injectible Liposomal Epidural [**] mg/ml [**]; (ii) '\n",
      "                   'DepoDur Injectible Liposomal Epidural  [**] mg/[**] ml '\n",
      "                   '[**]; (iii) such other presentations and do'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:15<00:00, 12.62s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'mprov',\n",
      "        'context': 'any acts, events, non-happenings, omissions or accidents '\n",
      "                   'beyond the  reasonable control of the Party to perform and '\n",
      "                   'in particular but without limiting the generality thereof '\n",
      "                   'shall  include strikes and labor disturbances, lock-outs, '\n",
      "                   'industrial action, civil commotion, riot, invasion, war, '\n",
      "                   'threat of  or preparation for war, terrorist activity, '\n",
      "                   'fire, explosion, storm, flood, earthquake, subsidence, '\n",
      "                   'epidemic or other  natural physical disaster, '\n",
      "                   'impossibility of the use of railways, shipping, aircraft, '\n",
      "                   'motor transport, or other means  of public or private '\n",
      "                   'transport, failure or suspension of utilities, '\n",
      "                   'unavailability, shortage or interruption in the  supply of '\n",
      "                   'raw material, and political interference with the normal '\n",
      "                   'operation of either Party;\"Improvements\"Means any '\n",
      "                   'discovery, development, improvement, know-how or patent '\n",
      "                   'relating to the Product generated,  conceived, reduced to '\n",
      "                   'practice or otherwise created during the Term by PPI or '\n",
      "                   'EKR (or any Affiliate of PPI or  EKR);\"Joint '\n",
      "                   'Improvements\"   Means any Improvements generated, '\n",
      "                   'conceived, reduced to practice or other created jointly by '\n",
      "                   'EKR and PPI or  their Affiliates.\"Known In-Channel  '\n",
      "                   'Product Units\"   Shall have the meaning set forth in '\n",
      "                   'Section 3.19 hereof;   -8-\"Marketing Authorization\"Means '\n",
      "                   'the new drug application (\"NDA\") and all other necessary '\n",
      "                   'regulatory and governmental approvals by a  Regulatory '\n",
      "                   'Authority or other governmental body required to market '\n",
      "                   'and sell the Product in any country of the  Territory, '\n",
      "                   'including, but not li'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:16<00:00, 12.71s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9915, -9902) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ct in a country',\n",
      "        'context': 'ct\") and the Controlled Substances  Act, as amended (21 '\n",
      "                   'U.S.C. §801 et seq.), or as defined in attendant '\n",
      "                   'regulations promulgated under authorities  granted by the '\n",
      "                   'FD&C Act, together with any equivalent laws, rules, '\n",
      "                   'regulations, codes or guidelines having  effect in any '\n",
      "                   'jurisdiction in the Territory;\"Calendar Year\"    Shall '\n",
      "                   'mean the period of twelve months commencing on 1st January '\n",
      "                   'in any year, and each consecutive period  of twelve months '\n",
      "                   'thereafter during the Term;\"cGMP\"    Means Current Good '\n",
      "                   'Manufacturing Practices pursuant to 21 CFR Parts 210 and '\n",
      "                   '211, as may be amended from  time to time;\"Commercial '\n",
      "                   'Launch\"Shall mean the date of the first arm\\'s length sale '\n",
      "                   'by EKR to an unaffiliated Third Party customer for '\n",
      "                   'commercial  use of Product in a country within the '\n",
      "                   'Territory following the grant of Marketing Authorization '\n",
      "                   'and any  necessary pricing approval in that '\n",
      "                   'country;\"Commercialization  Committee\"   Shall mean the '\n",
      "                   'committee to be set up under the terms of Article 5;   '\n",
      "                   '-4-\"Competing Product\"Means any [**] ([**] hours) [**] '\n",
      "                   'preparation (other than the Product) available in a '\n",
      "                   'country in the Territory  which competes or would compete '\n",
      "                   'directly with the Product. For the avoidance of doubt, the '\n",
      "                   'definition of  \"Competing Product\" does not include '\n",
      "                   'Depobupivacaine or any improvement thereto;\"Confidential '\n",
      "                   'Information\"Means all confidential information, data and '\n",
      "                   'materials in whatever form disclosed by or on behalf of '\n",
      "                   'one Party  or its Affiliates to the other Party or its '\n",
      "                   'Affiliates includ'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:16<00:00, 12.71s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9915, -9902) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'ct in a country',\n",
      "        'context': 'ct\") and the Controlled Substances  Act, as amended (21 '\n",
      "                   'U.S.C. §801 et seq.), or as defined in attendant '\n",
      "                   'regulations promulgated under authorities  granted by the '\n",
      "                   'FD&C Act, together with any equivalent laws, rules, '\n",
      "                   'regulations, codes or guidelines having  effect in any '\n",
      "                   'jurisdiction in the Territory;\"Calendar Year\"    Shall '\n",
      "                   'mean the period of twelve months commencing on 1st January '\n",
      "                   'in any year, and each consecutive period  of twelve months '\n",
      "                   'thereafter during the Term;\"cGMP\"    Means Current Good '\n",
      "                   'Manufacturing Practices pursuant to 21 CFR Parts 210 and '\n",
      "                   '211, as may be amended from  time to time;\"Commercial '\n",
      "                   'Launch\"Shall mean the date of the first arm\\'s length sale '\n",
      "                   'by EKR to an unaffiliated Third Party customer for '\n",
      "                   'commercial  use of Product in a country within the '\n",
      "                   'Territory following the grant of Marketing Authorization '\n",
      "                   'and any  necessary pricing approval in that '\n",
      "                   'country;\"Commercialization  Committee\"   Shall mean the '\n",
      "                   'committee to be set up under the terms of Article 5;   '\n",
      "                   '-4-\"Competing Product\"Means any [**] ([**] hours) [**] '\n",
      "                   'preparation (other than the Product) available in a '\n",
      "                   'country in the Territory  which competes or would compete '\n",
      "                   'directly with the Product. For the avoidance of doubt, the '\n",
      "                   'definition of  \"Competing Product\" does not include '\n",
      "                   'Depobupivacaine or any improvement thereto;\"Confidential '\n",
      "                   'Information\"Means all confidential information, data and '\n",
      "                   'materials in whatever form disclosed by or on behalf of '\n",
      "                   'one Party  or its Affiliates to the other Party or its '\n",
      "                   'Affiliates includ'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:16<00:00, 12.76s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'its own cost and expense take all actions necessary to '\n",
      "                  'comply with all Applicable Laws and  obtain and maintain '\n",
      "                  'all necessary license, permits, records and authorizations '\n",
      "                  'PPI is required to obtain and maintain hereunder so as to  '\n",
      "                  'enable PPI to perform its obligations hereunder and under '\n",
      "                  'the Supply Agreement so as to enable EKR to fully exercise '\n",
      "                  'the Distribution  Rights.   3.18 Assignment of ICS '\n",
      "                  'Agreement. The Part',\n",
      "        'context': ' enable EKR to  fully exploit the Distribution Rights '\n",
      "                   'granted hereunder. For purpose of this Section, the '\n",
      "                   'contact person for each of the parties is set forth  '\n",
      "                   'below.3.15 Reserved.   3.16 Recalls and PostMarket '\n",
      "                   'Notifications. All costs of safety alerts and all other '\n",
      "                   'forms of notifications regarding safety risks associated '\n",
      "                   'with the Products in the United States shall be borne by '\n",
      "                   'PPI to the extent arising prior to the Agreement Date and '\n",
      "                   'by EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.91s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'The Lease Term shall automatically renew at the end of each '\n",
      "                  'calendar quarter of  the Lease Term.',\n",
      "        'context': 'n principal amount of [**]  Dollars ($[**]), such note to '\n",
      "                   'be substantially in the form attached hereto as Exhibit '\n",
      "                   '3.20(b) (the \"Promissory Note\").  (c) Commencing as of the '\n",
      "                   'Agreement Date, EKR agrees to lease the Transferred '\n",
      "                   'Equipment to PPI through the end of the then-current  '\n",
      "                   'calendar quarter and, subject to renewal as provided '\n",
      "                   'below, on a calendar quarter-to-calendar quarter   '\n",
      "                   '-21-basis thereafter (the \"Lease Term\"), for use solely in '\n",
      "                   \"connection with the (i) performance of PPI's obligations \"\n",
      "                   'under the Supply  Agreement, (ii) the supply of Products '\n",
      "                   \"to PPI's other licensees and collaborators and (iii) the \"\n",
      "                   \"supply of placebo for PPI's Exparel  product to PPI's \"\n",
      "                   'other licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; '}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.87s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 't described in Section 17.5 below.(d) At any time between '\n",
      "                  'the Agreement Date and July 1, 2015, EKR shall have the',\n",
      "        'context': 'r and, subject to renewal as provided below, on a calendar '\n",
      "                   'quarter-to-calendar quarter   -21-basis thereafter (the '\n",
      "                   '\"Lease Term\"), for use solely in connection with the (i) '\n",
      "                   \"performance of PPI's obligations under the Supply  \"\n",
      "                   \"Agreement, (ii) the supply of Products to PPI's other \"\n",
      "                   'licensees and collaborators and (iii) the supply of '\n",
      "                   \"placebo for PPI's Exparel  product to PPI's other \"\n",
      "                   'licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; and '\n",
      "                   '(ii) the termination of the Step-in Right described in  '\n",
      "                   'Section 17.5.(e) At any time after July 1, 2015, PPI shall '\n",
      "                   'have the right, exercisable upon sixty (60) days prior '\n",
      "                   'written notice to EKR, to terminate the Lease Term and '\n",
      "                   'repurchase the Transferred Equipment from EKR, subject to '\n",
      "                   'payment'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.88s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-14412, -14055) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': '(including, but not limited to, any license or other rights '\n",
      "                  'of PPI or any of its Affiliates, whether as a licensor,  '\n",
      "                  'licensee or otherwise relation to any of the fore',\n",
      "        'context': ' in relation to any Party or an Affiliate the possession '\n",
      "                   'directly or indirectly, of the power to direct or  cause '\n",
      "                   'the direction of the management and policies of such firm, '\n",
      "                   'person or entity, by contract or otherwise, or  the '\n",
      "                   'ownership either directly or indirectly of 50% or more of '\n",
      "                   'the voting securities of such Party;\"Copyrights\"Means (i) '\n",
      "                   'the copyright registrations and applications for '\n",
      "                   'registration identified on Schedule III, (ii) works of  '\n",
      "                   'authorship whether or not copyrightable and (iii) any '\n",
      "                   'other copyrights and works, together with all common law  '\n",
      "                   'rights, used or held for use by PPI or any of its '\n",
      "                   'Affiliates in connection with the Products in the '\n",
      "                   'Territory  (including, but not limited to, any license or '\n",
      "                   'other rights of PPI or any of its Affiliates, whether as a '\n",
      "                   'licensor,  licensee or otherwise relation to any of the '\n",
      "                   'foregoing);\"Current Base Price\"    Means the Product\\'s '\n",
      "                   'current (as of the Effective Date) net average selling '\n",
      "                   'price of $[**] ([**] mg) and $[**]  ([**] mg);\"DEA\"    '\n",
      "                   'Shall mean the United States Drug Enforcement '\n",
      "                   'Administration and any successor thereto performing '\n",
      "                   'similar  functions;\"Distribution Rights\"   Shall have the '\n",
      "                   'meaning set forth in Section 2.1 hereof;\"Domain Name\"    '\n",
      "                   'Shall mean Depodur.com and any other domain names owned or '\n",
      "                   'licensed by PPI related to the Product set forth  on '\n",
      "                   'Schedule IV hereto;   -6-\"EKR Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'other created during the Term by EKR or  any of its '\n",
      "                   'Affiliates.Endo'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.86s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28124, -27557) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24013, -23763) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': \"ment, PPI has   -19-assigned to EKR all of PPI's right, \"\n",
      "                  'title and interest under that certain Commercial '\n",
      "                  'Outsourcing Services Agreement between PPI (f/k/a  '\n",
      "                  'SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                  'Solutions, Inc. (\"ICS\")  dated',\n",
      "        'context': 'y EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of  the Effective Date, the Parties have entered into an '\n",
      "                   'Assignment and Assumption Agreement to further evidence '\n",
      "                   'the foregoing assignment  and assumption of the ICS '\n",
      "                   'Agreement.   3.19 Product in Channel. All sales of Product '\n",
      "                   'conducted by PPI and its distributors and wholesalers '\n",
      "                   '(and, to the knowledge of PPI, by Endo Pharmaceuticals and '\n",
      "                   'its distributors and wholesalers) during the six month '\n",
      "                   'period prior to the Effective Date have been condu'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:16<00:00, 12.79s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-1498, -1241) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-191, -11) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-19849, -19217) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'nment for the benefit of creditors;      -86-$900,000   '\n",
      "                  'October  , 2009(c) A receiver is appointed for the assets '\n",
      "                  'of Maker upon request by any Person(s) other than Maker, or '\n",
      "                  'Maker makes a formal  request for appointment of a '\n",
      "                  'receiver; or   (d) Any proceedin',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:16<00:00, 12.70s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24858, -24517) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24858, -24611) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': \"[**]   [**][**] Attorneys'  Ref:   Country   Application  \"\n",
      "                  'date   Application  no.   Patent/  Publication no.   Grant '\n",
      "                  'date   Expiry date   Status  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [*',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.89s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-29016, -28733) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-30125, -29908) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22284, -21925) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24743, -24088) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'fect. It is agreed that:  (a) no Party has entered into '\n",
      "                  'this Agreement in reliance upon any representation, '\n",
      "                  'warranty or undertaking of the other Party  which is not '\n",
      "                  'expressly set out in this Agreement;   -64-  (b) no Party '\n",
      "                  'shall have any remedy in respect of misrepresentation or '\n",
      "                  'unt',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:17<00:00, 12.92s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '53' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'bination with the Trademarks.   2.3 Grant of Trademark '\n",
      "                  'Rights. PPI hereby grants to EKR a royalty free and '\n",
      "                  'exclusive license (with the right to sublicense) to use '\n",
      "                  'the  Trademarks in the Territory solely in conn',\n",
      "        'context': 'ouse the Products (the \"Distribution Rights\") in the Field '\n",
      "                   'in the Territory during the Term, as  well as to make or '\n",
      "                   'have made the Products anywhere in the world for import or '\n",
      "                   'sale in the Field in the Territory in each case, under the '\n",
      "                   'PPI  IP provided that PPI retains all rights necessary to '\n",
      "                   'manufacture and supply the Products to EKR in accordance '\n",
      "                   'with this Agreement and the  Supply Agreement. Such grant '\n",
      "                   'by PPI shall include the right of EKR to market the '\n",
      "                   'Product in the Territory during the Term as an EKR  '\n",
      "                   \"product using in addition to the Trademarks, EKR's own \"\n",
      "                   'trademarks, trade dress, trade names and other proprietary '\n",
      "                   'designations in  combination with the Trademarks.   2.3 '\n",
      "                   'Grant of Trademark Rights. PPI hereby grants to EKR a '\n",
      "                   'royalty free and exclusive license (with the right to '\n",
      "                   'sublicense) to use the  Trademarks in the Territory solely '\n",
      "                   'in connection with the exercise of the Distribution Rights '\n",
      "                   'in the Territory during the Term (and thereafter  as set '\n",
      "                   'forth in Section 17.4) and EKR shall market and sell the '\n",
      "                   'Products under the Trademarks. For the avoidance of doubt, '\n",
      "                   'the term  \"exclusive\" for the   -14-purposes of Sections '\n",
      "                   '2.1, 2.2 and 2.3 means to the exclusion of all others, '\n",
      "                   'including PPI and its Affiliates, except to the extent '\n",
      "                   'necessary to  enable PPI to perform its specific '\n",
      "                   'obligations under this Agreement and the Supply Agreement. '\n",
      "                   'Notwithstanding the foregoing, nothing  contained herein '\n",
      "                   'shall prohibit PPI from utilizing the Trademarks in the '\n",
      "                   'Territory in connection with its'}]\n",
      "contract5\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.16s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ENDORSEMENT',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.50s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Lutheran Brotherhood Variable Insurance Products Company',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.27s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.59s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.41s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.38s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'Society membership rights and privileges cannot be '\n",
      "                  'transferred or assigned.',\n",
      "        'context': 'ife Insurance Company.Is amended to read:We, we, Our, our, '\n",
      "                   'Us, us, Society. Thrivent Financial for Lutherans.ENTIRE '\n",
      "                   'CONTRACTIn the ENTIRE CONTRACT section, the first phrase '\n",
      "                   'and numbered list are amended to read:The Entire Contract '\n",
      "                   'consists of: 1) This contract including any attached '\n",
      "                   'riders, amendments, or endorsements; 2) The Application '\n",
      "                   'attached to this contract; and 3) The Articles of '\n",
      "                   'Incorporation and Bylaws of the Society and all amendments '\n",
      "                   'to them. Benefits will not be reduced or eliminated by any '\n",
      "                   'future amendments to our Articles of Incorporation or '\n",
      "                   'Bylaws.ASSIGNMENTThe ASSIGNMENT section is amended to '\n",
      "                   'include the following:You may transfer ownership of this '\n",
      "                   'contract in accordance with our bylaws. Society membership '\n",
      "                   'rights and privileges cannot be transferred or assigned. '\n",
      "                   'VB-TL-TFFL (18) page TL-2Source: THRIVENT VARIABLE '\n",
      "                   'INSURANCE ACCOUNT B, N-6, 7/1/2019Contract Number: '\n",
      "                   'ENDORSEMENT (continued)The following words or phrases in '\n",
      "                   'this contract are amended as follows. Any reference to: Is '\n",
      "                   'amended to read:Thrivent Life Insurance Company Thrivent '\n",
      "                   'Financial for Lutheransthe Company the Societythe company. '\n",
      "                   'the SocietyA Stock Life Insurance Company. A Fraternal '\n",
      "                   'Benefit Society625 Fourth Avenue South. 4321 North Ballard '\n",
      "                   'Road Minneapolis, MN 55415 Appleton, WI '\n",
      "                   '54919-0001Minneapolis, MN Appleton, WIHome Office. Service '\n",
      "                   'CenterNonparticipating Eligible for annual dividends '\n",
      "                   'Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABL'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.46s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.57s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'You may make the extra payment by an equivalent reduction '\n",
      "                  'in benefits or by a payment in cash.',\n",
      "        'context': 'for Lutherans.\" All benefits and other terms of this '\n",
      "                   'contract remain unchanged except as described below.You '\n",
      "                   'may direct inquiries to:Thrivent Financial for Lutherans '\n",
      "                   '4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute '}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.35s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.36s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'You may make the extra payment by an equivalent reduction '\n",
      "                  'in benefits or by a payment in cash.',\n",
      "        'context': 'for Lutherans.\" All benefits and other terms of this '\n",
      "                   'contract remain unchanged except as described below.You '\n",
      "                   'may direct inquiries to:Thrivent Financial for Lutherans '\n",
      "                   '4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute '}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.40s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.47s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.60s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '54' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'That includes contracts of insurance, separate accounts, '\n",
      "                  'and cash and investment securities.',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n"
     ]
    }
   ],
   "source": [
    "if __name__ == '__main__':\n",
    "    test6()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "0be5e801",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model7 Result\n",
      "contract1\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "03f8919c0d0c467ab2f7a36b25561071",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Downloading:   0%|          | 0.00/508 [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Haiying\\anaconda3\\envs\\ml\\lib\\site-packages\\huggingface_hub\\file_download.py:123: UserWarning: `huggingface_hub` cache-system uses symlinks by default to efficiently store duplicated files but your machine does not support them in C:\\Users\\Haiying\\.cache\\huggingface\\hub. Caching files will still work but in a degraded version that might require more space on your disk. This warning can be disabled by setting the `HF_HUB_DISABLE_SYMLINKS_WARNING` environment variable. For more details, see https://huggingface.co/docs/huggingface_hub/how-to-cache#limitations.\n",
      "To support symlinks on Windows, you either need to activate Developer Mode or to run Python as an administrator. In order to see activate developer mode, see this article: https://docs.microsoft.com/en-us/windows/apps/get-started/enable-your-device-for-development\n",
      "  warnings.warn(message)\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "aaa738d355174aae956ebb3d29c5971f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Downloading:   0%|          | 0.00/433M [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "50e026e6b0d34586b27668fde3d8feeb",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Downloading:   0%|          | 0.00/152 [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d89c9e89cbec4603a48efe26bf78759c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Downloading:   0%|          | 0.00/213k [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f0f1fb37a4524883a6c4b73b5407e34a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Downloading:   0%|          | 0.00/112 [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.62s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'The agreement and order 2.1',\n",
      "        'context': 'r: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: '\n",
      "                   'Tel No. : Fax No. : The seller: ADD: The Contract is '\n",
      "                   'concluded and signed by the Buyer and Seller on , in Hong '\n",
      "                   'Kong. 1. General provisions 1.1 This is a framework '\n",
      "                   'agreement, the terms and conditions are applied to all '\n",
      "                   'purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'sell'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.42s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'both parties',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.57s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'The agreement and order 2.1',\n",
      "        'context': 'r: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: '\n",
      "                   'Tel No. : Fax No. : The seller: ADD: The Contract is '\n",
      "                   'concluded and signed by the Buyer and Seller on , in Hong '\n",
      "                   'Kong. 1. General provisions 1.1 This is a framework '\n",
      "                   'agreement, the terms and conditions are applied to all '\n",
      "                   'purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'sell'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.49s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'The agreement and order 2.1',\n",
      "        'context': 'r: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: '\n",
      "                   'Tel No. : Fax No. : The seller: ADD: The Contract is '\n",
      "                   'concluded and signed by the Buyer and Seller on , in Hong '\n",
      "                   'Kong. 1. General provisions 1.1 This is a framework '\n",
      "                   'agreement, the terms and conditions are applied to all '\n",
      "                   'purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'sell'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.39s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'In case the accident lasts for more than 10 weeks',\n",
      "        'context': 'RCE MAJEURE: The Sellers shall not be held responsible for '\n",
      "                   'the delay in shipment or non-delivery, of the goods due to '\n",
      "                   'Force Majeure, which might occur during the process of '\n",
      "                   'manufacturing or in the course of loading or transit. The '\n",
      "                   'Sellers shall advise the Buyers immediately of the '\n",
      "                   'occurrence mentioned above and within fourteen days '\n",
      "                   'thereafter, the Sellers shall send by airmail to the '\n",
      "                   'Buyers a certificate of the accident issued by the '\n",
      "                   'competent government authorities, Chamber of Commerce or '\n",
      "                   'registered notary public of the place where the accident '\n",
      "                   'occurs as evidence thereof. Under such circumstances the '\n",
      "                   'Sellers, however, are still under the obligation to take '\n",
      "                   'all necessary measures to hasten the delivery of the '\n",
      "                   'goods. In case the accident lasts for more than 10 weeks, '\n",
      "                   'the Buyers shall have the right to cancel the Contract. '\n",
      "                   '18. LATE DELIVERY AND PENALTY: Should the Sellers fail to '\n",
      "                   'make delivery on time as stipulated in the Contract, with '\n",
      "                   'exception of Force Majeure causes specified in Clause 17 '\n",
      "                   'of this Contract, the Buyers shall agree to postpone the '\n",
      "                   'delivery on condition that the Sellers agree to pay a '\n",
      "                   'penalty which shall be deducted by the paying bank from '\n",
      "                   'the payment. The penalty, however, shall not exceed 5% of '\n",
      "                   'the total value of the goods involved in the late '\n",
      "                   'delivery. The rate of penalty is charged at 0.5% for every '\n",
      "                   'seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment s'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.45s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': '110% invoice value against All Risks',\n",
      "        'context': ', by the agent whom is certified by the government where '\n",
      "                   'the goods is exported. And the goods must be marked with '\n",
      "                   'the IPPC stamps, which are certified by the government '\n",
      "                   'agent of Botanical-Inspection and Quarantine Bureau. 6. '\n",
      "                   'SHIPPING MARK: The Sellers shall mark on each package with '\n",
      "                   'fadeless paint the package number, gross weight, net '\n",
      "                   'weight, measurements and the wordings: \"KEEP AWAY FROM '\n",
      "                   'MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the '\n",
      "                   'shipping mark on each package with fadeless paint. 7. DATE '\n",
      "                   'OF SHIPMENT: According to specific order by YICHANGTAI or '\n",
      "                   'LEHEYUAN. 8. PORT OF SHIPMENT:2Source: LOHA CO. LTD., F-1, '\n",
      "                   '12/9/20199. PORT OF DESTINATION: SHENZHEN, GUANGDONG, '\n",
      "                   'CHINA 10. INSURANCE: To be covered by the Seller for 110% '\n",
      "                   'invoice value against All Risks and War Risk. 11. PAYMENT: '\n",
      "                   'Under Letter of Credit or T/T: Under the Letter of Credit: '\n",
      "                   'The Buyer shall open an irrevocable letter of credit with '\n",
      "                   'the bank within 30 days after signing the contract, in '\n",
      "                   'favor of the Seller, for 100% value of the total contract '\n",
      "                   'value. The letter of credit should state that partial '\n",
      "                   \"shipments are allowed. The Buyer's agent agrees to pay for \"\n",
      "                   'the goods in accordance with the actual amount of the '\n",
      "                   'goods shipped. 80% of the system value being shipped will '\n",
      "                   'be paid against the documents stipulated in Clause 12.1. '\n",
      "                   'The remaining 20% of the system value being shipped will '\n",
      "                   'be paid against the documents stipulated in Clause 12.2. '\n",
      "                   'The Letter of Credit shall be valid until 90 days after '\n",
      "                   'the latest shipment is'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.62s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'If the Sellers fail to answer the Buyers within one weeks',\n",
      "        'context': 'tion Bureau, have the right to claim for replacement with '\n",
      "                   'new goods, or for compensation, and all the expenses (such '\n",
      "                   'as inspection charges, freight for returning the goods and '\n",
      "                   'for sending the replacement, insurance premium, storage '\n",
      "                   'and loading and unloading charges etc.) shall be borne by '\n",
      "                   'the Sellers. The Certificate so issued shall be accepted '\n",
      "                   'as the base of a claim. The Sellers, in accordance with '\n",
      "                   \"the Buyers' claim, shall be responsible for the immediate \"\n",
      "                   'elimination of the defect(s), complete or partial '\n",
      "                   'replacement of the commodity or shall devaluate the '\n",
      "                   'commodity according to the state of defect(s). Where '\n",
      "                   'necessary, the Buyers shall be at liberty to eliminate the '\n",
      "                   \"defect(s) themselves at the Sellers' expenses. If the \"\n",
      "                   'Sellers fail to answer the Buyers within one weeks after '\n",
      "                   'receipt of the aforesaid claim, the claim shall be '\n",
      "                   'reckoned as having been accepted by the Sellers.4Source: '\n",
      "                   'LOHA CO. LTD., F-1, 12/9/201917. FORCE MAJEURE: The '\n",
      "                   'Sellers shall not be held responsible for the delay in '\n",
      "                   'shipment or non-delivery, of the goods due to Force '\n",
      "                   'Majeure, which might occur during the process of '\n",
      "                   'manufacturing or in the course of loading or transit. The '\n",
      "                   'Sellers shall advise the Buyers immediately of the '\n",
      "                   'occurrence mentioned above and within fourteen days '\n",
      "                   'thereafter, the Sellers shall send by airmail to the '\n",
      "                   'Buyers a certificate of the accident issued by the '\n",
      "                   'competent government authorities, Chamber of Commerce or '\n",
      "                   'registered notary public of the place where the accident '\n",
      "                   'occurs as evidence '}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.52s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': \"the People's Republic of China\",\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.94s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'neither party shall seek recourse to a law court nor other '\n",
      "                  'authorities to appeal for revision of the decision',\n",
      "        'context': ' Buyers without delay, the seller should refund the money '\n",
      "                   'received and pay the 30% of the total goods price of the '\n",
      "                   'penalty 19. ARBITRATION: All disputes in connection with '\n",
      "                   'this Contract or the execution thereof shall be settled '\n",
      "                   'friendly through negotiations. In case no settlement can '\n",
      "                   'be reached, the case may then be submitted for arbitration '\n",
      "                   'to the Foreign Economic and Trade Arbitration Committee of '\n",
      "                   'the China Beijing Council for the Promotion of '\n",
      "                   'International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language be'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.43s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'neither party shall seek recourse to a law court nor other '\n",
      "                  'authorities to appeal for revision of the decision',\n",
      "        'context': ' Buyers without delay, the seller should refund the money '\n",
      "                   'received and pay the 30% of the total goods price of the '\n",
      "                   'penalty 19. ARBITRATION: All disputes in connection with '\n",
      "                   'this Contract or the execution thereof shall be settled '\n",
      "                   'friendly through negotiations. In case no settlement can '\n",
      "                   'be reached, the case may then be submitted for arbitration '\n",
      "                   'to the Foreign Economic and Trade Arbitration Committee of '\n",
      "                   'the China Beijing Council for the Promotion of '\n",
      "                   'International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language be'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.02s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'neither party shall seek recourse to a law court nor other '\n",
      "                  'authorities to appeal for revision of the decision',\n",
      "        'context': ' Buyers without delay, the seller should refund the money '\n",
      "                   'received and pay the 30% of the total goods price of the '\n",
      "                   'penalty 19. ARBITRATION: All disputes in connection with '\n",
      "                   'this Contract or the execution thereof shall be settled '\n",
      "                   'friendly through negotiations. In case no settlement can '\n",
      "                   'be reached, the case may then be submitted for arbitration '\n",
      "                   'to the Foreign Economic and Trade Arbitration Committee of '\n",
      "                   'the China Beijing Council for the Promotion of '\n",
      "                   'International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language be'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.56s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': '110% invo',\n",
      "        'context': 'ureau of China, by the agent whom is certified by the '\n",
      "                   'government where the goods is exported. And the goods must '\n",
      "                   'be marked with the IPPC stamps, which are certified by the '\n",
      "                   'government agent of Botanical-Inspection and Quarantine '\n",
      "                   'Bureau. 6. SHIPPING MARK: The Sellers shall mark on each '\n",
      "                   'package with fadeless paint the package number, gross '\n",
      "                   'weight, net weight, measurements and the wordings: \"KEEP '\n",
      "                   'AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. '\n",
      "                   'and the shipping mark on each package with fadeless paint. '\n",
      "                   '7. DATE OF SHIPMENT: According to specific order by '\n",
      "                   'YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:2Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/20199. PORT OF DESTINATION: SHENZHEN, '\n",
      "                   'GUANGDONG, CHINA 10. INSURANCE: To be covered by the '\n",
      "                   'Seller for 110% invoice value against All Risks and War '\n",
      "                   'Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under '\n",
      "                   'the Letter of Credit: The Buyer shall open an irrevocable '\n",
      "                   'letter of credit with the bank within 30 days after '\n",
      "                   'signing the contract, in favor of the Seller, for 100% '\n",
      "                   'value of the total contract value. The letter of credit '\n",
      "                   'should state that partial shipments are allowed. The '\n",
      "                   \"Buyer's agent agrees to pay for the goods in accordance \"\n",
      "                   'with the actual amount of the goods shipped. 80% of the '\n",
      "                   'system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.1. The remaining 20% of '\n",
      "                   'the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the late'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.83s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '60' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'To be covered by the Seller for 110% invoice value against '\n",
      "                  'All Risks and War Risk',\n",
      "        'context': 'u of China, by the agent whom is certified by the '\n",
      "                   'government where the goods is exported. And the goods must '\n",
      "                   'be marked with the IPPC stamps, which are certified by the '\n",
      "                   'government agent of Botanical-Inspection and Quarantine '\n",
      "                   'Bureau. 6. SHIPPING MARK: The Sellers shall mark on each '\n",
      "                   'package with fadeless paint the package number, gross '\n",
      "                   'weight, net weight, measurements and the wordings: \"KEEP '\n",
      "                   'AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. '\n",
      "                   'and the shipping mark on each package with fadeless paint. '\n",
      "                   '7. DATE OF SHIPMENT: According to specific order by '\n",
      "                   'YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:2Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/20199. PORT OF DESTINATION: SHENZHEN, '\n",
      "                   'GUANGDONG, CHINA 10. INSURANCE: To be covered by the '\n",
      "                   'Seller for 110% invoice value against All Risks and War '\n",
      "                   'Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under '\n",
      "                   'the Letter of Credit: The Buyer shall open an irrevocable '\n",
      "                   'letter of credit with the bank within 30 days after '\n",
      "                   'signing the contract, in favor of the Seller, for 100% '\n",
      "                   'value of the total contract value. The letter of credit '\n",
      "                   'should state that partial shipments are allowed. The '\n",
      "                   \"Buyer's agent agrees to pay for the goods in accordance \"\n",
      "                   'with the actual amount of the goods shipped. 80% of the '\n",
      "                   'system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.1. The remaining 20% of '\n",
      "                   'the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest s'}]\n",
      "contract2\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.31s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'The provisions of this Agreement relating to '\n",
      "                  \"indemnification shall survive termination of the Customer's \"\n",
      "                  'Hosted Site',\n",
      "        'context': 'tort, including negligence, shall be limited to one (1) '\n",
      "                   \"month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees.INDEMNIFICATIONThe Customer agrees to indemnify and '\n",
      "                   'hold harmless i-on, against any lawsuits, claims, damages, '\n",
      "                   'or liabilities (or actions or proceedings in respect '\n",
      "                   'thereof) to which i-on may become subject related to or '\n",
      "                   \"arising out of Customer's use of i-on's services, and will \"\n",
      "                   'reimburse i-on for all legal and other expenses, including '\n",
      "                   \"attorney's fees, incurred in connection with \"\n",
      "                   'investigating, defending, or settling any such loss, '\n",
      "                   'claim, damage, liability, action, or proceeding whether or '\n",
      "                   'not in connection with pending or threatened litigation in '\n",
      "                   'which i-on is a party. The provisions of this Agreement '\n",
      "                   'relating to indemnification shall survive termination of '\n",
      "                   \"the Customer's Hosted Site.THIRD-PARTY SOFTWAREi-on \"\n",
      "                   'expressly assumes no responsibility of the proper '\n",
      "                   'operation or maintenance of any of the Centrack site '\n",
      "                   'software that we authored by Imaginet and/or other third '\n",
      "                   'parties.MISCELLANEOUSThis Agreement constitutes the entire '\n",
      "                   'understanding and agreement between the parties hereto and '\n",
      "                   'supersedes any and all prior or contemporaneous '\n",
      "                   'representations, understandings, and agreements between '\n",
      "                   'the Customer and i-on with respect to the subject matter '\n",
      "                   'hereof, all of which are merged herein. The parties '\n",
      "                   'understand that work i-on does in the development and '\n",
      "                   'maintenance of Web content and applications for Centrack '\n",
      "                   'International is governed by separate agreement(s).Nothing '\n",
      "                   'conta'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.34s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Neither party',\n",
      "        'context': ' of the proper operation or maintenance of any of the '\n",
      "                   'Centrack site software that we authored by Imaginet and/or '\n",
      "                   'other third parties.MISCELLANEOUSThis Agreement '\n",
      "                   'constitutes the entire understanding and agreement between '\n",
      "                   'the parties hereto and supersedes any and all prior or '\n",
      "                   'contemporaneous representations, understandings, and '\n",
      "                   'agreements between the Customer and i-on with respect to '\n",
      "                   'the subject matter hereof, all of which are merged herein. '\n",
      "                   'The parties understand that work i-on does in the '\n",
      "                   'development and maintenance of Web content and '\n",
      "                   'applications for Centrack International is governed by '\n",
      "                   'separate agreement(s).Nothing contained herein shall be '\n",
      "                   'deemed or construed to create a joint venture or '\n",
      "                   'partnership between the Customer and i-on. Neither party '\n",
      "                   'is, by virtue of this Agreement or otherwise, authorized '\n",
      "                   'as an agent or legal representative of the other party. '\n",
      "                   'Neither party is granted any such right or authority to '\n",
      "                   'assume or to create any obligation or responsibility, '\n",
      "                   'express or implied, on behalf of or in the name of the '\n",
      "                   'other party or to bind such other party in any manner.No '\n",
      "                   'waiver of any provision of this Agreement or any rights or '\n",
      "                   'obligations of either party hereunder shall be effective, '\n",
      "                   'except pursuant to a written instrument signed by the '\n",
      "                   'party or parties waiving compliance, and any such waiver '\n",
      "                   'shall be effective only in the specific instance and for '\n",
      "                   'the specific purpose stated in such writing.In the event '\n",
      "                   'that any provision hereof is found invalid or '\n",
      "                   'unenforceable pursu'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.54s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.62s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'April 1, 1999',\n",
      "        'context': \"ransmitting on or through any of i-on'sservices, any \"\n",
      "                   \"information that is, in i-on's sole discretion, unlawful, \"\n",
      "                   'obscene, threatening, abusive, libelous, or harmful, or '\n",
      "                   'encourages conduct that would constitute a criminal '\n",
      "                   'offense, give rise to civil liability, or otherwise '\n",
      "                   'violate any local, state, national, or International '\n",
      "                   \"law.The Customer expressly agrees to use all of i-on's \"\n",
      "                   'services only for lawful purposes. Transmission or storage '\n",
      "                   'of any information, data, or material in violation of '\n",
      "                   'United States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts '}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.60s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': \"termination of the Customer's Hosted Site\",\n",
      "        'context': \"limited to one (1) month's fees and the remaining portion \"\n",
      "                   'of any prepaid fees.INDEMNIFICATIONThe Customer agrees to '\n",
      "                   'indemnify and hold harmless i-on, against any lawsuits, '\n",
      "                   'claims, damages, or liabilities (or actions or proceedings '\n",
      "                   'in respect thereof) to which i-on may become subject '\n",
      "                   \"related to or arising out of Customer's use of i-on's \"\n",
      "                   'services, and will reimburse i-on for all legal and other '\n",
      "                   \"expenses, including attorney's fees, incurred in \"\n",
      "                   'connection with investigating, defending, or settling any '\n",
      "                   'such loss, claim, damage, liability, action, or proceeding '\n",
      "                   'whether or not in connection with pending or threatened '\n",
      "                   'litigation in which i-on is a party. The provisions of '\n",
      "                   'this Agreement relating to indemnification shall survive '\n",
      "                   \"termination of the Customer's Hosted Site.THIRD-PARTY \"\n",
      "                   'SOFTWAREi-on expressly assumes no responsibility of the '\n",
      "                   'proper operation or maintenance of any of the Centrack '\n",
      "                   'site software that we authored by Imaginet and/or other '\n",
      "                   'third parties.MISCELLANEOUSThis Agreement constitutes the '\n",
      "                   'entire understanding and agreement between the parties '\n",
      "                   'hereto and supersedes any and all prior or contemporaneous '\n",
      "                   'representations, understandings, and agreements between '\n",
      "                   'the Customer and i-on with respect to the subject matter '\n",
      "                   'hereof, all of which are merged herein. The parties '\n",
      "                   'understand that work i-on does in the development and '\n",
      "                   'maintenance of Web content and applications for Centrack '\n",
      "                   'International is governed by separate agreement(s).Nothing '\n",
      "                   'contained herein shall be deemed or constr'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.72s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': \"shall survive termination of the Customer's Hosted Site\",\n",
      "        'context': \"all be limited to one (1) month's fees and the remaining \"\n",
      "                   'portion of any prepaid fees.INDEMNIFICATIONThe Customer '\n",
      "                   'agrees to indemnify and hold harmless i-on, against any '\n",
      "                   'lawsuits, claims, damages, or liabilities (or actions or '\n",
      "                   'proceedings in respect thereof) to which i-on may become '\n",
      "                   \"subject related to or arising out of Customer's use of \"\n",
      "                   \"i-on's services, and will reimburse i-on for all legal and \"\n",
      "                   \"other expenses, including attorney's fees, incurred in \"\n",
      "                   'connection with investigating, defending, or settling any '\n",
      "                   'such loss, claim, damage, liability, action, or proceeding '\n",
      "                   'whether or not in connection with pending or threatened '\n",
      "                   'litigation in which i-on is a party. The provisions of '\n",
      "                   'this Agreement relating to indemnification shall survive '\n",
      "                   \"termination of the Customer's Hosted Site.THIRD-PARTY \"\n",
      "                   'SOFTWAREi-on expressly assumes no responsibility of the '\n",
      "                   'proper operation or maintenance of any of the Centrack '\n",
      "                   'site software that we authored by Imaginet and/or other '\n",
      "                   'third parties.MISCELLANEOUSThis Agreement constitutes the '\n",
      "                   'entire understanding and agreement between the parties '\n",
      "                   'hereto and supersedes any and all prior or contemporaneous '\n",
      "                   'representations, understandings, and agreements between '\n",
      "                   'the Customer and i-on with respect to the subject matter '\n",
      "                   'hereof, all of which are merged herein. The parties '\n",
      "                   'understand that work i-on does in the development and '\n",
      "                   'maintenance of Web content and applications for Centrack '\n",
      "                   'International is governed by separate agreement(s).Nothing '\n",
      "                   'contained herein shall be deemed or'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.67s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'not less than fifteen (15) days',\n",
      "        'context': \"ll of i-on's services only for lawful purposes. \"\n",
      "                   'Transmission or storage of any information, data, or '\n",
      "                   'material in violation of United States or state regulation '\n",
      "                   'or law is prohibited, including but not limited to, '\n",
      "                   'material protected by copyright, trademark, trade secret, '\n",
      "                   'or any other statute.TERM AND TERMINATIONThe term of this '\n",
      "                   'Agreement for the Hosted Site shall commence upon April 1, '\n",
      "                   '1999 and shall continue for a period of six (6) months, '\n",
      "                   'unless earlier terminated in accordance with provisions '\n",
      "                   'hereof. This Agreement shall automatically be renewed for '\n",
      "                   'one (1) or more one (1) month periods unless either the '\n",
      "                   'Customer or i-on gives notice to the other party of its '\n",
      "                   'intention not to renew the4 Agreement, which notice must '\n",
      "                   'be given not less than fifteen (15) days before the end of '\n",
      "                   'the respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether '}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.77s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'State of Florida applicable to contracts entered into and '\n",
      "                  'performed entirely within the State of Florida',\n",
      "        'context': 'vision of this Agreement or any rights or obligations of '\n",
      "                   'either party hereunder shall be effective, except pursuant '\n",
      "                   'to a written instrument signed by the party or parties '\n",
      "                   'waiving compliance, and any such waiver shall be effective '\n",
      "                   'only in the specific instance and for the specific purpose '\n",
      "                   'stated in such writing.In the event that any provision '\n",
      "                   'hereof is found invalid or unenforceable pursuant to '\n",
      "                   'judicial decree or decision, the remainder of this '\n",
      "                   'Agreement shall remain valid and enforceable according to '\n",
      "                   'its terms.This Agreement was entered into in the State of '\n",
      "                   'Florida, and its validity, construction, interpretation, '\n",
      "                   'and legal effect shall be governed by the laws and '\n",
      "                   'judicial decisions of the State of Florida applicable to '\n",
      "                   'contracts entered into and performed entirely within the '\n",
      "                   'State of Florida.Neither the Customer nor i-on shall be '\n",
      "                   'deemed in default if its performance or obligations '\n",
      "                   'hereunder are delayed or become impossible or impractical '\n",
      "                   'by reason of any act of God, war,5 fire, earthquake, labor '\n",
      "                   'dispute, sickness, accident, civil commotion, epidemic, '\n",
      "                   'act of government or government agency or offices, or any '\n",
      "                   \"other cause beyondsuch party's control.IN WITNESS WHEREOF, \"\n",
      "                   'the parties have executed this Agreement as of the date '\n",
      "                   'first set forth above.CENTRACK INTERNATIONAL, '\n",
      "                   'INC.            I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '-------------------------               '\n",
      "                   '----------------------------- Name: John J. '\n",
      "                   'Lofquist                  N'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.87s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice\",\n",
      "        'context': 'd States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fee'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.69s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'No waiver of any provision of this Agreement or any rights '\n",
      "                  'or obligations of either party hereunder shall be '\n",
      "                  'effective, except pursuant to a written instrument signed '\n",
      "                  'by the party or parties waiving compliance',\n",
      "        'context': 'The parties understand that work i-on does in the '\n",
      "                   'development and maintenance of Web content and '\n",
      "                   'applications for Centrack International is governed by '\n",
      "                   'separate agreement(s).Nothing contained herein shall be '\n",
      "                   'deemed or construed to create a joint venture or '\n",
      "                   'partnership between the Customer and i-on. Neither party '\n",
      "                   'is, by virtue of this Agreement or otherwise, authorized '\n",
      "                   'as an agent or legal representative of the other party. '\n",
      "                   'Neither party is granted any such right or authority to '\n",
      "                   'assume or to create any obligation or responsibility, '\n",
      "                   'express or implied, on behalf of or in the name of the '\n",
      "                   'other party or to bind such other party in any manner.No '\n",
      "                   'waiver of any provision of this Agreement or any rights or '\n",
      "                   'obligations of either party hereunder shall be effective, '\n",
      "                   'except pursuant to a written instrument signed by the '\n",
      "                   'party or parties waiving compliance, and any such waiver '\n",
      "                   'shall be effective only in the specific instance and for '\n",
      "                   'the specific purpose stated in such writing.In the event '\n",
      "                   'that any provision hereof is found invalid or '\n",
      "                   'unenforceable pursuant to judicial decree or decision, the '\n",
      "                   'remainder of this Agreement shall remain valid and '\n",
      "                   'enforceable according to its terms.This Agreement was '\n",
      "                   'entered into in the State of Florida, and its validity, '\n",
      "                   'construction, interpretation, and legal effect shall be '\n",
      "                   'governed by the laws and judicial decisions of the State '\n",
      "                   'of Florida applicable to contracts entered into and '\n",
      "                   'performed entirely within the State of Florida.Neither the '\n",
      "                   'Customer nor i-on s'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.76s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'The provisions of this Agreement relating to '\n",
      "                  \"indemnification shall survive termination of the Customer's \"\n",
      "                  'Hosted Site',\n",
      "        'context': 'tort, including negligence, shall be limited to one (1) '\n",
      "                   \"month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees.INDEMNIFICATIONThe Customer agrees to indemnify and '\n",
      "                   'hold harmless i-on, against any lawsuits, claims, damages, '\n",
      "                   'or liabilities (or actions or proceedings in respect '\n",
      "                   'thereof) to which i-on may become subject related to or '\n",
      "                   \"arising out of Customer's use of i-on's services, and will \"\n",
      "                   'reimburse i-on for all legal and other expenses, including '\n",
      "                   \"attorney's fees, incurred in connection with \"\n",
      "                   'investigating, defending, or settling any such loss, '\n",
      "                   'claim, damage, liability, action, or proceeding whether or '\n",
      "                   'not in connection with pending or threatened litigation in '\n",
      "                   'which i-on is a party. The provisions of this Agreement '\n",
      "                   'relating to indemnification shall survive termination of '\n",
      "                   \"the Customer's Hosted Site.THIRD-PARTY SOFTWAREi-on \"\n",
      "                   'expressly assumes no responsibility of the proper '\n",
      "                   'operation or maintenance of any of the Centrack site '\n",
      "                   'software that we authored by Imaginet and/or other third '\n",
      "                   'parties.MISCELLANEOUSThis Agreement constitutes the entire '\n",
      "                   'understanding and agreement between the parties hereto and '\n",
      "                   'supersedes any and all prior or contemporaneous '\n",
      "                   'representations, understandings, and agreements between '\n",
      "                   'the Customer and i-on with respect to the subject matter '\n",
      "                   'hereof, all of which are merged herein. The parties '\n",
      "                   'understand that work i-on does in the development and '\n",
      "                   'maintenance of Web content and applications for Centrack '\n",
      "                   'International is governed by separate agreement(s).Nothing '\n",
      "                   'conta'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.71s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'one (1) month',\n",
      "        'context': 'd constitute a criminal offense, give rise to civil '\n",
      "                   'liability, or otherwise violate any local, state, '\n",
      "                   'national, or International law.The Customer expressly '\n",
      "                   \"agrees to use all of i-on's services only for lawful \"\n",
      "                   'purposes. Transmission or storage of any information, '\n",
      "                   'data, or material in violation of United States or state '\n",
      "                   'regulation or law is prohibited, including but not limited '\n",
      "                   'to, material protected by copyright, trademark, trade '\n",
      "                   'secret, or any other statute.TERM AND TERMINATIONThe term '\n",
      "                   'of this Agreement for the Hosted Site shall commence upon '\n",
      "                   'April 1, 1999 and shall continue for a period of six (6) '\n",
      "                   'months, unless earlier terminated in accordance with '\n",
      "                   'provisions hereof. This Agreement shall automatically be '\n",
      "                   'renewed for one (1) or more one (1) month periods unless '\n",
      "                   'either the Customer or i-on gives notice to the other '\n",
      "                   'party of its intention not to renew the4 Agreement, which '\n",
      "                   'notice must be given not less than fifteen (15) days '\n",
      "                   'before the end of the respective initial or renewal '\n",
      "                   'term.Either party may terminate this Agreement without '\n",
      "                   \"cause at any time effective upon thirty (30) days' written \"\n",
      "                   'notice. Notwithstanding anything to the contrary contained '\n",
      "                   'in this Agreement, no termination of this Agreement for '\n",
      "                   'any reason whatsoever shall relieve the Customer of the '\n",
      "                   'obligation to pay all amounts due to i-on and to make such '\n",
      "                   'payments on a timely basis.LIMITATION OF LIABILITYi-on '\n",
      "                   'will not be liable under any circumstances for any lost '\n",
      "                   'profits or other consequential damages, even if i-on ha'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:06<00:00,  6.72s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '61' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'Neither the Customer nor i-on shall be deemed in default',\n",
      "        'context': 'hall be effective, except pursuant to a written instrument '\n",
      "                   'signed by the party or parties waiving compliance, and any '\n",
      "                   'such waiver shall be effective only in the specific '\n",
      "                   'instance and for the specific purpose stated in such '\n",
      "                   'writing.In the event that any provision hereof is found '\n",
      "                   'invalid or unenforceable pursuant to judicial decree or '\n",
      "                   'decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '-------------------------               '\n",
      "                   '----------------------------- Name: John J. '\n",
      "                   'Lofquist                  Name:   Anna Talerico Title: '\n",
      "                   'President & CEO                  Title:  Vice Preside'}]\n",
      "contract3\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:27<00:00, 12.52s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-17683, -17656) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-29863, -29848) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-29209, -29191) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6821, -6775) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'BE NEWSWIRE) -- Dova Pharma',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:30<00:00, 12.86s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24640, -24611) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'both Parties',\n",
      "        'context': 'esearch, development efforts, promotional efforts, '\n",
      "                   'regulatory matters, patent applications or business and '\n",
      "                   'any other materials that have not been made available by '\n",
      "                   'the disclosing Party to the general public. All such '\n",
      "                   'information related to this Agreement disclosed by or on '\n",
      "                   'behalf of a Party (or its Affiliate) to the other Party '\n",
      "                   '(or its Affiliate) pursuant to the Confidentiality '\n",
      "                   \"Agreement shall be deemed to be such Party's Confidential \"\n",
      "                   'Information disclosed hereunder. For purposes of clarity, '\n",
      "                   \"(i) Dova's Confidential Information shall include all \"\n",
      "                   'Product Materials unless and until made available by Dova '\n",
      "                   'to the general public (including through Valeant) and (ii) '\n",
      "                   'the terms of this Agreement shall be considered '\n",
      "                   'Confidential Information of both Parties.1.17 '\n",
      "                   '\"Confidentiality Agreement\" shall have the meaning set '\n",
      "                   'forth in Section 9.1.1.3CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/20181.18 \"Designated '\n",
      "                   'Product\" shall mean a specific pharmaceutical product '\n",
      "                   'marketed by Valeant which is agreed to in writing by the '\n",
      "                   'Parties on or prior to the Effective Date.1.19 \"Detail(s)\" '\n",
      "                   'shall mean a Product presentation during a face-to-face '\n",
      "                   'sales call between a Target Professional and a Sales '\n",
      "                   'Representative, duri'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:34<00:00, 13.43s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22802, -22762) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:38<00:00, 14.01s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13613, -13606) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6703, -6696) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-32000, -31984) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:35<00:00, 13.64s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13613, -13606) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22778, -22762) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': '26, 2018',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:38<00:00, 14.07s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13233, -13198) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'in both the 40 mg (ADAPT-1, 88% vs.',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:38<00:00, 14.02s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': \", as determined in accordance with Dova's revenue \"\n",
      "                  'recognition policies, which is in accordance with GAAP (on '\n",
      "                  'a consistent basis),',\n",
      "        'context': 'SSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/20181.31 \"Gross to Net Fraction\" shall mean, '\n",
      "                   'for each SKU of the Product, a fraction (i) the numerator '\n",
      "                   'of which is the net sales of the SKU of the Product in the '\n",
      "                   'Territory for an applicable period (based on the '\n",
      "                   'gross-to-net discounts for all sales of such SKU of the '\n",
      "                   'Product (i.e., sales attributable to the Specialty, as '\n",
      "                   'well as all other sales of such SKU of the Product), and '\n",
      "                   '(ii) the denominator of which is gross sales of such SKU '\n",
      "                   'of the Product in the Territory for an applicable period, '\n",
      "                   \"in each case, as determined in accordance with Dova's \"\n",
      "                   'revenue recognition policies, which is in accordance with '\n",
      "                   'GAAP (on a consistent basis), for quarterly financial '\n",
      "                   \"reporting purposes, as reported in Dova's quarterly \"\n",
      "                   'filings with the U.S. Securities Exchange Commission.1.32 '\n",
      "                   '\"Indemnified Party\" shall have the meaning set forth in '\n",
      "                   'Section 11.3.1.33 \"Indemnifying Party\" shall have the '\n",
      "                   'meaning set forth in Section 11.3.1.34 \"Intellectual '\n",
      "                   'Property\" shall have the meaning set forth in Section '\n",
      "                   '8.1.2.1.35 \"Intermediary\" shall mean any wholesaler or '\n",
      "                   'distributor who sells Product to Retail Pharmacies and '\n",
      "                   'Non-Retail Institutions, but not patients, and with which '\n",
      "                   'Dova (or its Affiliates) has entered into an agreement or '\n",
      "                   'otherwise has arrangements.1.36 \"Inventions\" shall have '\n",
      "                   'the meaning set forth in Section 8.1.2.1.37 \"JSC\" s'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:37<00:00, 13.95s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-26857, -26854) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'state',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:38<00:00, 14.04s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-14288, -14201) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'From time to time',\n",
      "        'context': 'tion for such SKU of the Product for the applicable '\n",
      "                   'period.1.54 \"Sales Representative\" shall mean an '\n",
      "                   'individual employed and compensated by Valeant as a '\n",
      "                   'full-time employee as part of its sales forces and who '\n",
      "                   'engages in Detailing of the Designated Product (or the '\n",
      "                   'Alternate Product, as the case may be) in the Territory, '\n",
      "                   'and who is also trained with respect to the Product in '\n",
      "                   'accordance with this Agreement (including the Product '\n",
      "                   'Labeling and the use of the Promotional Materials) to '\n",
      "                   'deliver Details for the Product in the Field in the '\n",
      "                   'Territory.1.55 \"Senior Officer\" shall mean, with respect '\n",
      "                   'to Dova, its President and Chief Executive Officer (or '\n",
      "                   \"such officer's designee), and with respect to Valeant, its \"\n",
      "                   \"[***] (or such officer's designee). From time to time, \"\n",
      "                   'each Party may change its Senior Officer by giving written '\n",
      "                   'notice to the other Party.1.56 \"Specialty\" shall mean (i) '\n",
      "                   'Target Professionals with a primary or secondary specialty '\n",
      "                   'designation of Gastroenterology, Colorectal Surgery or '\n",
      "                   'Proctology (excluding any such Target Professionals with a '\n",
      "                   'primary or secondary specialty designation of Hepatology '\n",
      "                   '(including Transplant Hepatology), in each case, as '\n",
      "                   \"determined by data reported by Dova's Third Party Data \"\n",
      "                   'Source, subject to any adjustments determined pursuant to '\n",
      "                   'the process set out in Section 6.5, and (ii) all '\n",
      "                   'healthcare professionals with Nurse or Physician Assistant '\n",
      "                   'specialty designations affiliated with the Target '\n",
      "                   'Professionals described in subsection (i), as '\n",
      "                   'adjusted.1.57 \"Specialt'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:39<00:00, 14.27s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-27083, -26859) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'maceutical product mar',\n",
      "        'context': \"(i) Dova's Confidential Information shall include all \"\n",
      "                   'Product Materials unless and until made available by Dova '\n",
      "                   'to the general public (including through Valeant) and (ii) '\n",
      "                   'the terms of this Agreement shall be considered '\n",
      "                   'Confidential Information of both Parties.1.17 '\n",
      "                   '\"Confidentiality Agreement\" shall have the meaning set '\n",
      "                   'forth in Section 9.1.1.3CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/20181.18 \"Designated '\n",
      "                   'Product\" shall mean a specific pharmaceutical product '\n",
      "                   'marketed by Valeant which is agreed to in writing by the '\n",
      "                   'Parties on or prior to the Effective Date.1.19 \"Detail(s)\" '\n",
      "                   'shall mean a Product presentation during a face-to-face '\n",
      "                   'sales call between a Target Professional and a Sales '\n",
      "                   'Representative, during which a presentation of the '\n",
      "                   \"Product's attributes, benefits, prescribing information \"\n",
      "                   'and safety information are orally presented, for use in '\n",
      "                   'the Field in the Territory. Neither e-details, nor '\n",
      "                   'presentations made at conventions, exhibit booths, a '\n",
      "                   'sample drop, educational programs or speaker meetings, or '\n",
      "                   'similar gatherings, shall constitute a Detail.1.20 \"Detail '\n",
      "                   'Report\" shall have the meaning set forth in Section '\n",
      "                   '4.2.2.1.21 \"Dispute\" shall have the meaning set forth in '\n",
      "                   'Section 13.6.1.1.22 \"Dol'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:38<00:00, 14.13s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'through Valeant) and (ii) the terms of this Agreement shall '\n",
      "                  'be',\n",
      "        'context': \"ncluding information relating to the disclosing Party's \"\n",
      "                   'existing or proposed research, development efforts, '\n",
      "                   'promotional efforts, regulatory matters, patent '\n",
      "                   'applications or business and any other materials that have '\n",
      "                   'not been made available by the disclosing Party to the '\n",
      "                   'general public. All such information related to this '\n",
      "                   'Agreement disclosed by or on behalf of a Party (or its '\n",
      "                   'Affiliate) to the other Party (or its Affiliate) pursuant '\n",
      "                   'to the Confidentiality Agreement shall be deemed to be '\n",
      "                   \"such Party's Confidential Information disclosed hereunder. \"\n",
      "                   \"For purposes of clarity, (i) Dova's Confidential \"\n",
      "                   'Information shall include all Product Materials unless and '\n",
      "                   'until made available by Dova to the general public '\n",
      "                   '(including through Valeant) and (ii) the terms of this '\n",
      "                   'Agreement shall be considered Confidential Information of '\n",
      "                   'both Parties.1.17 \"Confidentiality Agreement\" shall have '\n",
      "                   'the meaning set forth in Section 9.1.1.3CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/20181.18 \"Designated '\n",
      "                   'Product\" shall mean a specific pharmaceutical product '\n",
      "                   'marketed by Valeant which is agreed to in writing by the '\n",
      "                   'Parties on or prior to the Effective Date.1.19 \"Detail(s)\" '\n",
      "                   'shall mean a Product presentation during a face-to-'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:41<00:00, 14.46s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13613, -13611) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'gn',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 7/7 [01:42<00:00, 14.61s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24440, -24425) with a span answer. \n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '62' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'ion of an issue',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "contract4\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:18<00:00, 13.12s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Regulatory Authority',\n",
      "        'context': ' Liposomal Epidural [**] mg/ml [**]; (ii) DepoDur '\n",
      "                   'Injectible Liposomal Epidural  [**] mg/[**] ml [**]; (iii) '\n",
      "                   'such other presentations and dosages which hereafter '\n",
      "                   'receive Marketing  Authorization in any country of the '\n",
      "                   'Territory; in each case for epidural administration '\n",
      "                   'presented in Vials or  other approved vessels, '\n",
      "                   'appropriately packaged and labeled for sale to end users '\n",
      "                   'and (iv) any and all  Improvements of the items listed in '\n",
      "                   'clauses (i) through (iii).\"Promotional Materials\"   Means '\n",
      "                   'promotional, sales, marketing, educational and training '\n",
      "                   'materials which are necessary to support the  marketing of '\n",
      "                   'the Products;\"Quarter\"   Means a three month period ending '\n",
      "                   'on the last day of March, June, September or December in '\n",
      "                   'any Calendar  Year;\"Regulatory Authority\"   Means any '\n",
      "                   'competent regulatory authority or other governmental body '\n",
      "                   '(for example, but not by way of  limitation the FDA and '\n",
      "                   'DEA) responsible for granting a Marketing Authorization in '\n",
      "                   'the Territory;\"Royalty Cap\"   Shall have the meaning set '\n",
      "                   'forth in Section 6.4;\"Supply Agreement\"Means: (i) with '\n",
      "                   'respect to periods between the Effective Date and the '\n",
      "                   'Agreement Date, that certain Supply  Agreement entered '\n",
      "                   'into by the Parties on the Effective Date and (ii) with '\n",
      "                   'respect to periods on or after the  Agreement Date, that '\n",
      "                   'certain Amended and Restated Supply Agreement entered into '\n",
      "                   'by the Parties on the  Agreement Date (as may be amended '\n",
      "                   'from time to time);   -12-\"Term\"   Means the term of this '\n",
      "                   'Agreement as set out in Section 15;\"Territory'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.26s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9134, -9122) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-21979, -21594) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'UIPMENTDepoD',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:21<00:00, 13.64s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-20658, -20646) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'duct;\"PPI Patent',\n",
      "        'context': 't generated, conceived, reduced to practice or otherwise '\n",
      "                   'created during the Term by  PPI or any of its '\n",
      "                   'Affiliates;   -10-\"PPI IP\"   Means the Copyrights, PPI '\n",
      "                   \"Know-How, PPI Patents and PPI Improvements; and PPI's \"\n",
      "                   'interest in Joint  Improvements;\"PPI Know-How\"Means all '\n",
      "                   'information, procedures, instructions, techniques, data, '\n",
      "                   'technical information, knowledge and  experience '\n",
      "                   '(including, without limitation, toxicological, '\n",
      "                   'pharmaceutical, clinical, non-clinical and medical data,  '\n",
      "                   'health registration data and marketing data), designs, '\n",
      "                   'dossiers (including, without limitation, manufacturing  '\n",
      "                   'assay and quality control dossiers) manufacturing '\n",
      "                   'formulae, processing specifications, sales and marketing  '\n",
      "                   'materials and technology relating to the Product;\"PPI '\n",
      "                   'Patents\"Means those patents set out in Schedule I which '\n",
      "                   'cover the Products and such other patents as PPI may '\n",
      "                   'include  from time to time, including additions, '\n",
      "                   'divisions, confirmations, continuations-in-part, '\n",
      "                   'substitutions, re-issues,  re-examinations, extensions, '\n",
      "                   'registrations, patent terms extensions, supplementary '\n",
      "                   'protection certificates and  renewals of any of the above '\n",
      "                   'or any other patents owned or licensed by PPI subsequent '\n",
      "                   'to the Effective Date  which cover the Products or any '\n",
      "                   'Improvements;   -11-\"Product(s)\"Means: (i) DepoDur '\n",
      "                   'Injectible Liposomal Epidural [**] mg/ml [**]; (ii) '\n",
      "                   'DepoDur Injectible Liposomal Epidural  [**] mg/[**] ml '\n",
      "                   '[**]; (iii) such other presentations and dosages which '\n",
      "                   'hereafter receive Marketing  Authorization in an'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.22s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'August 10, 2007',\n",
      "        'context': 'ited States Drug Enforcement Administration and any '\n",
      "                   'successor thereto performing similar  '\n",
      "                   'functions;\"Distribution Rights\"   Shall have the meaning '\n",
      "                   'set forth in Section 2.1 hereof;\"Domain Name\"    Shall '\n",
      "                   'mean Depodur.com and any other domain names owned or '\n",
      "                   'licensed by PPI related to the Product set forth  on '\n",
      "                   'Schedule IV hereto;   -6-\"EKR Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'other created during the Term by EKR or  any of its '\n",
      "                   'Affiliates.Endo/PPI Unit Sales   Shall have the meaning '\n",
      "                   'set forth in Section 3.19 hereof;Endo Product   Means: (i) '\n",
      "                   'DepoDur Injectible Liposomal Epidural 10 mg/ml NDC # [**]; '\n",
      "                   'and (ii) DepoDur Injectible Liposomal  Epidural 15 mg/1.5 '\n",
      "                   'ml NDC # [**];\"Effective Date\"   Means August 10, '\n",
      "                   '2007;\"FDA\"   Means the United States Food and Drug '\n",
      "                   'Administration or any successor thereto performing similar '\n",
      "                   'functions;\"Field\"   Means the management of post-operative '\n",
      "                   'pain following major orthopedic, abdominal or pelvic '\n",
      "                   'surgery;   -7-\"Force Majeure\"Means in relation to either '\n",
      "                   'Party, any cause affecting the performance of this '\n",
      "                   'Agreement or the Supply  Agreement arising from or '\n",
      "                   'attributable to any acts, events, non-happenings, '\n",
      "                   'omissions or accidents beyond the  reasonable control of '\n",
      "                   'the Party to perform and in particular but without '\n",
      "                   'limiting the generality thereof shall  include strikes and '\n",
      "                   'labor disturbances, lock-outs, industrial action, civil '\n",
      "                   'commotion, riot, invasion, war, threat of  or preparation '\n",
      "                   'for war, terrorist activity, fire,'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:20<00:00, 13.36s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-11357, -11348) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'DIESA Dep',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.29s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-23272, -23259) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': '2.5 Condition of Appointment',\n",
      "        'context': '  enable PPI to perform its specific obligations under '\n",
      "                   'this Agreement and the Supply Agreement. Notwithstanding '\n",
      "                   'the foregoing, nothing  contained herein shall prohibit '\n",
      "                   'PPI from utilizing the Trademarks in the Territory in '\n",
      "                   'connection with its business for the sole purpose of '\n",
      "                   'signifying that PPI is the manufacturer of the Products '\n",
      "                   'for EKR.   2.4 Transfer of Domain Names. On the Effective '\n",
      "                   'Date, PPI has transferred the Domain Names to EKR for use '\n",
      "                   'in connection with the exercise of  the Distribution '\n",
      "                   'Rights. PPI has provided EKR with reasonable assistance as '\n",
      "                   'was necessary to effectuate the transfer of the Domain  '\n",
      "                   'Names. Upon any termination or expiration of this '\n",
      "                   'Agreement, EKR shall promptly transfer the Domain Names '\n",
      "                   'back to PPI.   2.5 Condition of Appointment. The '\n",
      "                   'acceptance of forecasts and orders for the Products (as '\n",
      "                   \"provided in the Supply Agreement), and PPI's obligation to \"\n",
      "                   'supply the Product to EKR shall at all times be '\n",
      "                   'conditioned by the Marketing Authorization for the Product '\n",
      "                   'being in force in  the country of Territory to which such '\n",
      "                   'acceptance and order relates.3. Undertakings of PPI   3.1 '\n",
      "                   'Manufacturing Activities. Subject to Section 17.5, PPI '\n",
      "                   'shall manufacture and supply, or procure the manufacture '\n",
      "                   'and supply of, the Product  in accordance with the terms '\n",
      "                   'and conditions of the Supply Agreement.   3.2 Transfer of '\n",
      "                   'Transferred NDA. Effective as of the Agreement Date, PPI '\n",
      "                   'hereby sells, transfers, conveys and assigns to EKR all '\n",
      "                   'right, title  and interest in and to [**] (the \"Tran'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:22<00:00, 13.71s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'twelve months',\n",
      "        'context': 'the countries and territories listed in Schedule '\n",
      "                   'VII;\"Third Party\"   Means any company, corporation, firm, '\n",
      "                   'individual or other entity but excluding a Party to this '\n",
      "                   'Agreement or an  Affiliate;\"Trademarks\"   Means those '\n",
      "                   'Trademarks registered or applied for set out in Schedule '\n",
      "                   'II;\"Transition Services and  Inventory Agreement\"   Means '\n",
      "                   'that certain Transition Services and Inventory Agreement '\n",
      "                   'entered into between the Parties on the  Effective '\n",
      "                   'Date;\"Vial\"   Means a vial containing the Product supplied '\n",
      "                   'to EKR in presentations and dosages and other relevant '\n",
      "                   'terms  set out in the Supply Agreement;\"Year\"   Means the '\n",
      "                   'period of twelve months commencing on the first Commercial '\n",
      "                   'Launch of the Product in the Territory,  and each '\n",
      "                   'consecutive period of twelve months thereafter during the '\n",
      "                   'Term.  1.2 In this Agreement, unless the context requires '\n",
      "                   'otherwise:     (a) the headings are included for '\n",
      "                   'convenience only and shall not affect the construction of '\n",
      "                   'this Agreement;  (b) references to \"persons\" includes '\n",
      "                   'individuals, bodies corporate (wherever incorporated), '\n",
      "                   'unincorporated associations and  partnerships;     (c) '\n",
      "                   'words denoting the singular shall include the plural and '\n",
      "                   'vice versa;     (d) words denoting one gender shall '\n",
      "                   'include each gender and all genders; and   -13-  (e) any '\n",
      "                   'reference to an enactment or statutory provision is a '\n",
      "                   'reference to it as it may have been, or may from time to '\n",
      "                   'time be  amended, modified, consolidated or re-enacted.   '\n",
      "                   '1.3 The Schedules comprise part of and shall be construe'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:21<00:00, 13.52s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-14299, -14285) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'which cover the',\n",
      "        'context': 'd medical data,  health registration data and marketing '\n",
      "                   'data), designs, dossiers (including, without limitation, '\n",
      "                   'manufacturing  assay and quality control dossiers) '\n",
      "                   'manufacturing formulae, processing specifications, sales '\n",
      "                   'and marketing  materials and technology relating to the '\n",
      "                   'Product;\"PPI Patents\"Means those patents set out in '\n",
      "                   'Schedule I which cover the Products and such other patents '\n",
      "                   'as PPI may include  from time to time, including '\n",
      "                   'additions, divisions, confirmations, '\n",
      "                   'continuations-in-part, substitutions, re-issues,  '\n",
      "                   're-examinations, extensions, registrations, patent terms '\n",
      "                   'extensions, supplementary protection certificates and  '\n",
      "                   'renewals of any of the above or any other patents owned or '\n",
      "                   'licensed by PPI subsequent to the Effective Date  which '\n",
      "                   'cover the Products or any Improvements;   '\n",
      "                   '-11-\"Product(s)\"Means: (i) DepoDur Injectible Liposomal '\n",
      "                   'Epidural [**] mg/ml [**]; (ii) DepoDur Injectible '\n",
      "                   'Liposomal Epidural  [**] mg/[**] ml [**]; (iii) such other '\n",
      "                   'presentations and dosages which hereafter receive '\n",
      "                   'Marketing  Authorization in any country of the Territory; '\n",
      "                   'in each case for epidural administration presented in '\n",
      "                   'Vials or  other approved vessels, appropriately packaged '\n",
      "                   'and labeled for sale to end users and (iv) any and all  '\n",
      "                   'Improvements of the items listed in clauses (i) through '\n",
      "                   '(iii).\"Promotional Materials\"   Means promotional, sales, '\n",
      "                   'marketing, educational and training materials which are '\n",
      "                   'necessary to support the  marketing of the '\n",
      "                   'Products;\"Quarter\"   Means a three month period ending'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:20<00:00, 13.47s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-21979, -21727) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-29132, -29069) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-26392, -26301) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'In the event of any inconsistency',\n",
      "        'context': ' the context requires otherwise:     (a) the headings are '\n",
      "                   'included for convenience only and shall not affect the '\n",
      "                   'construction of this Agreement;  (b) references to '\n",
      "                   '\"persons\" includes individuals, bodies corporate (wherever '\n",
      "                   'incorporated), unincorporated associations and  '\n",
      "                   'partnerships;     (c) words denoting the singular shall '\n",
      "                   'include the plural and vice versa;     (d) words denoting '\n",
      "                   'one gender shall include each gender and all genders; '\n",
      "                   'and   -13-  (e) any reference to an enactment or statutory '\n",
      "                   'provision is a reference to it as it may have been, or may '\n",
      "                   'from time to time be  amended, modified, consolidated or '\n",
      "                   're-enacted.   1.3 The Schedules comprise part of and shall '\n",
      "                   'be construed in accordance with the terms of this '\n",
      "                   'Agreement. In the event of any inconsistency  between the '\n",
      "                   'Schedules and the terms of this Agreement, the terms of '\n",
      "                   'this Agreement shall prevail.2. Grant of Rights   2.1 '\n",
      "                   'Retention of EKR. Subject to the terms of this Agreement, '\n",
      "                   'PPI hereby appoints EKR and EKR agrees to be retained as '\n",
      "                   'the exclusive  distributor, and Authorized Distributor of '\n",
      "                   'Record, of the Products in the Field in the Territory '\n",
      "                   'during the Term to market, distribute,  warehouse and sell '\n",
      "                   'the Products. EKR shall have the right to appoint '\n",
      "                   'sub-distributors hereunder in each country of the '\n",
      "                   'Territory.   2.2 Grant of License and Distribution Rights. '\n",
      "                   'PPI hereby grants EKR the exclusive right and license '\n",
      "                   '(with the right to sublicense) to use, market, promote, '\n",
      "                   'sell, distribute and warehouse the Products (the \"Dist'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:21<00:00, 13.57s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-21979, -21727) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'by contract or otherwise, or  the ownership either directly '\n",
      "                  'or indirectly of 50% or more of the voting securities of '\n",
      "                  'such Party;',\n",
      "        'context': 'f disclosure, is in the public domain or is public '\n",
      "                   'knowledge;(ii) after disclosure, becomes part of the '\n",
      "                   'public domain by publication, except by breach of any '\n",
      "                   'obligation of  confidentiality by a Party hereto or an '\n",
      "                   'Affiliate of such Party;(iii) was already in its '\n",
      "                   'possession at the time of its receipt and was not acquired '\n",
      "                   'directly or indirectly from the  other Party or its '\n",
      "                   'Affiliates; or(iv) received from Third Parties who were '\n",
      "                   'lawfully entitled to disclose such information;   '\n",
      "                   '-5-\"Control\"Means in relation to any Party or an Affiliate '\n",
      "                   'the possession directly or indirectly, of the power to '\n",
      "                   'direct or  cause the direction of the management and '\n",
      "                   'policies of such firm, person or entity, by contract or '\n",
      "                   'otherwise, or  the ownership either directly or indirectly '\n",
      "                   'of 50% or more of the voting securities of such '\n",
      "                   'Party;\"Copyrights\"Means (i) the copyright registrations '\n",
      "                   'and applications for registration identified on Schedule '\n",
      "                   'III, (ii) works of  authorship whether or not '\n",
      "                   'copyrightable and (iii) any other copyrights and works, '\n",
      "                   'together with all common law  rights, used or held for use '\n",
      "                   'by PPI or any of its Affiliates in connection with the '\n",
      "                   'Products in the Territory  (including, but not limited to, '\n",
      "                   'any license or other rights of PPI or any of its '\n",
      "                   'Affiliates, whether as a licensor,  licensee or otherwise '\n",
      "                   'relation to any of the foregoing);\"Current Base Price\"    '\n",
      "                   \"Means the Product's current (as of the Effective Date) net \"\n",
      "                   'average selling price of $[**] ([**] mg) and $[**]  ([**] '\n",
      "                   'mg);\"DEA\"    Shall me'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:22<00:00, 13.75s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-21979, -21727) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-16516, -16415) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'Inc., a specialty pharmaceutical company focused on '\n",
      "                  'acquiring, developing, and  commercializing proprietary '\n",
      "                  'products to enhance patient quality-of-life in the acute '\n",
      "                  'care setting, today announced it has acquired exclusive  '\n",
      "                  'marketing and distribution rig',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:24<00:00, 14.01s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-21789, -21726) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'unced it has acquired exclusive  marketing and distribution '\n",
      "                  'rig',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:21<00:00, 13.50s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-16888, -16773) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31636, -31584) with a span answer. \n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '63' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'atforms: DepoFoam  and Biosphere . Revenues are generated '\n",
      "                  'from two marketed products: DepoCyt  for lymphomatous  me',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "contract5\n",
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.98s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'MAINTENANCE OF SOLVENCY',\n",
      "        'context': ' for Lutherans. That includes contracts of insurance, '\n",
      "                   'separate accounts, and cash and investment securities. '\n",
      "                   'Thrivent Financial for Lutherans now has all obligations '\n",
      "                   'under this contract. It is the same as if Thrivent '\n",
      "                   'Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'payment in cash. If you do not make the extra payment '\n",
      "                   'within 60 days from the date we notify you of your share '\n",
      "                   'of the deficiency, the amount will be charged as an '\n",
      "                   'indebtedness against the contract with interest compounded '\n",
      "                   'at the rate of 5% per year.MEMBERSHIP. The person(s) named '\n",
      "                   'as the Insured(s) or the Annuitant(s) is a benefit member '\n",
      "                   'of the Soci'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.15s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'The Articles of Incorporation and Bylaws of the Society and '\n",
      "                  'all amendments to them',\n",
      "        'context': ' to include the following:Service Center. Where this '\n",
      "                   'contract is administered. Our Service Center address is '\n",
      "                   '4321 North Ballard Road, Appleton, WI 54919-0001.And in '\n",
      "                   'the DEFINITIONS section, the definition:We, Our, Us. '\n",
      "                   'Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.Which previously was amended to read:We, Our, Us. '\n",
      "                   'Thrivent Life Insurance Company.Is amended to read:We, we, '\n",
      "                   'Our, our, Us, us, Society. Thrivent Financial for '\n",
      "                   'Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT section, '\n",
      "                   'the first phrase and numbered list are amended to read:The '\n",
      "                   'Entire Contract consists of: 1) This contract including '\n",
      "                   'any attached riders, amendments, or endorsements; 2) The '\n",
      "                   'Application attached to this contract; and 3) The Articles '\n",
      "                   'of Incorporation and Bylaws of the Society and all '\n",
      "                   'amendments to them. Benefits will not be reduced or '\n",
      "                   'eliminated by any future amendments to our Articles of '\n",
      "                   'Incorporation or Bylaws.ASSIGNMENTThe ASSIGNMENT section '\n",
      "                   'is amended to include the following:You may transfer '\n",
      "                   'ownership of this contract in accordance with our bylaws. '\n",
      "                   'Society membership rights and privileges cannot be '\n",
      "                   'transferred or assigned. VB-TL-TFFL (18) page TL-2Source: '\n",
      "                   'THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company.'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.28s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                  '7/1/2019',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.68s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'Service CenterNonparticipating Eligible for annual '\n",
      "                  'dividends Signed for Thrivent Financial for '\n",
      "                  'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                  'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                  '7/1/2019',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.29s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': '7/1/2019',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.67s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'Benefits will not be reduced or eliminated by any future '\n",
      "                  'amendments to our Articles of Incorporation or Bylaws',\n",
      "        'context': 'address is 4321 North Ballard Road, Appleton, WI '\n",
      "                   '54919-0001.And in the DEFINITIONS section, the '\n",
      "                   'definition:We, Our, Us. Lutheran Brotherhood Variable '\n",
      "                   'Insurance Products Company.Which previously was amended to '\n",
      "                   'read:We, Our, Us. Thrivent Life Insurance Company.Is '\n",
      "                   'amended to read:We, we, Our, our, Us, us, Society. '\n",
      "                   'Thrivent Financial for Lutherans.ENTIRE CONTRACTIn the '\n",
      "                   'ENTIRE CONTRACT section, the first phrase and numbered '\n",
      "                   'list are amended to read:The Entire Contract consists of: '\n",
      "                   '1) This contract including any attached riders, '\n",
      "                   'amendments, or endorsements; 2) The Application attached '\n",
      "                   'to this contract; and 3) The Articles of Incorporation and '\n",
      "                   'Bylaws of the Society and all amendments to them. Benefits '\n",
      "                   'will not be reduced or eliminated by any future amendments '\n",
      "                   'to our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.44s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'Each year',\n",
      "        'context': 'rs will determine the amount of any extra payment. It will '\n",
      "                   \"be based on each member's fair share of the deficiency. \"\n",
      "                   'You may make the extra payment by an equivalent reduction '\n",
      "                   'in benefits or by a payment in cash. If you do not make '\n",
      "                   'the extra payment within 60 days from the date we notify '\n",
      "                   'you of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under this contract, dividends will be paid '\n",
      "                   'in cash. Otherwise, dividends will be applied under the '\n",
      "                   'Payment of Premium option unless the Cash option has been '\n",
      "                   'chosen in writing.Cash. Dividends are paid in cash.Payment '\n",
      "                   'of Premium. Dividends are applied as payment of a Net '\n",
      "                   'Premium. VB-TL-TFFL (18) page TL-1 @TL18#AASource: '\n",
      "                   'THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following pr'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.24s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'The Articles of Incorporation and Bylaws of the Society',\n",
      "        'context': 'act is amended to include the following:Service Center. '\n",
      "                   'Where this contract is administered. Our Service Center '\n",
      "                   'address is 4321 North Ballard Road, Appleton, WI '\n",
      "                   '54919-0001.And in the DEFINITIONS section, the '\n",
      "                   'definition:We, Our, Us. Lutheran Brotherhood Variable '\n",
      "                   'Insurance Products Company.Which previously was amended to '\n",
      "                   'read:We, Our, Us. Thrivent Life Insurance Company.Is '\n",
      "                   'amended to read:We, we, Our, our, Us, us, Society. '\n",
      "                   'Thrivent Financial for Lutherans.ENTIRE CONTRACTIn the '\n",
      "                   'ENTIRE CONTRACT section, the first phrase and numbered '\n",
      "                   'list are amended to read:The Entire Contract consists of: '\n",
      "                   '1) This contract including any attached riders, '\n",
      "                   'amendments, or endorsements; 2) The Application attached '\n",
      "                   'to this contract; and 3) The Articles of Incorporation and '\n",
      "                   'Bylaws of the Society and all amendments to them. Benefits '\n",
      "                   'will not be reduced or eliminated by any future amendments '\n",
      "                   'to our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insu'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.51s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'Benefits will not be reduced or eliminated by any future '\n",
      "                  'amendments to our Articles of Incorporation or Bylaws',\n",
      "        'context': 'address is 4321 North Ballard Road, Appleton, WI '\n",
      "                   '54919-0001.And in the DEFINITIONS section, the '\n",
      "                   'definition:We, Our, Us. Lutheran Brotherhood Variable '\n",
      "                   'Insurance Products Company.Which previously was amended to '\n",
      "                   'read:We, Our, Us. Thrivent Life Insurance Company.Is '\n",
      "                   'amended to read:We, we, Our, our, Us, us, Society. '\n",
      "                   'Thrivent Financial for Lutherans.ENTIRE CONTRACTIn the '\n",
      "                   'ENTIRE CONTRACT section, the first phrase and numbered '\n",
      "                   'list are amended to read:The Entire Contract consists of: '\n",
      "                   '1) This contract including any attached riders, '\n",
      "                   'amendments, or endorsements; 2) The Application attached '\n",
      "                   'to this contract; and 3) The Articles of Incorporation and '\n",
      "                   'Bylaws of the Society and all amendments to them. Benefits '\n",
      "                   'will not be reduced or eliminated by any future amendments '\n",
      "                   'to our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.46s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'will not be reduced or eliminated by any future amendments '\n",
      "                  'to our Articles of Incorporation or Bylaws',\n",
      "        'context': 'ess is 4321 North Ballard Road, Appleton, WI '\n",
      "                   '54919-0001.And in the DEFINITIONS section, the '\n",
      "                   'definition:We, Our, Us. Lutheran Brotherhood Variable '\n",
      "                   'Insurance Products Company.Which previously was amended to '\n",
      "                   'read:We, Our, Us. Thrivent Life Insurance Company.Is '\n",
      "                   'amended to read:We, we, Our, our, Us, us, Society. '\n",
      "                   'Thrivent Financial for Lutherans.ENTIRE CONTRACTIn the '\n",
      "                   'ENTIRE CONTRACT section, the first phrase and numbered '\n",
      "                   'list are amended to read:The Entire Contract consists of: '\n",
      "                   '1) This contract including any attached riders, '\n",
      "                   'amendments, or endorsements; 2) The Application attached '\n",
      "                   'to this contract; and 3) The Articles of Incorporation and '\n",
      "                   'Bylaws of the Society and all amendments to them. Benefits '\n",
      "                   'will not be reduced or eliminated by any future amendments '\n",
      "                   'to our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 App'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.63s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'This provision applies only to benefits provided through '\n",
      "                  'the General Account',\n",
      "        'context': ', separate accounts, and cash and investment securities. '\n",
      "                   'Thrivent Financial for Lutherans now has all obligations '\n",
      "                   'under this contract. It is the same as if Thrivent '\n",
      "                   'Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'payment in cash. If you do not make the extra payment '\n",
      "                   'within 60 days from the date we notify you of your share '\n",
      "                   'of the deficiency, the amount will be charged as an '\n",
      "                   'indebtedness against the contract with interest compounded '\n",
      "                   'at the rate of 5% per year.MEMBERSHIP. The person(s) named '\n",
      "                   'as the Insured(s) or the Annuitant(s) is a benefit member '\n",
      "                   'of the Society. Rights and privileges of membership are '\n",
      "                   'set for'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.28s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': '7/1/2019',\n",
      "        'context': 'separate from the ownership of this contract.DIVIDENDS. '\n",
      "                   'Each year, we will determine our divisible surplus. This '\n",
      "                   \"contract's share, if any, will be credited as a dividend. \"\n",
      "                   'Since we do not expect this contract to contribute to '\n",
      "                   'divisible surplus, it is not expected that any dividends '\n",
      "                   'will be credited.DIVIDEND OPTIONS. If dividends are '\n",
      "                   'credited after premiums can no longer be paid under this '\n",
      "                   'contract, dividends will be paid in cash. Otherwise, '\n",
      "                   'dividends will be applied under the Payment of Premium '\n",
      "                   'option unless the Cash option has been chosen in '\n",
      "                   'writing.Cash. Dividends are paid in cash.Payment of '\n",
      "                   'Premium. Dividends are applied as payment of a Net '\n",
      "                   'Premium. VB-TL-TFFL (18) page TL-1 @TL18#AASource: '\n",
      "                   'THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following provisions of this contract are '\n",
      "                   'amended:DEFINITIONSThe DEFINITIONS section of the contract '\n",
      "                   'is amended to include the following:Service Center. Where '\n",
      "                   'this contract is administered. Our Service Center address '\n",
      "                   'is 4321 North Ballard Road, Appleton, WI 54919-0001.And in '\n",
      "                   'the DEFINITIONS section, the definition:We, Our, Us. '\n",
      "                   'Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.Which previously was amended to read:We, Our, Us. '\n",
      "                   'Thrivent Life Insurance Company.Is amended to read:We, we, '\n",
      "                   'Our, our, Us, us, Society. Thrivent Financial for '\n",
      "                   'Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT section, '\n",
      "                   'the first phrase and numbered list are amended to read:The '\n",
      "                   'Entire Contract consists of: 1) This cont'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:03<00:00,  3.44s/ Batches]\n",
      "WARNING:haystack.document_stores.search_engine:Deletion of default index '64' detected. If you plan to use this index again, please reinstantiate 'ElasticsearchDocumentStore' in order to avoid side-effects.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'All benefits and other terms of this contract remain '\n",
      "                  'unchanged',\n",
      "        'context': 'ontract Number: ENDORSEMENTEffective Date: July 1, '\n",
      "                   '2019Thrivent Life Insurance Company has been dissolved. '\n",
      "                   '(Thrivent Life Insurance Company was formerly known as '\n",
      "                   'Lutheran Brotherhood Variable Insurance Products Company.) '\n",
      "                   'All assets and related liabilities of Thrivent Life '\n",
      "                   'Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'payment in cash.'}]\n"
     ]
    }
   ],
   "source": [
    "if __name__ == '__main__':\n",
    "    test7()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "6ef8c685",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model8 Result\n",
      "contract1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "The tokenizer class you load from this checkpoint is not the same type as the class this function is called from. It may result in unexpected tokenization. \n",
      "The tokenizer class you load from this checkpoint is 'DPRQuestionEncoderTokenizer'. \n",
      "The class this function is called from is 'DPRContextEncoderTokenizerFast'.\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2dd88c16ae734b19b9320b2f228614f4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Updating embeddings:   0%|          | 0/1 [00:00<?, ? Docs/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.79s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'SUPPLY CONTRACT',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.59s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD',\n",
      "        'context': 'act is concluded and signed by the Buyer and Seller on , '\n",
      "                   'in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'seller accepts, any party shall not unilaterally cancel '\n",
      "                   'the order before the two sides agreed . 2.3 If the '}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.76s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is concluded and signed by the Buyer and '\n",
      "                  'Seller on , in Hong Kong.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.67s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.70s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The Contract is valid for 5 years, beginning from and ended '\n",
      "                  'on .',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.18s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'During the validity term of this agreement,',\n",
      "        'context': 'ement Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: '\n",
      "                   'The Contract is concluded and signed by the Buyer and '\n",
      "                   'Seller on , in Hong Kong. 1. General provisions 1.1 This '\n",
      "                   'is a framework agreement, the terms and conditions are '\n",
      "                   'applied to all purchase orders which signed by this '\n",
      "                   'agreement (hereinafter referred to as the \"order\"). 1.2 If '\n",
      "                   'the provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have been '\n",
      "                   'accepted the order. The orders become effective once the '\n",
      "                   'seller accepts, any party shall not unil'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.80s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:04<00:00,  4.83s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': \"It will be governed by the law of the People's Republic of \"\n",
      "                  'China ,otherwise it is governed by United Nations '\n",
      "                  'Convention on Contract for the International Sale of Goods.',\n",
      "        'context': 'rbitration to the Foreign Economic and Trade Arbitration '\n",
      "                   'Committee of the China Beijing Council for the Promotion '\n",
      "                   'of International Trade in accordance with its Provisional '\n",
      "                   'Rules of Procedures by the said Arbitration Committee. The '\n",
      "                   'Arbitration shall take place in Beijing and the decision '\n",
      "                   'of the Arbitration Committee shall be final and binding '\n",
      "                   'upon both parties; neither party shall seek recourse to a '\n",
      "                   'law court nor other authorities to appeal for revision of '\n",
      "                   'the decision. Arbitration fee shall be borne by the losing '\n",
      "                   'party. 20. This final price is the confidential '\n",
      "                   'information. Dissemination, distribution or duplication of '\n",
      "                   'this price is strictly prohibited.5Source: LOHA CO. LTD., '\n",
      "                   'F-1, 12/9/201921. Law application It will be governed by '\n",
      "                   \"the law of the People's Republic of China ,otherwise it is \"\n",
      "                   'governed by United Nations Convention on Contract for the '\n",
      "                   'International Sale of Goods. 22. <<Incoterms 2000>> The '\n",
      "                   'terms in the contract are based on (INCOTERMS 2000) of the '\n",
      "                   'International Chamber of Commerce. 23. The Contract is '\n",
      "                   'valid for 5 years, beginning from and ended on . This '\n",
      "                   'Contract is made out in three originals in both Chinese '\n",
      "                   'and English, each language being legally of the equal '\n",
      "                   'effect. Conflicts between these two languages arising '\n",
      "                   'there from, if any, shall be subject to Chinese version. '\n",
      "                   'One copy for the Sellers, two copies for the Buyers. The '\n",
      "                   'Contract becomes effective after signed by both parties. '\n",
      "                   'THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6Source: LOHA '\n",
      "                   'CO. LTD., F-1, 12/9/2019'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.32s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'In case the accident lasts for more than 10 weeks, the '\n",
      "                  'Buyers shall have the right to cancel the Contract.',\n",
      "        'context': 'l not be held responsible for the delay in shipment or '\n",
      "                   'non-delivery, of the goods due to Force Majeure, which '\n",
      "                   'might occur during the process of manufacturing or in the '\n",
      "                   'course of loading or transit. The Sellers shall advise the '\n",
      "                   'Buyers immediately of the occurrence mentioned above and '\n",
      "                   'within fourteen days thereafter, the Sellers shall send by '\n",
      "                   'airmail to the Buyers a certificate of the accident issued '\n",
      "                   'by the competent government authorities, Chamber of '\n",
      "                   'Commerce or registered notary public of the place where '\n",
      "                   'the accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, th'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.54s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Any modification, supplementary, give up should been '\n",
      "                  'written records, only to be valid by buyers and sellers '\n",
      "                  'authorized representative signature and confirmation, '\n",
      "                  'otherwise will be deemed invalid.',\n",
      "        'context': 'Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The '\n",
      "                   'buyer/End-User: Shenzhen LOHAS Supply Chain Management '\n",
      "                   'Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The '\n",
      "                   'Contract is concluded and signed by the Buyer and Seller '\n",
      "                   'on , in Hong Kong. 1. General provisions 1.1 This is a '\n",
      "                   'framework agreement, the terms and conditions are applied '\n",
      "                   'to all purchase orders which signed by this agreement '\n",
      "                   '(hereinafter referred to as the \"order\"). 1.2 If the '\n",
      "                   'provisions of the agreement are inconsistent with the '\n",
      "                   'order, the order shall prevail. Not stated in order '\n",
      "                   'content will be subject to the provisions of agreement. '\n",
      "                   'Any modification, supplementary, give up should been '\n",
      "                   'written records, only to be valid by buyers and sellers '\n",
      "                   'authorized representative signature and confirmation, '\n",
      "                   'otherwise will be deemed invalid. 2. The agreement and '\n",
      "                   'order 2.1 During the validity term of this agreement, The '\n",
      "                   'buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE '\n",
      "                   'CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter '\n",
      "                   'referred to as the \"entrusted party\" or \"YICHANGTAI\" or '\n",
      "                   '\"LEHEYUAN\"), to purchase the products specified in this '\n",
      "                   'agreement from the seller in the form of orders. 2.2 The '\n",
      "                   'seller shall be confirmed within three working days after '\n",
      "                   'receipt of order. If the seller finds order is not '\n",
      "                   'acceptable or need to modify, should note entrusted party '\n",
      "                   'in two working days after receipt of the order, If the '\n",
      "                   'seller did not confirm orders in time or notice not accept '\n",
      "                   'orders or modifications, the seller is deemed to have '}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.41s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'The penalty, however, shall not exceed 5% of the total '\n",
      "                  'value of the goods involved in the late delivery.',\n",
      "        'context': 'rce or registered notary public of the place where the '\n",
      "                   'accident occurs as evidence thereof. Under such '\n",
      "                   'circumstances the Sellers, however, are still under the '\n",
      "                   'obligation to take all necessary measures to hasten the '\n",
      "                   'delivery of the goods. In case the accident lasts for more '\n",
      "                   'than 10 weeks, the Buyers shall have the right to cancel '\n",
      "                   'the Contract. 18. LATE DELIVERY AND PENALTY: Should the '\n",
      "                   'Sellers fail to make delivery on time as stipulated in the '\n",
      "                   'Contract, with exception of Force Majeure causes specified '\n",
      "                   'in Clause 17 of this Contract, the Buyers shall agree to '\n",
      "                   'postpone the delivery on condition that the Sellers agree '\n",
      "                   'to pay a penalty which shall be deducted by the paying '\n",
      "                   'bank from the payment. The penalty, however, shall not '\n",
      "                   'exceed 5% of the total value of the goods involved in the '\n",
      "                   'late delivery. The rate of penalty is charged at 0.5% for '\n",
      "                   'every seven days, odd days less than seven days should be '\n",
      "                   'counted as seven days. In case the Sellers fail to make '\n",
      "                   'delivery ten weeks later than the time of shipment '\n",
      "                   'stipulated in the Contract, the Buyers have the right to '\n",
      "                   'cancel the contract and the Sellers, in spite of the '\n",
      "                   'cancellation, shall still pay the aforesaid penalty to the '\n",
      "                   'Buyers without delay, the seller should refund the money '\n",
      "                   'received and pay the 30% of the total goods price of the '\n",
      "                   'penalty 19. ARBITRATION: All disputes in connection with '\n",
      "                   'this Contract or the execution thereof shall be settled '\n",
      "                   'friendly through negotiations. In case no settlement can '\n",
      "                   'be reached, the case may then be sub'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.37s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'The Letter of Credit shall be valid until 90 days after the '\n",
      "                  'latest shipment is effected.',\n",
      "        'context': ' the Seller for 110% invoice value against All Risks and '\n",
      "                   'War Risk. 11. PAYMENT: Under Letter of Credit or T/T: '\n",
      "                   'Under the Letter of Credit: The Buyer shall open an '\n",
      "                   'irrevocable letter of credit with the bank within 30 days '\n",
      "                   'after signing the contract, in favor of the Seller, for '\n",
      "                   '100% value of the total contract value. The letter of '\n",
      "                   'credit should state that partial shipments are allowed. '\n",
      "                   \"The Buyer's agent agrees to pay for the goods in \"\n",
      "                   'accordance with the actual amount of the goods shipped. '\n",
      "                   '80% of the system value being shipped will be paid against '\n",
      "                   'the documents stipulated in Clause 12.1. The remaining 20% '\n",
      "                   'of the system value being shipped will be paid against the '\n",
      "                   'documents stipulated in Clause 12.2. The Letter of Credit '\n",
      "                   'shall be valid until 90 days after the latest shipment is '\n",
      "                   'effected. Under the T/T The trustee of the buyer remitted '\n",
      "                   'the goods to the seller by telegraphic transfer in batches '\n",
      "                   'as agreed upon after signing each order. 12. DOCUMENTS: '\n",
      "                   '12.1 (1) Invoice in 5 originals indicating contract number '\n",
      "                   'and Shipping Mark (in case of more than one shipping mark, '\n",
      "                   'the invoice shall be issued separately). (2) One '\n",
      "                   'certificate of origin of the goods. (3) Four original '\n",
      "                   'copies of the packing list. (4) Certificate of Quality and '\n",
      "                   'Quantity in 1 original issued by the agriculture products '\n",
      "                   'base. (5) One copy of insurance coverage (6) Copy of '\n",
      "                   'cable/letter to the transportation department of Buyer '\n",
      "                   'advising of particulars as to shipment immediately after '\n",
      "                   'shipment is made.3Source: LOHA CO. LTD.'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:05<00:00,  5.04s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': '(5) One copy of insurance coverage (6) Copy of cable/letter '\n",
      "                  'to the transportation department of Buyer advising of '\n",
      "                  'particulars as to shipment immediately after shipment is '\n",
      "                  'made.',\n",
      "        'context': 'ped will be paid against the documents stipulated in '\n",
      "                   'Clause 12.2. The Letter of Credit shall be valid until 90 '\n",
      "                   'days after the latest shipment is effected. Under the T/T '\n",
      "                   'The trustee of the buyer remitted the goods to the seller '\n",
      "                   'by telegraphic transfer in batches as agreed upon after '\n",
      "                   'signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 '\n",
      "                   'originals indicating contract number and Shipping Mark (in '\n",
      "                   'case of more than one shipping mark, the invoice shall be '\n",
      "                   'issued separately). (2) One certificate of origin of the '\n",
      "                   'goods. (3) Four original copies of the packing list. (4) '\n",
      "                   'Certificate of Quality and Quantity in 1 original issued '\n",
      "                   'by the agriculture products base. (5) One copy of '\n",
      "                   'insurance coverage (6) Copy of cable/letter to the '\n",
      "                   'transportation department of Buyer advising of particulars '\n",
      "                   'as to shipment immediately after shipment is made.3Source: '\n",
      "                   'LOHA CO. LTD., F-1, 12/9/201912.2 (1) Invoice in 3 '\n",
      "                   'originals indicating contract number and L/C number. (2) '\n",
      "                   'Final acceptance certificate signed by the Buyer and the '\n",
      "                   'Seller. 13. SHIPMENT: CIP The seller shall contract on '\n",
      "                   'usual terms at his own expenses for the carriage of the '\n",
      "                   'goods to the agreed point at the named place of '\n",
      "                   'destination and bear all risks and expenses until the '\n",
      "                   'goods have been delivered to the port of destination. The '\n",
      "                   'Sellers shall ship the goods within the shipment time from '\n",
      "                   'the port of shipment to the port of destination. '\n",
      "                   'Transshipment is allowed. Partial Shipment is allowed. In '\n",
      "                   'case the goods are to be dispatched by parcel post/'}]\n",
      "contract2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "The tokenizer class you load from this checkpoint is not the same type as the class this function is called from. It may result in unexpected tokenization. \n",
      "The tokenizer class you load from this checkpoint is 'DPRQuestionEncoderTokenizer'. \n",
      "The class this function is called from is 'DPRContextEncoderTokenizerFast'.\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "47b2a5571ba348b896ea98270d7657a3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Updating embeddings:   0%|          | 0/1 [00:00<?, ? Docs/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.02s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'WEB SITE HOSTING AGREEMENT',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.37s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'I-ON INTERACTIVE, INC.',\n",
      "        'context': 'll be effective, except pursuant to a written instrument '\n",
      "                   'signed by the party or parties waiving compliance, and any '\n",
      "                   'such waiver shall be effective only in the specific '\n",
      "                   'instance and for the specific purpose stated in such '\n",
      "                   'writing.In the event that any provision hereof is found '\n",
      "                   'invalid or unenforceable pursuant to judicial decree or '\n",
      "                   'decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '-------------------------               '\n",
      "                   '----------------------------- Name: John J. '\n",
      "                   'Lofquist                  Name:   Anna Talerico Title: '\n",
      "                   'President & CEO                  Title:  Vice President'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.05s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.10s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': '6th day of April, 1999',\n",
      "        'context': '1                                                                     '\n",
      "                   'Exhibit 10.3I-on. (LOGO) www.i-on.com 561.394.9484 o '\n",
      "                   '561.394-9773 fax 1733 avenida del sol, boca raton, '\n",
      "                   'florida, 33432WEB SITE HOSTING AGREEMENTThis WEB SITE '\n",
      "                   'HOSTING AGREEMENT (\"this Agreement\") is entered into this '\n",
      "                   '6th day of April, 1999 by and between Centrack '\n",
      "                   'International, a Florida corporation (\"the Customer\"), and '\n",
      "                   'i-on interactive, a Florida corporation '\n",
      "                   '(\"i-on\").DEFINITIONSAs used in this Agreement, the term '\n",
      "                   '\"Web site\" shall mean a computer system intended to be '\n",
      "                   'accessed through the World Wide Web segment of the '\n",
      "                   'Internet, including software and content intended to be '\n",
      "                   'viewed and/or operated upon by persons accessing the '\n",
      "                   'computer system via the Internet. A Web site may exist on '\n",
      "                   'a single computer system with other Web sites.The term '\n",
      "                   '\"Hosted Site\" shall mean the Web site of the Customer that '\n",
      "                   'is hosted by i-on under the terms and conditions of this '\n",
      "                   'Agreement.The term \"Hosting Computer\" shall mean the '\n",
      "                   'computer system and related equipment on which the Hosted '\n",
      "                   'Site exists.SERVICES PROVIDED TO THE CUSTOMERi-on will '\n",
      "                   'maintain the operation of the Hosted Site continuously, '\n",
      "                   'twenty-four (24) hours per day, seven (7) days per week, '\n",
      "                   'including holidays, with the exception of reasonable '\n",
      "                   'hardware and software maintenance that must be performed '\n",
      "                   'on the Hosting Computer and/or the Hosted Site. i-on will '\n",
      "                   'use best efforts to schedule and perform such maintenance '\n",
      "                   'between the hours of 8pm and 8am Eastern Standard Time on '\n",
      "                   'weekd'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.17s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'The term of this Agreement for the Hosted Site shall '\n",
      "                  'commence upon April 1, 1999 and shall continue for a period '\n",
      "                  'of six (6) months, unless earlier terminated in accordance '\n",
      "                  'with provisions hereof.',\n",
      "        'context': \"h any of i-on'sservices, any information that is, in \"\n",
      "                   \"i-on's sole discretion, unlawful, obscene, threatening, \"\n",
      "                   'abusive, libelous, or harmful, or encourages conduct that '\n",
      "                   'would constitute a criminal offense, give rise to civil '\n",
      "                   'liability, or otherwise violate any local, state, '\n",
      "                   'national, or International law.The Customer expressly '\n",
      "                   \"agrees to use all of i-on's services only for lawful \"\n",
      "                   'purposes. Transmission or storage of any information, '\n",
      "                   'data, or material in violation of United States or state '\n",
      "                   'regulation or law is prohibited, including but not limited '\n",
      "                   'to, material protected by copyright, trademark, trade '\n",
      "                   'secret, or any other statute.TERM AND TERMINATIONThe term '\n",
      "                   'of this Agreement for the Hosted Site shall commence upon '\n",
      "                   'April 1, 1999 and shall continue for a period of six (6) '\n",
      "                   'months, unless earlier terminated in accordance with '\n",
      "                   'provisions hereof. This Agreement shall automatically be '\n",
      "                   'renewed for one (1) or more one (1) month periods unless '\n",
      "                   'either the Customer or i-on gives notice to the other '\n",
      "                   'party of its intention not to renew the4 Agreement, which '\n",
      "                   'notice must be given not less than fifteen (15) days '\n",
      "                   'before the end of the respective initial or renewal '\n",
      "                   'term.Either party may terminate this Agreement without '\n",
      "                   \"cause at any time effective upon thirty (30) days' written \"\n",
      "                   'notice. Notwithstanding anything to the contrary contained '\n",
      "                   'in this Agreement, no termination of this Agreement for '\n",
      "                   'any reason whatsoever shall relieve the Customer of the '\n",
      "                   'obligation to pay all amounts due to i-on and to make '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.32s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement shall automatically be renewed for one (1) '\n",
      "                  'or more one (1) month periods unless either the Customer or '\n",
      "                  'i-on gives notice to the other party of its intention not '\n",
      "                  'to renew the4 Agreement, which notice must be given not '\n",
      "                  'less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'y local, state, national, or International law.The '\n",
      "                   \"Customer expressly agrees to use all of i-on's services \"\n",
      "                   'only for lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to \"}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.31s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.25s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'This Agreement was entered into in the State of Florida, '\n",
      "                  'and its validity, construction, interpretation, and legal '\n",
      "                  'effect shall be governed by the laws and judicial decisions '\n",
      "                  'of the State of Florida applicable to contracts entered '\n",
      "                  'into and performed entirely within the State of Florida.',\n",
      "        'context': ' the name of the other party or to bind such other party '\n",
      "                   'in any manner.No waiver of any provision of this Agreement '\n",
      "                   'or any rights or obligations of either party hereunder '\n",
      "                   'shall be effective, except pursuant to a written '\n",
      "                   'instrument signed by the party or parties waiving '\n",
      "                   'compliance, and any such waiver shall be effective only in '\n",
      "                   'the specific instance and for the specific purpose stated '\n",
      "                   'in such writing.In the event that any provision hereof is '\n",
      "                   'found invalid or unenforceable pursuant to judicial decree '\n",
      "                   'or decision, the remainder of this Agreement shall remain '\n",
      "                   'valid and enforceable according to its terms.This '\n",
      "                   'Agreement was entered into in the State of Florida, and '\n",
      "                   'its validity, construction, interpretation, and legal '\n",
      "                   'effect shall be governed by the laws and judicial '\n",
      "                   'decisions of the State of Florida applicable to contracts '\n",
      "                   'entered into and performed entirely within the State of '\n",
      "                   'Florida.Neither the Customer nor i-on shall be deemed in '\n",
      "                   'default if its performance or obligations hereunder are '\n",
      "                   'delayed or become impossible or impractical by reason of '\n",
      "                   'any act of God, war,5 fire, earthquake, labor dispute, '\n",
      "                   'sickness, accident, civil commotion, epidemic, act of '\n",
      "                   'government or government agency or offices, or any other '\n",
      "                   \"cause beyondsuch party's control.IN WITNESS WHEREOF, the \"\n",
      "                   'parties have executed this Agreement as of the date first '\n",
      "                   'set forth above.CENTRACK INTERNATIONAL, INC.            '\n",
      "                   'I-ON INTERACTIVE, INC.By: /s/ JOHN J. '\n",
      "                   'LOFQUIST                By: /s/ ANNA TALERICO    '\n",
      "                   '--------------------'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.39s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.46s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.30s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': \"i-on's liability for damages to the Customer for any cause \"\n",
      "                  'whatsoever, regardless of the form of action, and whether '\n",
      "                  'in contract or in tort, including negligence, shall be '\n",
      "                  \"limited to one (1) month's fees and the remaining portion \"\n",
      "                  'of any prepaid fees.',\n",
      "        'context': '15) days before the end of the respective initial or '\n",
      "                   'renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to the Customer for \"\n",
      "                   'any cause whatsoever, regardless of the form of action, '\n",
      "                   'and whether in contract or in tort, including negligence, '\n",
      "                   \"shall be limited to one (1) month's fees and the remaining \"\n",
      "                   'portion of any prepaid fees.INDEMNIFICATIONThe Customer '\n",
      "                   'agrees to indemnify and hold harmless i-on, against any '\n",
      "                   'lawsuits, claims, damages, or liabilities (or actions or '\n",
      "                   'proceedings in respect thereof) to which i-on may become '\n",
      "                   \"subject related to or arising out of Customer's use of \"\n",
      "                   \"i-on's services, and will reimburse i-on for all legal and \"\n",
      "                   \"other expenses, including attorney's fees, incurred in \"\n",
      "                   'connection with investigating, defending, or settling any '\n",
      "                   'such loss, claim, damage, liability, action, or proceeding '\n",
      "                   'whether or not in connection with pending or threatened '\n",
      "                   'litigation in which i-on is a party. The provisions of '\n",
      "                   'this Agreement relating to ind'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.40s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'not less than fifteen (15) days before the end of the '\n",
      "                  'respective initial or renewal term.',\n",
      "        'context': 'r lawful purposes. Transmission or storage of any '\n",
      "                   'information, data, or material in violation of United '\n",
      "                   'States or state regulation or law is prohibited, including '\n",
      "                   'but not limited to, material protected by copyright, '\n",
      "                   'trademark, trade secret, or any other statute.TERM AND '\n",
      "                   'TERMINATIONThe term of this Agreement for the Hosted Site '\n",
      "                   'shall commence upon April 1, 1999 and shall continue for a '\n",
      "                   'period of six (6) months, unless earlier terminated in '\n",
      "                   'accordance with provisions hereof. This Agreement shall '\n",
      "                   'automatically be renewed for one (1) or more one (1) month '\n",
      "                   'periods unless either the Customer or i-on gives notice to '\n",
      "                   'the other party of its intention not to renew the4 '\n",
      "                   'Agreement, which notice must be given not less than '\n",
      "                   'fifteen (15) days before the end of the respective initial '\n",
      "                   'or renewal term.Either party may terminate this Agreement '\n",
      "                   \"without cause at any time effective upon thirty (30) days' \"\n",
      "                   'written notice. Notwithstanding anything to the contrary '\n",
      "                   'contained in this Agreement, no termination of this '\n",
      "                   'Agreement for any reason whatsoever shall relieve the '\n",
      "                   'Customer of the obligation to pay all amounts due to i-on '\n",
      "                   'and to make such payments on a timely basis.LIMITATION OF '\n",
      "                   'LIABILITYi-on will not be liable under any circumstances '\n",
      "                   'for any lost profits or other consequential damages, even '\n",
      "                   'if i-on has been advised as to the possibility of such '\n",
      "                   \"damages. i-on's liability for damages to the Customer for \"\n",
      "                   'any cause whatsoever, regardless of the form of action, '\n",
      "                   'and whether in contract or in tort, inclu'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:07<00:00,  7.67s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'Either party may terminate this Agreement without cause at '\n",
      "                  \"any time effective upon thirty (30) days' written notice.\",\n",
      "        'context': ' States or state regulation or law is prohibited, '\n",
      "                   'including but not limited to, material protected by '\n",
      "                   'copyright, trademark, trade secret, or any other '\n",
      "                   'statute.TERM AND TERMINATIONThe term of this Agreement for '\n",
      "                   'the Hosted Site shall commence upon April 1, 1999 and '\n",
      "                   'shall continue for a period of six (6) months, unless '\n",
      "                   'earlier terminated in accordance with provisions hereof. '\n",
      "                   'This Agreement shall automatically be renewed for one (1) '\n",
      "                   'or more one (1) month periods unless either the Customer '\n",
      "                   'or i-on gives notice to the other party of its intention '\n",
      "                   'not to renew the4 Agreement, which notice must be given '\n",
      "                   'not less than fifteen (15) days before the end of the '\n",
      "                   'respective initial or renewal term.Either party may '\n",
      "                   'terminate this Agreement without cause at any time '\n",
      "                   \"effective upon thirty (30) days' written notice. \"\n",
      "                   'Notwithstanding anything to the contrary contained in this '\n",
      "                   'Agreement, no termination of this Agreement for any reason '\n",
      "                   'whatsoever shall relieve the Customer of the obligation to '\n",
      "                   'pay all amounts due to i-on and to make such payments on a '\n",
      "                   'timely basis.LIMITATION OF LIABILITYi-on will not be '\n",
      "                   'liable under any circumstances for any lost profits or '\n",
      "                   'other consequential damages, even if i-on has been advised '\n",
      "                   \"as to the possibility of such damages. i-on's liability \"\n",
      "                   'for damages to the Customer for any cause whatsoever, '\n",
      "                   'regardless of the form of action, and whether in contract '\n",
      "                   'or in tort, including negligence, shall be limited to one '\n",
      "                   \"(1) month's fees and the remaining portion of any prepaid \"\n",
      "                   'fees'}]\n",
      "contract3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "The tokenizer class you load from this checkpoint is not the same type as the class this function is called from. It may result in unexpected tokenization. \n",
      "The tokenizer class you load from this checkpoint is 'DPRQuestionEncoderTokenizer'. \n",
      "The class this function is called from is 'DPRContextEncoderTokenizerFast'.\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0d7960c4514b4bd48d20da5fcbef0925",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Updating embeddings:   0%|          | 0/1 [00:00<?, ? Docs/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:16<00:00, 12.78s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'CO-PROMOTION AGREEMENT',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.27s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22842, -22820) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Valeant Pharmaceuticals North America LLC, a Delaware '\n",
      "                  'limited liability company (\"Valeant\"). Dova and Valeant are '\n",
      "                  'each referred to individually as a \"Party\" and together as '\n",
      "                  'the \"Parties\".',\n",
      "        'context': '.16 Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the following mutual promises and obligations, and for '\n",
      "                   'other good and valuable consideration the adequacy and '\n",
      "                   'sufficiency of which are hereby acknowledged, the Parties '\n",
      "                   'agree as follows:CONFIDENTIAL TREATMENT HAS BE'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:22<00:00, 13.70s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:23<00:00, 13.93s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'September 26, 2018',\n",
      "        'context': 'endments. 4613.9 Headings. 4613.10 Independent '\n",
      "                   'Contractors. 4613.11 Third Party Beneficiaries. 4613.12 '\n",
      "                   'Waiver. 4613.13 Cumulative Remedies. 4613.14 Waiver of '\n",
      "                   'Rule of Construction. 4613.15 Use of Names. 4613.16 '\n",
      "                   'Further Actions and Documents. 4713.17 Certain '\n",
      "                   'Conventions. 4713.18 Counterparts. 47iiiCONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018CO-PROMOTION '\n",
      "                   'AGREEMENTThis Co-Promotion Agreement (this \"Agreement\") is '\n",
      "                   'entered into and dated as of September 26, 2018 (the '\n",
      "                   '\"Effective Date\") by and between Dova Pharmaceuticals, '\n",
      "                   'Inc., a Delaware corporation (\"Dova\"), and Valeant '\n",
      "                   'Pharmaceuticals North America LLC, a Delaware limited '\n",
      "                   'liability company (\"Valeant\"). Dova and Valeant are each '\n",
      "                   'referred to individually as a \"Party\" and together as the '\n",
      "                   '\"Parties\".RECITALSWHEREAS, Dova has developed and has '\n",
      "                   'rights to market and sell the Product (as defined below) '\n",
      "                   'in the Territory;WHEREAS, the Parties believe that it '\n",
      "                   'would be mutually beneficial to collaborate on promotional '\n",
      "                   'activities for the Product and, accordingly, Dova desires '\n",
      "                   'that Valeant conduct certain promotional activities, and '\n",
      "                   'Valeant desires to conduct such activities, for the '\n",
      "                   'Product in the Territory;NOW, THEREFORE, in consideration '\n",
      "                   'of the foll'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:27<00:00, 14.54s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended f',\n",
      "        'context': 'ccordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Ad'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:32<00:00, 15.44s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'IES AND EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS '\n",
      "                  'INC., 10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall '\n",
      "                  'mean the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § '\n",
      "                  '301 et seq., as it may be amended f',\n",
      "        'context': 'ccordingly, Dova desires that Valeant conduct certain '\n",
      "                   'promotional activities, and Valeant desires to conduct '\n",
      "                   'such activities, for the Product in the Territory;NOW, '\n",
      "                   'THEREFORE, in consideration of the following mutual '\n",
      "                   'promises and obligations, and for other good and valuable '\n",
      "                   'consideration the adequacy and sufficiency of which are '\n",
      "                   'hereby acknowledged, the Parties agree as '\n",
      "                   'follows:CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018ARTICLE 1   DEFINITIONS1.1 \"Act\" shall mean '\n",
      "                   'the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 '\n",
      "                   'et seq., as it may be amended from time to time, and the '\n",
      "                   'regulations promulgated thereunder.1.2 \"Adverse Event\" '\n",
      "                   'shall mean any untoward medical occurrence in a patient or '\n",
      "                   'clinical investigation subject who is administered the '\n",
      "                   'Product, but which does not necessarily have a causal '\n",
      "                   'relationship with the treatment for which the Product is '\n",
      "                   'used. An \"Adverse Event\" can include any unfavorable and '\n",
      "                   'unintended sign (including an abnormal laboratory '\n",
      "                   'finding), symptom or disease temporally associated with '\n",
      "                   'the use of the Product, whether or not related to the '\n",
      "                   'Product. A pre-existing condition that worsened in '\n",
      "                   'severity after administration of the Product would be '\n",
      "                   'considered an \"Ad'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:31<00:00, 15.26s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28588, -28480) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'icians, generally accepted standards of good clinical '\n",
      "                  'practices adopted by current FDA regulations, as well as '\n",
      "                  'any state laws and regulations (i) impacting the promotion '\n",
      "                  'of pharmaceutical products, (ii) governing the provision of '\n",
      "                  'meals',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:32<00:00, 15.34s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13683, -13613) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6773, -6703) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'ments, interest), together with all documented out-of- '\n",
      "                  \"pocket costs and expenses, including attorney's fees, \"\n",
      "                  'reasonably incurred.1.40 \"Net Sales\" shall mean, for an '\n",
      "                  'applicable period, the aggregate amount, without '\n",
      "                  'duplication, equal to the Specialty Pharmacy Net Sales for '\n",
      "                  'each SKU, the Retail Net Sales for each SKU, if any, and '\n",
      "                  'the Non-Retail Net Sales f',\n",
      "        'context': '\" shall have the meaning set forth in Section 3.1.1.38 '\n",
      "                   '\"Know-How\" shall mean information, whether or not in '\n",
      "                   'written form, including biological, chemical, '\n",
      "                   'pharmacological, toxicological, medical or clinical, '\n",
      "                   'analytical, quality, manufacturing, research, or sales and '\n",
      "                   'marketing information, including processes, methods, '\n",
      "                   'procedures, techniques, plans, programs and data.1.39 '\n",
      "                   '\"Losses\" shall mean any and all amounts paid or payable to '\n",
      "                   'Third Parties with respect to a Claim (including any and '\n",
      "                   'all losses, damages, obligations, liabilities, fines, '\n",
      "                   'fees, penalties, awards, judgments, interest), together '\n",
      "                   'with all documented out-of- pocket costs and expenses, '\n",
      "                   'including attorney\\'s fees, reasonably incurred.1.40 \"Net '\n",
      "                   'Sales\" shall mean, for an applicable period, the aggregate '\n",
      "                   'amount, without duplication, equal to the Specialty '\n",
      "                   'Pharmacy Net Sales for each SKU, the Retail Net Sales for '\n",
      "                   'each SKU, if any, and the Non-Retail Net Sales for each '\n",
      "                   'SKU.1.41 \"Non-Retail Institution\" shall mean any '\n",
      "                   'institution (other than the Specialty Pharmacies, Retail '\n",
      "                   'Pharmacies and Intermediaries) to which Dova (or its '\n",
      "                   'Affiliates or its Intermediaries) sells and/or ships units '\n",
      "                   'of Product during the Term, which shall include group '\n",
      "                   'purchasing organizations (GPOs), hospitals, clinics, long '\n",
      "                   'term care facilities and any outlets that are a member of '\n",
      "                   'an Integrated Delivery Network (IDN), and with which Dova '\n",
      "                   'or its Affiliates do not have data agreements which '\n",
      "                   'enables Dova to track shipments of Product from such '\n",
      "                   'institution t'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:30<00:00, 15.02s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28588, -28480) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'icians, generally accepted standards of good clinical '\n",
      "                  'practices adopted by current FDA regulations, as well as '\n",
      "                  'any state laws and regulations (i) impacting the promotion '\n",
      "                  'of pharmaceutical products, (ii) governing the provision of '\n",
      "                  'meals',\n",
      "        'context': 'pplicable, the Act, the Generic Drug Enforcement Act of '\n",
      "                   '1992 (21 U.S.C. § 335a et seq.), the Anti- Kickback '\n",
      "                   'Statute (42 U.S.C. § 1320a-7b et seq.), the Health '\n",
      "                   'Insurance Portability and Accountability Act of 1996, the '\n",
      "                   'Federal False Claims Act (31 U.S.C. §§ 3729-3733) (and '\n",
      "                   'applicable state false claims acts), the Physician '\n",
      "                   'Payments Sunshine Act, the Code, the Department of Health '\n",
      "                   'and Human Services Office of Inspector General Compliance '\n",
      "                   'Program Guidance for Pharmaceutical Manufacturers, '\n",
      "                   'released April 2003, the Antifraud and Abuse Amendment to '\n",
      "                   'the Social Security Act, the American Medical Association '\n",
      "                   'guidelines on gifts to physicians, generally accepted '\n",
      "                   'standards of good clinical practices adopted by current '\n",
      "                   'FDA regulations, as well as any state laws and regulations '\n",
      "                   '(i) impacting the promotion of pharmaceutical products, '\n",
      "                   '(ii) governing the provision of meals and other gifts to '\n",
      "                   'medical professionals, including pharmacists, or (iii) '\n",
      "                   'governing consumer2CONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                   'REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED '\n",
      "                   'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018protection and '\n",
      "                   'deceptive trade practices, including any state '\n",
      "                   'anti-kickback/fraud and abuse related laws, all as amended '\n",
      "                   'from time to time.1.8 \"Business Day\" means each day of the '\n",
      "                   'week, excluding'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:28<00:00, 14.78s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-27976, -27891) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-13288, -13116) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'l of the terms and conditions hereof in all respects and '\n",
      "                  'shall assume all obligations',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:30<00:00, 15.01s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-8074, -7659) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-20465, -20209) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'ugs to the FDA. Visit www.fda.gov/medwatch or call 1-800- '\n",
      "                  'FDA-1088.CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                  'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE '\n",
      "                  'INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS '\n",
      "                  'ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT '\n",
      "                  'HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE '\n",
      "                  'COMMISSION.Source: DOVA PHARMACEUTICALS INC., 10-Q, '\n",
      "                  '11/8/2018For p',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:31<00:00, 15.20s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-6806, -6437) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-15781, -15555) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'licensed, developed, and marketed innovative products to '\n",
      "                  \"improve patients' lives and arm health care providers with \"\n",
      "                  'life-changing solutions for many chronic and debilitating '\n",
      "                  'conditions. Salix currently markets its product line to '\n",
      "                  'U.S. health care providers through an expanded sales force '\n",
      "                  'that focuses on gastroenterology, hepatology, pain '\n",
      "                  'specialists, and primary care',\n",
      "        'context': 'Exhibit '\n",
      "                   '10.2______________________________________________________________________________CO-PROMOTION '\n",
      "                   'AGREEMENTby and betweenDOVA PHARMACEUTICALS, '\n",
      "                   'INC.andVALEANT PHARMACEUTICALS NORTH AMERICA LLCSeptember '\n",
      "                   '26, '\n",
      "                   '2018______________________________________________________________________________CONFIDENTIAL '\n",
      "                   'TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. '\n",
      "                   'THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF '\n",
      "                   'CONTENTSPageARTICLE 1 DEFINITIONS 1ARTICLE 2 RIGHTS AND '\n",
      "                   'OBLIGATIONS 82.1 Engagement; Grant of Rights. 82.2 '\n",
      "                   'Retention of Rights. 92.3 Non-Competition; '\n",
      "                   'Non-Solicitation. 92.4 Dova Trademarks and Copyrights. '\n",
      "                   '10ARTICLE 3 JOINT STEERING COMMITTEE 113.1 Formation of '\n",
      "                   'the JSC. 113.2 Meetings and Minutes. 113.3 Purpose of the '\n",
      "                   'JSC. 113.4 Decision Making. 133.5 Marketing Sub-Committee. '\n",
      "                   '13ARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 144.1 '\n",
      "                   'Valeant Activities. 144.2 Detailing. 154.3 Compliance with '\n",
      "                   'Applicable Law. 174.4 Field Force Personnel Training; '\n",
      "                   'Product Materials. 194.5 Provisions Related to Field Force '\n",
      "                   'Personnel. 214.6 Responsibility for Valeant Activity Costs '\n",
      "                   'and Expenses. 224.7 Data Sharing. 22ARTICLE 5 REGULATORY, '\n",
      "                   'SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 235.1 Dova '\n",
      "                   'Responsibility. 235.2 Valeant Involvement. 235.3 '\n",
      "                   'Inspections. 235.4 Pharmacovigil'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:30<00:00, 15.02s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'ive Remedies. 4613.14 Waiver of Rule of Construction. '\n",
      "                  '4613.15 Use of Names. 4613.16 Further Actions and '\n",
      "                  'Documents. 4713.17 Certain Conventions. 4713.18 '\n",
      "                  'Counterparts. 47iiiCONFIDENTIAL TREATMENT HAS BEEN '\n",
      "                  'REQUESTED FOR PORTIONS OF',\n",
      "        'context': 'HEREWITH OMITS THE INFORMATION SUBJECT TO A '\n",
      "                   'CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A '\n",
      "                   'COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY '\n",
      "                   'WITH THE SECURITIES AND EXCHANGE COMMISSION.Source: DOVA '\n",
      "                   'PHARMACEUTICALS INC., 10-Q, 11/8/2018TABLE OF CONTENTS '\n",
      "                   '(continued)12.6 Survival. 43ARTICLE 13 MISCELLANEOUS '\n",
      "                   '4313.1 Force Majeure. 4313.2 Assignment. 4313.3 '\n",
      "                   'Severability. 4413.4 Notices. 4413.5 Governing Law. 4513.6 '\n",
      "                   'Dispute Resolution. 4513.7 Waiver of Jury Trial. 4513.8 '\n",
      "                   'Entire Agreement; Amendments. 4613.9 Headings. 4613.10 '\n",
      "                   'Independent Contractors. 4613.11 Third Party '\n",
      "                   'Beneficiaries. 4613.12 Waiver. 4613.13 Cumulative '\n",
      "                   'Remedies. 4613.14 Waiver of Rule of Construction. 4613.15 '\n",
      "                   'Use of Names. 4613.16 Further Actions and Documents. '\n",
      "                   '4713.17 Certain Conventions. 4713.18 Counterparts. '\n",
      "                   '47iiiCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR '\n",
      "                   'PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS '\n",
      "                   'THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. '\n",
      "                   'OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS '\n",
      "                   'EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND '\n",
      "                   'EXCHANGE COMMISSION.Source: DOVA PHARMACEUTICALS INC., '\n",
      "                   '10-Q, 11/8/2018CO-PROMOTION AGREEMENTThis Co-Promotion '\n",
      "                   'Agreement (this \"Agreement\") is entered into and dated as '\n",
      "                   'of September 26, 2018 (the \"Effective Date\") by and '\n",
      "                   'between Dova Pharmaceuticals, Inc., a Delaware corporation '\n",
      "                   '(\"Dova\"), and Valeant Pharmaceuticals North America LLC, a '\n",
      "                   'Delaware limited liability company (\"Valeant\"). Dova and '\n",
      "                   'Valeant are each referred'}]\n",
      "contract4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "The tokenizer class you load from this checkpoint is not the same type as the class this function is called from. It may result in unexpected tokenization. \n",
      "The tokenizer class you load from this checkpoint is 'DPRQuestionEncoderTokenizer'. \n",
      "The class this function is called from is 'DPRContextEncoderTokenizerFast'.\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1975472ea7dd4c1aa6c1776a66a5e29f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Updating embeddings:   0%|          | 0/1 [00:00<?, ? Docs/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:18<00:00, 13.01s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'processing specifications, sales and marketing  materials '\n",
      "                  'and technology relatin',\n",
      "        'context': 'ng price of Product;\"PPI Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'otherwise created during the Term by  PPI or any of its '\n",
      "                   'Affiliates;   -10-\"PPI IP\"   Means the Copyrights, PPI '\n",
      "                   \"Know-How, PPI Patents and PPI Improvements; and PPI's \"\n",
      "                   'interest in Joint  Improvements;\"PPI Know-How\"Means all '\n",
      "                   'information, procedures, instructions, techniques, data, '\n",
      "                   'technical information, knowledge and  experience '\n",
      "                   '(including, without limitation, toxicological, '\n",
      "                   'pharmaceutical, clinical, non-clinical and medical data,  '\n",
      "                   'health registration data and marketing data), designs, '\n",
      "                   'dossiers (including, without limitation, manufacturing  '\n",
      "                   'assay and quality control dossiers) manufacturing '\n",
      "                   'formulae, processing specifications, sales and marketing  '\n",
      "                   'materials and technology relating to the Product;\"PPI '\n",
      "                   'Patents\"Means those patents set out in Schedule I which '\n",
      "                   'cover the Products and such other patents as PPI may '\n",
      "                   'include  from time to time, including additions, '\n",
      "                   'divisions, confirmations, continuations-in-part, '\n",
      "                   'substitutions, re-issues,  re-examinations, extensions, '\n",
      "                   'registrations, patent terms extensions, supplementary '\n",
      "                   'protection certificates and  renewals of any of the above '\n",
      "                   'or any other patents owned or licensed by PPI subsequent '\n",
      "                   'to the Effective Date  which cover the Products or any '\n",
      "                   'Improvements;   -11-\"Product(s)\"Means: (i) DepoDur '\n",
      "                   'Injectible Liposomal Epidural [**] mg/ml [**]; (ii) '\n",
      "                   'DepoDur Injectible Liposomal Epidural  [**] mg/[**] ml '\n",
      "                   '[**]; (iii) such other presentations and do'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:21<00:00, 13.60s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'mprov',\n",
      "        'context': 'any acts, events, non-happenings, omissions or accidents '\n",
      "                   'beyond the  reasonable control of the Party to perform and '\n",
      "                   'in particular but without limiting the generality thereof '\n",
      "                   'shall  include strikes and labor disturbances, lock-outs, '\n",
      "                   'industrial action, civil commotion, riot, invasion, war, '\n",
      "                   'threat of  or preparation for war, terrorist activity, '\n",
      "                   'fire, explosion, storm, flood, earthquake, subsidence, '\n",
      "                   'epidemic or other  natural physical disaster, '\n",
      "                   'impossibility of the use of railways, shipping, aircraft, '\n",
      "                   'motor transport, or other means  of public or private '\n",
      "                   'transport, failure or suspension of utilities, '\n",
      "                   'unavailability, shortage or interruption in the  supply of '\n",
      "                   'raw material, and political interference with the normal '\n",
      "                   'operation of either Party;\"Improvements\"Means any '\n",
      "                   'discovery, development, improvement, know-how or patent '\n",
      "                   'relating to the Product generated,  conceived, reduced to '\n",
      "                   'practice or otherwise created during the Term by PPI or '\n",
      "                   'EKR (or any Affiliate of PPI or  EKR);\"Joint '\n",
      "                   'Improvements\"   Means any Improvements generated, '\n",
      "                   'conceived, reduced to practice or other created jointly by '\n",
      "                   'EKR and PPI or  their Affiliates.\"Known In-Channel  '\n",
      "                   'Product Units\"   Shall have the meaning set forth in '\n",
      "                   'Section 3.19 hereof;   -8-\"Marketing Authorization\"Means '\n",
      "                   'the new drug application (\"NDA\") and all other necessary '\n",
      "                   'regulatory and governmental approvals by a  Regulatory '\n",
      "                   'Authority or other governmental body required to market '\n",
      "                   'and sell the Product in any country of the  Territory, '\n",
      "                   'including, but not li'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.29s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9915, -9902) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ct in a country',\n",
      "        'context': 'ct\") and the Controlled Substances  Act, as amended (21 '\n",
      "                   'U.S.C. §801 et seq.), or as defined in attendant '\n",
      "                   'regulations promulgated under authorities  granted by the '\n",
      "                   'FD&C Act, together with any equivalent laws, rules, '\n",
      "                   'regulations, codes or guidelines having  effect in any '\n",
      "                   'jurisdiction in the Territory;\"Calendar Year\"    Shall '\n",
      "                   'mean the period of twelve months commencing on 1st January '\n",
      "                   'in any year, and each consecutive period  of twelve months '\n",
      "                   'thereafter during the Term;\"cGMP\"    Means Current Good '\n",
      "                   'Manufacturing Practices pursuant to 21 CFR Parts 210 and '\n",
      "                   '211, as may be amended from  time to time;\"Commercial '\n",
      "                   'Launch\"Shall mean the date of the first arm\\'s length sale '\n",
      "                   'by EKR to an unaffiliated Third Party customer for '\n",
      "                   'commercial  use of Product in a country within the '\n",
      "                   'Territory following the grant of Marketing Authorization '\n",
      "                   'and any  necessary pricing approval in that '\n",
      "                   'country;\"Commercialization  Committee\"   Shall mean the '\n",
      "                   'committee to be set up under the terms of Article 5;   '\n",
      "                   '-4-\"Competing Product\"Means any [**] ([**] hours) [**] '\n",
      "                   'preparation (other than the Product) available in a '\n",
      "                   'country in the Territory  which competes or would compete '\n",
      "                   'directly with the Product. For the avoidance of doubt, the '\n",
      "                   'definition of  \"Competing Product\" does not include '\n",
      "                   'Depobupivacaine or any improvement thereto;\"Confidential '\n",
      "                   'Information\"Means all confidential information, data and '\n",
      "                   'materials in whatever form disclosed by or on behalf of '\n",
      "                   'one Party  or its Affiliates to the other Party or its '\n",
      "                   'Affiliates includ'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:23<00:00, 13.85s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-9915, -9902) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'ct in a country',\n",
      "        'context': 'ct\") and the Controlled Substances  Act, as amended (21 '\n",
      "                   'U.S.C. §801 et seq.), or as defined in attendant '\n",
      "                   'regulations promulgated under authorities  granted by the '\n",
      "                   'FD&C Act, together with any equivalent laws, rules, '\n",
      "                   'regulations, codes or guidelines having  effect in any '\n",
      "                   'jurisdiction in the Territory;\"Calendar Year\"    Shall '\n",
      "                   'mean the period of twelve months commencing on 1st January '\n",
      "                   'in any year, and each consecutive period  of twelve months '\n",
      "                   'thereafter during the Term;\"cGMP\"    Means Current Good '\n",
      "                   'Manufacturing Practices pursuant to 21 CFR Parts 210 and '\n",
      "                   '211, as may be amended from  time to time;\"Commercial '\n",
      "                   'Launch\"Shall mean the date of the first arm\\'s length sale '\n",
      "                   'by EKR to an unaffiliated Third Party customer for '\n",
      "                   'commercial  use of Product in a country within the '\n",
      "                   'Territory following the grant of Marketing Authorization '\n",
      "                   'and any  necessary pricing approval in that '\n",
      "                   'country;\"Commercialization  Committee\"   Shall mean the '\n",
      "                   'committee to be set up under the terms of Article 5;   '\n",
      "                   '-4-\"Competing Product\"Means any [**] ([**] hours) [**] '\n",
      "                   'preparation (other than the Product) available in a '\n",
      "                   'country in the Territory  which competes or would compete '\n",
      "                   'directly with the Product. For the avoidance of doubt, the '\n",
      "                   'definition of  \"Competing Product\" does not include '\n",
      "                   'Depobupivacaine or any improvement thereto;\"Confidential '\n",
      "                   'Information\"Means all confidential information, data and '\n",
      "                   'materials in whatever form disclosed by or on behalf of '\n",
      "                   'one Party  or its Affiliates to the other Party or its '\n",
      "                   'Affiliates includ'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:21<00:00, 13.59s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'its own cost and expense take all actions necessary to '\n",
      "                  'comply with all Applicable Laws and  obtain and maintain '\n",
      "                  'all necessary license, permits, records and authorizations '\n",
      "                  'PPI is required to obtain and maintain hereunder so as to  '\n",
      "                  'enable PPI to perform its obligations hereunder and under '\n",
      "                  'the Supply Agreement so as to enable EKR to fully exercise '\n",
      "                  'the Distribution  Rights.   3.18 Assignment of ICS '\n",
      "                  'Agreement. The Part',\n",
      "        'context': ' enable EKR to  fully exploit the Distribution Rights '\n",
      "                   'granted hereunder. For purpose of this Section, the '\n",
      "                   'contact person for each of the parties is set forth  '\n",
      "                   'below.3.15 Reserved.   3.16 Recalls and PostMarket '\n",
      "                   'Notifications. All costs of safety alerts and all other '\n",
      "                   'forms of notifications regarding safety risks associated '\n",
      "                   'with the Products in the United States shall be borne by '\n",
      "                   'PPI to the extent arising prior to the Agreement Date and '\n",
      "                   'by EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of '}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:20<00:00, 13.38s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'The Lease Term shall automatically renew at the end of each '\n",
      "                  'calendar quarter of  the Lease Term.',\n",
      "        'context': 'n principal amount of [**]  Dollars ($[**]), such note to '\n",
      "                   'be substantially in the form attached hereto as Exhibit '\n",
      "                   '3.20(b) (the \"Promissory Note\").  (c) Commencing as of the '\n",
      "                   'Agreement Date, EKR agrees to lease the Transferred '\n",
      "                   'Equipment to PPI through the end of the then-current  '\n",
      "                   'calendar quarter and, subject to renewal as provided '\n",
      "                   'below, on a calendar quarter-to-calendar quarter   '\n",
      "                   '-21-basis thereafter (the \"Lease Term\"), for use solely in '\n",
      "                   \"connection with the (i) performance of PPI's obligations \"\n",
      "                   'under the Supply  Agreement, (ii) the supply of Products '\n",
      "                   \"to PPI's other licensees and collaborators and (iii) the \"\n",
      "                   \"supply of placebo for PPI's Exparel  product to PPI's \"\n",
      "                   'other licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; '}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:20<00:00, 13.48s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-31070, -30531) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 't described in Section 17.5 below.(d) At any time between '\n",
      "                  'the Agreement Date and July 1, 2015, EKR shall have the',\n",
      "        'context': 'r and, subject to renewal as provided below, on a calendar '\n",
      "                   'quarter-to-calendar quarter   -21-basis thereafter (the '\n",
      "                   '\"Lease Term\"), for use solely in connection with the (i) '\n",
      "                   \"performance of PPI's obligations under the Supply  \"\n",
      "                   \"Agreement, (ii) the supply of Products to PPI's other \"\n",
      "                   'licensees and collaborators and (iii) the supply of '\n",
      "                   \"placebo for PPI's Exparel  product to PPI's other \"\n",
      "                   'licensees and collaborators. The Lease Term shall '\n",
      "                   'automatically renew at the end of each calendar quarter '\n",
      "                   'of  the Lease Term. The Lease Term will automatically '\n",
      "                   'terminate immediately upon (i) any termination or '\n",
      "                   'expiration of this Agreement  and/or the Supply Agreement '\n",
      "                   'or (ii) any exercise by EKR of the Step-in Right described '\n",
      "                   'in Section 17.5 below.(d) At any time between the '\n",
      "                   'Agreement Date and July 1, 2015, EKR shall have the right, '\n",
      "                   'exercisable upon sixty (60) days prior written  notice to '\n",
      "                   'PPI, to terminate the Lease Term and sell the Transferred '\n",
      "                   'Equipment back to PPI, subject to payment by PPI to EKR '\n",
      "                   'within  five (5) days of such notice of $[**] in cash, '\n",
      "                   'which if exercised shall result in (i) an offset against '\n",
      "                   'the unpaid balance of principal and  interest under the '\n",
      "                   'Promissory Note pursuant to Section 3.20(f) below; and '\n",
      "                   '(ii) the termination of the Step-in Right described in  '\n",
      "                   'Section 17.5.(e) At any time after July 1, 2015, PPI shall '\n",
      "                   'have the right, exercisable upon sixty (60) days prior '\n",
      "                   'written notice to EKR, to terminate the Lease Term and '\n",
      "                   'repurchase the Transferred Equipment from EKR, subject to '\n",
      "                   'payment'}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.19s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-14412, -14055) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': '(including, but not limited to, any license or other rights '\n",
      "                  'of PPI or any of its Affiliates, whether as a licensor,  '\n",
      "                  'licensee or otherwise relation to any of the fore',\n",
      "        'context': ' in relation to any Party or an Affiliate the possession '\n",
      "                   'directly or indirectly, of the power to direct or  cause '\n",
      "                   'the direction of the management and policies of such firm, '\n",
      "                   'person or entity, by contract or otherwise, or  the '\n",
      "                   'ownership either directly or indirectly of 50% or more of '\n",
      "                   'the voting securities of such Party;\"Copyrights\"Means (i) '\n",
      "                   'the copyright registrations and applications for '\n",
      "                   'registration identified on Schedule III, (ii) works of  '\n",
      "                   'authorship whether or not copyrightable and (iii) any '\n",
      "                   'other copyrights and works, together with all common law  '\n",
      "                   'rights, used or held for use by PPI or any of its '\n",
      "                   'Affiliates in connection with the Products in the '\n",
      "                   'Territory  (including, but not limited to, any license or '\n",
      "                   'other rights of PPI or any of its Affiliates, whether as a '\n",
      "                   'licensor,  licensee or otherwise relation to any of the '\n",
      "                   'foregoing);\"Current Base Price\"    Means the Product\\'s '\n",
      "                   'current (as of the Effective Date) net average selling '\n",
      "                   'price of $[**] ([**] mg) and $[**]  ([**] mg);\"DEA\"    '\n",
      "                   'Shall mean the United States Drug Enforcement '\n",
      "                   'Administration and any successor thereto performing '\n",
      "                   'similar  functions;\"Distribution Rights\"   Shall have the '\n",
      "                   'meaning set forth in Section 2.1 hereof;\"Domain Name\"    '\n",
      "                   'Shall mean Depodur.com and any other domain names owned or '\n",
      "                   'licensed by PPI related to the Product set forth  on '\n",
      "                   'Schedule IV hereto;   -6-\"EKR Improvement\"   Means any '\n",
      "                   'Improvement generated, conceived, reduced to practice or '\n",
      "                   'other created during the Term by EKR or  any of its '\n",
      "                   'Affiliates.Endo'}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.18s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-28124, -27557) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24013, -23763) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': \"ment, PPI has   -19-assigned to EKR all of PPI's right, \"\n",
      "                  'title and interest under that certain Commercial '\n",
      "                  'Outsourcing Services Agreement between PPI (f/k/a  '\n",
      "                  'SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                  'Solutions, Inc. (\"ICS\")  dated',\n",
      "        'context': 'y EKR to the extent arising  after the Agreement Date.   '\n",
      "                   '3.17 Compliance. During the Term PPI shall at its own cost '\n",
      "                   'and expense take all actions necessary to comply with all '\n",
      "                   'Applicable Laws and  obtain and maintain all necessary '\n",
      "                   'license, permits, records and authorizations PPI is '\n",
      "                   'required to obtain and maintain hereunder so as to  enable '\n",
      "                   'PPI to perform its obligations hereunder and under the '\n",
      "                   'Supply Agreement so as to enable EKR to fully exercise the '\n",
      "                   'Distribution  Rights.   3.18 Assignment of ICS Agreement. '\n",
      "                   'The Parties acknowledge that effective upon the '\n",
      "                   'termination or expiration of the Transition Services and '\n",
      "                   'Inventory Agreement, PPI has   -19-assigned to EKR all of '\n",
      "                   \"PPI's right, title and interest under that certain \"\n",
      "                   'Commercial Outsourcing Services Agreement between PPI '\n",
      "                   '(f/k/a  SkyePharma, Inc.) and Integrated Commercialization '\n",
      "                   'Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS '\n",
      "                   'Agreement\"), and EKR has  assumed all obligations and '\n",
      "                   'liabilities under the ICS Agreement arising after the '\n",
      "                   'Effective Date. The Parties further acknowledge that as '\n",
      "                   'of  the Effective Date, the Parties have entered into an '\n",
      "                   'Assignment and Assumption Agreement to further evidence '\n",
      "                   'the foregoing assignment  and assumption of the ICS '\n",
      "                   'Agreement.   3.19 Product in Channel. All sales of Product '\n",
      "                   'conducted by PPI and its distributors and wholesalers '\n",
      "                   '(and, to the knowledge of PPI, by Endo Pharmaceuticals and '\n",
      "                   'its distributors and wholesalers) during the six month '\n",
      "                   'period prior to the Effective Date have been condu'}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:20<00:00, 13.38s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-1498, -1241) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-191, -11) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-19849, -19217) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'nment for the benefit of creditors;      -86-$900,000   '\n",
      "                  'October  , 2009(c) A receiver is appointed for the assets '\n",
      "                  'of Maker upon request by any Person(s) other than Maker, or '\n",
      "                  'Maker makes a formal  request for appointment of a '\n",
      "                  'receiver; or   (d) Any proceedin',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:19<00:00, 13.31s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24858, -24517) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24858, -24611) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': \"[**]   [**][**] Attorneys'  Ref:   Country   Application  \"\n",
      "                  'date   Application  no.   Patent/  Publication no.   Grant '\n",
      "                  'date   Expiry date   Status  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   '\n",
      "                  '[**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [*',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:20<00:00, 13.35s/ Batches]\n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-29016, -28733) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-30125, -29908) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-22284, -21925) with a span answer. \n",
      "ERROR:haystack.modeling.model.predictions:Invalid end offset: \n",
      "(-24743, -24088) with a span answer. \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'fect. It is agreed that:  (a) no Party has entered into '\n",
      "                  'this Agreement in reliance upon any representation, '\n",
      "                  'warranty or undertaking of the other Party  which is not '\n",
      "                  'expressly set out in this Agreement;   -64-  (b) no Party '\n",
      "                  'shall have any remedy in respect of misrepresentation or '\n",
      "                  'unt',\n",
      "        'context': 'Exhibit 10.13Confidential Materials omitted and filed '\n",
      "                   'separately with the Securities and Exchange Commission. '\n",
      "                   'Asterisks denote omissions.DATED: OCTOBER 15, 2009PACIRA '\n",
      "                   'PHARMACEUTICALS, INC.andEKR THERAPEUTICS, INC.        '\n",
      "                   'AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION '\n",
      "                   'AND MARKETING AGREEMENTTHIS AMENDED AND RESTATED STRATEGIC '\n",
      "                   'LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  '\n",
      "                   '\"Agreement\") is made on October 15, 2009 (the \"Agreement '\n",
      "                   'Date\") and is effective as of the Effective Date (as '\n",
      "                   'defined below), between:   PACIRA PHARMACEUTICALS, INC. '\n",
      "                   '(F/K/A SKYEPHARMA, INC.) a company incorporated in the '\n",
      "                   'state of California whose principal place of business is '\n",
      "                   '10450 Sciences Center Drive, San Diego, California 92121 '\n",
      "                   'USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company '\n",
      "                   'incorporated in the state of Delaware whose principal '\n",
      "                   'place of business is 1545 Route 206  South, Third Floor, '\n",
      "                   'Bedminster, New Jersey 07921 (\"EKR\").RecitalsPPI owns and '\n",
      "                   'has all right title and interest in or has acquired '\n",
      "                   'exclusive rights to the PPI IP (as defined below), the '\n",
      "                   'Trademark (as  defined below) and the Product (as defined '\n",
      "                   'below).EKR has, among other things, specialized knowledge '\n",
      "                   'and expertise in relation to the marketing and sale of '\n",
      "                   'pharmaceutical products.Pursuant to that certain Strategic '\n",
      "                   'Licensing, Distribution and Marketing Agreement between '\n",
      "                   'EKR and PPI dated as of August 10, 2007  (the \"Original '\n",
      "                   'Agreement\"), PPI granted and EKR acquired the exclusive '\n",
      "                   'right and license to sell, offer to sell, distr'}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 6/6 [01:26<00:00, 14.49s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'bination with the Trademarks.   2.3 Grant of Trademark '\n",
      "                  'Rights. PPI hereby grants to EKR a royalty free and '\n",
      "                  'exclusive license (with the right to sublicense) to use '\n",
      "                  'the  Trademarks in the Territory solely in conn',\n",
      "        'context': 'ouse the Products (the \"Distribution Rights\") in the Field '\n",
      "                   'in the Territory during the Term, as  well as to make or '\n",
      "                   'have made the Products anywhere in the world for import or '\n",
      "                   'sale in the Field in the Territory in each case, under the '\n",
      "                   'PPI  IP provided that PPI retains all rights necessary to '\n",
      "                   'manufacture and supply the Products to EKR in accordance '\n",
      "                   'with this Agreement and the  Supply Agreement. Such grant '\n",
      "                   'by PPI shall include the right of EKR to market the '\n",
      "                   'Product in the Territory during the Term as an EKR  '\n",
      "                   \"product using in addition to the Trademarks, EKR's own \"\n",
      "                   'trademarks, trade dress, trade names and other proprietary '\n",
      "                   'designations in  combination with the Trademarks.   2.3 '\n",
      "                   'Grant of Trademark Rights. PPI hereby grants to EKR a '\n",
      "                   'royalty free and exclusive license (with the right to '\n",
      "                   'sublicense) to use the  Trademarks in the Territory solely '\n",
      "                   'in connection with the exercise of the Distribution Rights '\n",
      "                   'in the Territory during the Term (and thereafter  as set '\n",
      "                   'forth in Section 17.4) and EKR shall market and sell the '\n",
      "                   'Products under the Trademarks. For the avoidance of doubt, '\n",
      "                   'the term  \"exclusive\" for the   -14-purposes of Sections '\n",
      "                   '2.1, 2.2 and 2.3 means to the exclusion of all others, '\n",
      "                   'including PPI and its Affiliates, except to the extent '\n",
      "                   'necessary to  enable PPI to perform its specific '\n",
      "                   'obligations under this Agreement and the Supply Agreement. '\n",
      "                   'Notwithstanding the foregoing, nothing  contained herein '\n",
      "                   'shall prohibit PPI from utilizing the Trademarks in the '\n",
      "                   'Territory in connection with its'}]\n",
      "contract5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "The tokenizer class you load from this checkpoint is not the same type as the class this function is called from. It may result in unexpected tokenization. \n",
      "The tokenizer class you load from this checkpoint is 'DPRQuestionEncoderTokenizer'. \n",
      "The class this function is called from is 'DPRContextEncoderTokenizerFast'.\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "dd3e279d3f6a4974a827974854e84f6b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Updating embeddings:   0%|          | 0/1 [00:00<?, ? Docs/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "qs1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.07s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'ENDORSEMENT',\n",
      "        'context': 'read:We, we, Our, our, Us, us, Society. Thrivent Financial '\n",
      "                   'for Lutherans.ENTIRE CONTRACTIn the ENTIRE CONTRACT '\n",
      "                   'section, the first phrase and numbered list are amended to '\n",
      "                   'read:The Entire Contract consists of: 1) This contract '\n",
      "                   'including any attached riders, amendments, or '\n",
      "                   'endorsements; 2) The Application attached to this '\n",
      "                   'contract; and 3) The Articles of Incorporation and Bylaws '\n",
      "                   'of the Society and all amendments to them. Benefits will '\n",
      "                   'not be reduced or eliminated by any future amendments to '\n",
      "                   'our Articles of Incorporation or Bylaws.ASSIGNMENTThe '\n",
      "                   'ASSIGNMENT section is amended to include the following:You '\n",
      "                   'may transfer ownership of this contract in accordance with '\n",
      "                   'our bylaws. Society membership rights and privileges '\n",
      "                   'cannot be transferred or assigned. VB-TL-TFFL (18) page '\n",
      "                   'TL-2Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019Contract Number: ENDORSEMENT (continued)The '\n",
      "                   'following words or phrases in this contract are amended as '\n",
      "                   'follows. Any reference to: Is amended to read:Thrivent '\n",
      "                   'Life Insurance Company Thrivent Financial for Lutheransthe '\n",
      "                   'Company the Societythe company. the SocietyA Stock Life '\n",
      "                   'Insurance Company. A Fraternal Benefit Society625 Fourth '\n",
      "                   'Avenue South. 4321 North Ballard Road Minneapolis, MN '\n",
      "                   '55415 Appleton, WI 54919-0001Minneapolis, MN Appleton, '\n",
      "                   'WIHome Office. Service CenterNonparticipating Eligible for '\n",
      "                   'annual dividends Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, '\n",
      "                   '7/1/2019'}]\n",
      "qs2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.06s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'Lutheran Brotherhood Variable Insurance Products Company',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.46s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.53s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: 'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.66s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?'.\n",
      "Answers:\n",
      "[   {   'answer': 'July 1, 2019',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n",
      "qs6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.61s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.\n",
      "Answers:\n",
      "[   {   'answer': 'Society membership rights and privileges cannot be '\n",
      "                  'transferred or assigned.',\n",
      "        'context': 'ife Insurance Company.Is amended to read:We, we, Our, our, '\n",
      "                   'Us, us, Society. Thrivent Financial for Lutherans.ENTIRE '\n",
      "                   'CONTRACTIn the ENTIRE CONTRACT section, the first phrase '\n",
      "                   'and numbered list are amended to read:The Entire Contract '\n",
      "                   'consists of: 1) This contract including any attached '\n",
      "                   'riders, amendments, or endorsements; 2) The Application '\n",
      "                   'attached to this contract; and 3) The Articles of '\n",
      "                   'Incorporation and Bylaws of the Society and all amendments '\n",
      "                   'to them. Benefits will not be reduced or eliminated by any '\n",
      "                   'future amendments to our Articles of Incorporation or '\n",
      "                   'Bylaws.ASSIGNMENTThe ASSIGNMENT section is amended to '\n",
      "                   'include the following:You may transfer ownership of this '\n",
      "                   'contract in accordance with our bylaws. Society membership '\n",
      "                   'rights and privileges cannot be transferred or assigned. '\n",
      "                   'VB-TL-TFFL (18) page TL-2Source: THRIVENT VARIABLE '\n",
      "                   'INSURANCE ACCOUNT B, N-6, 7/1/2019Contract Number: '\n",
      "                   'ENDORSEMENT (continued)The following words or phrases in '\n",
      "                   'this contract are amended as follows. Any reference to: Is '\n",
      "                   'amended to read:Thrivent Life Insurance Company Thrivent '\n",
      "                   'Financial for Lutheransthe Company the Societythe company. '\n",
      "                   'the SocietyA Stock Life Insurance Company. A Fraternal '\n",
      "                   'Benefit Society625 Fourth Avenue South. 4321 North Ballard '\n",
      "                   'Road Minneapolis, MN 55415 Appleton, WI '\n",
      "                   '54919-0001Minneapolis, MN Appleton, WIHome Office. Service '\n",
      "                   'CenterNonparticipating Eligible for annual dividends '\n",
      "                   'Signed for Thrivent Financial for '\n",
      "                   'LutheransPresidentSecretary VB-TL-TFFL (18) page '\n",
      "                   'TL-3Source: THRIVENT VARIABL'}]\n",
      "qs7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.50s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.50s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'You may make the extra payment by an equivalent reduction '\n",
      "                  'in benefits or by a payment in cash.',\n",
      "        'context': 'for Lutherans.\" All benefits and other terms of this '\n",
      "                   'contract remain unchanged except as described below.You '\n",
      "                   'may direct inquiries to:Thrivent Financial for Lutherans '\n",
      "                   '4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute '}]\n",
      "qs9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.44s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.53s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'You may make the extra payment by an equivalent reduction '\n",
      "                  'in benefits or by a payment in cash.',\n",
      "        'context': 'for Lutherans.\" All benefits and other terms of this '\n",
      "                   'contract remain unchanged except as described below.You '\n",
      "                   'may direct inquiries to:Thrivent Financial for Lutherans '\n",
      "                   '4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute '}]\n",
      "qs11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.72s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.42s/ Batches]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?\n",
      "Answers:\n",
      "[   {   'answer': 'If you do not make the extra payment within 60 days from '\n",
      "                  'the date we notify you of your share of the deficiency, the '\n",
      "                  'amount will be charged as an indebtedness against the '\n",
      "                  'contract with interest compounded at the rate of 5% per '\n",
      "                  'year.',\n",
      "        'context': 's 4321 N. Ballard Road Appleton, WI 54919-0001 (800) '\n",
      "                   '847-4836The following amendments apply in lieu of any '\n",
      "                   'contract provisions to the contrary.The following '\n",
      "                   'provisions are included as part of this '\n",
      "                   'contract:MAINTENANCE OF SOLVENCY. This provision applies '\n",
      "                   'only to benefits provided through the General Account. If '\n",
      "                   'the solvency of the Society becomes impaired, you may be '\n",
      "                   'required to make an extra payment. The Board of Directors '\n",
      "                   'will determine the amount of any extra payment. It will be '\n",
      "                   \"based on each member's fair share of the deficiency. You \"\n",
      "                   'may make the extra payment by an equivalent reduction in '\n",
      "                   'benefits or by a payment in cash. If you do not make the '\n",
      "                   'extra payment within 60 days from the date we notify you '\n",
      "                   'of your share of the deficiency, the amount will be '\n",
      "                   'charged as an indebtedness against the contract with '\n",
      "                   'interest compounded at the rate of 5% per year.MEMBERSHIP. '\n",
      "                   'The person(s) named as the Insured(s) or the Annuitant(s) '\n",
      "                   'is a benefit member of the Society. Rights and privileges '\n",
      "                   'of membership are set forth in the Articles of '\n",
      "                   'Incorporation and Bylaws of the Society. These rights and '\n",
      "                   'privileges are separate from the ownership of this '\n",
      "                   'contract.DIVIDENDS. Each year, we will determine our '\n",
      "                   \"divisible surplus. This contract's share, if any, will be \"\n",
      "                   'credited as a dividend. Since we do not expect this '\n",
      "                   'contract to contribute to divisible surplus, it is not '\n",
      "                   'expected that any dividends will be credited.DIVIDEND '\n",
      "                   'OPTIONS. If dividends are credited after premiums can no '\n",
      "                   'longer be paid under '}]\n",
      "qs13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inferencing Samples: 100%|█████████████████████████████████████████████████████████| 1/1 [00:02<00:00,  2.51s/ Batches]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Query: Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?\n",
      "Answers:\n",
      "[   {   'answer': 'That includes contracts of insurance, separate accounts, '\n",
      "                  'and cash and investment securities.',\n",
      "        'context': 'ENDORSEMENTContract Number: ENDORSEMENTEffective Date: '\n",
      "                   'July 1, 2019Thrivent Life Insurance Company has been '\n",
      "                   'dissolved. (Thrivent Life Insurance Company was formerly '\n",
      "                   'known as Lutheran Brotherhood Variable Insurance Products '\n",
      "                   'Company.) All assets and related liabilities of Thrivent '\n",
      "                   'Life Insurance Company have been transferred to Thrivent '\n",
      "                   'Financial for Lutherans. That includes contracts of '\n",
      "                   'insurance, separate accounts, and cash and investment '\n",
      "                   'securities. Thrivent Financial for Lutherans now has all '\n",
      "                   'obligations under this contract. It is the same as if '\n",
      "                   'Thrivent Financial for Lutherans had originally issued the '\n",
      "                   'contract. All references to \"Thrivent Life Insurance '\n",
      "                   'Company\" are amended to read \"Thrivent Financial for '\n",
      "                   'Lutherans.\" All benefits and other terms of this contract '\n",
      "                   'remain unchanged except as described below.You may direct '\n",
      "                   'inquiries to:Thrivent Financial for Lutherans 4321 N. '\n",
      "                   'Ballard Road Appleton, WI 54919-0001 (800) 847-4836The '\n",
      "                   'following amendments apply in lieu of any contract '\n",
      "                   'provisions to the contrary.The following provisions are '\n",
      "                   'included as part of this contract:MAINTENANCE OF SOLVENCY. '\n",
      "                   'This provision applies only to benefits provided through '\n",
      "                   'the General Account. If the solvency of the Society '\n",
      "                   'becomes impaired, you may be required to make an extra '\n",
      "                   'payment. The Board of Directors will determine the amount '\n",
      "                   \"of any extra payment. It will be based on each member's \"\n",
      "                   'fair share of the deficiency. You may make the extra '\n",
      "                   'payment by an equivalent reduction in benefits or by a '\n",
      "                   'paym'}]\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "if __name__ == '__main__':\n",
    "    test8()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f5d284fd",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ML",
   "language": "python",
   "name": "ml"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
